1	S	NN	O	s	nn	2	SENT_1	[p1l159t222r217b268],
2	EVIER	NN	O	evier	_	0	SENT_1	[p1l221t245r326b268],

1	Lymphocyte	NN	O	lymphocyte	nn	2	SENT_2	[p1l157t312r493b365],
2	Counts	NNS	O	count	nsubj	8	SENT_2	[p1l516t311r712b355],
3	in	IN	O	in	_	0	SENT_2	[p1l736t312r780b354],
4	Kidney	NN	O	kidney	nn	6	SENT_2	[p1l806t312r994b365],
5	Allograft	NN	O	allograft	nn	6	SENT_2	[p1l1013t312r1250b366],
6	Recipients	NNS	O	recipient	prep_in	2	SENT_2	[p1l1274t312r1563b365],
7	Are	VBP	O	be	cop	8	SENT_2	[p1l1584t312r1679b355],
8	Associated	NNP	O	Associated	_	0	SENT_2	[p1l1699t312r2007b355],
9	With	IN	O	with	_	0	SENT_2	[p1l153t378r275b421],
10	IMPDH2	NN	O	impdh2	nn	11	SENT_2	[p1l297t378r526b421],
11	3757T	NN	O	3757t	nn	15	SENT_2	[p1l546t377r800b422],
12	>	JJR	O	>	dep	13	SENT_2	[p1l546t377r800b422],
13	C	NN	O	c	amod	15	SENT_2	[p1l546t377r800b422],
14	Gene	NN	O	gene	nn	15	SENT_2	[p1l824t377r966b422],
15	Polymorphism	NN	O	polymorphism	prep_with	8	SENT_2	[p1l991t378r1385b431],

1	J.	NNP	PERSON	J.	nn	2	SENT_3	[p1l154t490r183b522],
2	Pazik	NNP	PERSON	Pazik	_	0	SENT_3	[p1l203t490r309b527],
3	,	,	O	,	_	0	SENT_3	[p1l203t490r309b527],
4	M.	NNP	PERSON	M.	nn	5	SENT_3	[p1l329t490r370b521],
5	Oidak	NNP	PERSON	Oidak	conj_and	2	SENT_3	[p1l389t490r505b527],
6	,	,	O	,	_	0	SENT_3	[p1l389t490r505b527],
7	M.	NNP	PERSON	M.	nn	8	SENT_3	[p1l526t490r567b521],
8	Podgérska	NNP	PERSON	Podgérska	conj_and	2	SENT_3	[p1l587t490r795b530],
9	,	,	O	,	_	0	SENT_3	[p1l587t490r795b530],
10	Z.	NNP	PERSON	Z.	nn	11	SENT_3	[p1l813t490r846b521],
11	Lewandowski	NNP	PERSON	Lewandowski	conj_and	2	SENT_3	[p1l866t490r1126b527],
12	,	,	O	,	_	0	SENT_3	[p1l866t490r1126b527],
13	E.	NNP	PERSON	E.	nn	14	SENT_3	[p1l1146t490r1177b521],
14	Sitarek	NNP	PERSON	Sitarek	conj_and	2	SENT_3	[p1l1195t490r1332b527],
15	,	,	O	,	_	0	SENT_3	[p1l1195t490r1332b527],
16	R.	NNP	PERSON	R.	nn	17	SENT_3	[p1l1352t490r1386b521],
17	Pioski	NNP	PERSON	Pioski	conj_and	2	SENT_3	[p1l1406t490r1524b527],
18	,	,	O	,	_	0	SENT_3	[p1l1406t490r1524b527],
19	J.	NNP	PERSON	J.	nn	20	SENT_3	[p1l1541t490r1571b522],
20	Szmidt	NNP	PERSON	Szmidt	conj_and	2	SENT_3	[p1l1589t490r1726b527],
21	,	,	O	,	_	0	SENT_3	[p1l1589t490r1726b527],
22	A.	NNP	PERSON	A.	nn	23	SENT_3	[p1l1742t490r1778b521],
23	Chmura	NNP	PERSON	Chmura	conj_and	2	SENT_3	[p1l1797t490r1952b527],
24	,	,	O	,	_	0	SENT_3	[p1l1797t490r1952b527],
25	M.	NNP	PERSON	M.	nn	26	SENT_3	[p1l156t540r198b571],
26	Durlik	NNP	PERSON	Durlik	conj_and	2	SENT_3	[p1l218t540r330b576],
27	,	,	O	,	_	0	SENT_3	[p1l218t540r330b576],
28	and	CC	O	and	_	0	SENT_3	[p1l348t540r414b571],
29	J.	NNP	PERSON	J.	nn	30	SENT_3	[p1l432t540r461b571],
30	Malejczyk	NNP	PERSON	Malejczyk	conj_and	2	SENT_3	[p1l481t540r662b579],

1	ABSTRACT	NN	O	abstract	nsubjpass	21	SENT_4	[p1l340t678r557b710],
2	Inosine	JJ	O	inosine	amod	7	SENT_4	[p1l342t732r471b763],
3	monophosphate	NN	O	monophosphate	nn	7	SENT_4	[p1l487t732r773b773],
4	dehydrogenase	NN	O	dehydrogenase	nn	7	SENT_4	[p1l790t732r1054b772],
5	(	CD	NUMBER	(	num	7	SENT_4	[p1l1072t731r1258b773],
6	IMPDH	NN	O	impdh	nn	7	SENT_4	[p1l1072t731r1258b773],
7	)	NN	O	)	dep	1	SENT_4	[p1l1072t731r1258b773],
8	,	,	O	,	_	0	SENT_4	[p1l1072t731r1258b773],
9	the	DT	O	the	det	11	SENT_4	[p1l1275t732r1330b763],
10	rate-limiting	JJ	O	rate-limiting	amod	11	SENT_4	[p1l1346t732r1566b772],
11	enzyme	NN	O	enzyme	appos	1	SENT_4	[p1l1582t742r1715b772],
12	for	IN	O	for	_	0	SENT_4	[p1l1731t732r1782b763],
13	de	FW	O	de	nn	15	SENT_4	[p1l1798t732r1839b763],
14	novo	FW	O	novo	nn	15	SENT_4	[p1l1855t742r1940b763],
15	synthesis	NN	O	synthesis	prep_for	11	SENT_4	[p1l342t782r497b822],
16	of	IN	O	of	_	0	SENT_4	[p1l516t782r553b813],
17	guanine	NN	O	guanine	nn	18	SENT_4	[p1l568t782r708b822],
18	nucleotides	NNS	O	nucleotide	prep_of	15	SENT_4	[p1l726t782r937b819],
19	,	,	O	,	_	0	SENT_4	[p1l726t782r937b819],
20	is	VBZ	O	be	auxpass	21	SENT_4	[p1l957t782r982b813],
21	required	VBN	O	require	_	0	SENT_4	[p1l1000t782r1152b822],
22	for	IN	O	for	_	0	SENT_4	[p1l1170t782r1221b813],
23	lymphocyte	NN	O	lymphocyte	nn	24	SENT_4	[p1l1239t782r1441b822],
24	proliferation	NN	O	proliferation	prep_for	21	SENT_4	[p1l1458t782r1692b822],
25	.	.	O	.	_	0	SENT_4	[p1l1458t782r1692b822],

1	Inhibition	NN	O	inhibition	nsubj	10	SENT_5	[p1l1712t782r1888b813],
2	of	IN	O	of	_	0	SENT_5	[p1l1906t782r1943b813],
3	IMPDH	NN	O	impdh	prep_of	1	SENT_5	[p1l342t832r488b862],
4	by	IN	O	by	_	0	SENT_5	[p1l502t831r543b871],
5	mycophenolic	JJ	O	mycophenolic	amod	6	SENT_5	[p1l557t831r802b872],
6	acid	NN	O	acid	prep_by	3	SENT_5	[p1l818t831r888b862],
7	(	CD	NUMBER	(	num	9	SENT_5	[p1l905t830r1028b872],
8	MPA	NN	ORGANIZATION	mpa	nn	9	SENT_5	[p1l905t830r1028b872],
9	)	NN	O	)	dep	6	SENT_5	[p1l905t830r1028b872],
10	constitutes	VBZ	O	constitute	_	0	SENT_5	[p1l1045t831r1234b862],
11	part	NN	O	part	dobj	10	SENT_5	[p1l1249t835r1321b872],
12	of	IN	O	of	_	0	SENT_5	[p1l1336t831r1373b862],
13	an	DT	O	a	det	15	SENT_5	[p1l1386t841r1427b862],
14	immunosuppressive	JJ	O	immunosuppressive	amod	15	SENT_5	[p1l1442t831r1792b872],
15	therapy	NN	O	therapy	prep_of	11	SENT_5	[p1l1807t831r1941b872],
16	in	IN	O	in	_	0	SENT_5	[p1l341t881r374b912],
17	kidney	NN	O	kidney	nn	19	SENT_5	[p1l395t881r512b921],
18	allograft	NN	O	allograft	nn	19	SENT_5	[p1l534t881r682b921],
19	recipients	NNS	O	recipient	prep_in	15	SENT_5	[p1l703t881r883b922],
20	.	.	O	.	_	0	SENT_5	[p1l703t881r883b922],

1	The	DT	O	the	det	9	SENT_6	[p1l906t881r975b912],
2	3757T	NN	O	3757t	npadvmod	5	SENT_6	[p1l997t881r1171b912],
3	>	JJR	O	>	dep	4	SENT_6	[p1l997t881r1171b912],
4	C	NN	O	c	amod	2	SENT_6	[p1l997t881r1171b912],
5	polymorphic	JJ	O	polymorphic	amod	9	SENT_6	[p1l1191t881r1414b922],
6	variant	JJ	O	variant	amod	9	SENT_6	[p1l1433t881r1558b912],
7	(	NN	O	(	nn	9	SENT_6	[p1l1580t880r1806b922],
8	rs11706052	NN	O	rs11706052	nn	9	SENT_6	[p1l1580t880r1806b922],
9	)	NN	O	)	nsubjpass	25	SENT_6	[p1l1580t880r1806b922],
10	of	IN	O	of	_	0	SENT_6	[p1l1829t881r1866b912],
11	the	DT	O	the	det	13	SENT_6	[p1l1885t881r1940b912],
12	IMPDH2	NN	O	impdh2	nn	13	SENT_6	[p1l338t932r501b961],
13	gene	NN	O	gene	prep_of	9	SENT_6	[p1l524t941r616b971],
14	,	,	O	,	_	0	SENT_6	[p1l524t941r616b971],
15	which	WDT	O	which	nsubj	16	SENT_6	[p1l638t931r742b962],
16	encodes	VBZ	O	encode	rcmod	9	SENT_6	[p1l765t931r907b962],
17	1	CD	TIME	1	dobj	16	SENT_6	[p1l933t931r947b961],
18	of	IN	TIME	of	_	0	SENT_6	[p1l972t931r1010b962],
19	2	CD	TIME	2	num	21	SENT_6	[p1l1030t931r1049b961],
20	IMPDH	NN	O	impdh	nn	21	SENT_6	[p1l1072t932r1219b961],
21	isoenzymes	NNS	O	isoenzyme	prep_of	17	SENT_6	[p1l1242t931r1450b971],
22	,	,	O	,	_	0	SENT_6	[p1l1242t931r1450b971],
23	has	VBZ	O	have	aux	25	SENT_6	[p1l1474t931r1532b962],
24	been	VBN	O	be	auxpass	25	SENT_6	[p1l1554t931r1640b962],
25	associated	VBN	O	associate	_	0	SENT_6	[p1l1663t931r1843b962],
26	with	IN	O	with	_	0	SENT_6	[p1l1864t931r1941b962],
27	increased	VBN	O	increase	amod	29	SENT_6	[p1l341t980r509b1011],
28	IMPDH	NN	O	impdh	nn	29	SENT_6	[p1l522t981r668b1010],
29	activity	NN	O	activity	prep_with	25	SENT_6	[p1l682t980r807b1020],
30	and	CC	O	and	_	0	SENT_6	[p1l819t980r883b1011],
31	reduced	VBN	O	reduce	amod	32	SENT_6	[p1l895t980r1038b1011],
32	ability	NN	O	ability	prep_with	25	SENT_6	[p1l1052t980r1159b1020],
33	of	IN	O	of	_	0	SENT_6	[p1l1171t980r1208b1011],
34	MPA	NN	ORGANIZATION	mpa	prep_of	32	SENT_6	[p1l1219t980r1315b1010],
35	to	TO	O	to	aux	36	SENT_6	[p1l1326t984r1360b1011],
36	exert	VB	O	exert	xcomp	25	SENT_6	[p1l1374t984r1461b1011],
37	antiproliferative	JJ	O	antiproliferative	amod	38	SENT_6	[p1l1475t980r1760b1020],
38	effects	NNS	O	effect	dobj	36	SENT_6	[p1l1773t980r1884b1011],
39	on	IN	O	on	_	0	SENT_6	[p1l1897t990r1941b1011],
40	lymphocytes	NNS	O	lymphocyte	prep_on	36	SENT_6	[p1l341t1029r568b1069],
41	.	.	O	.	_	0	SENT_6	[p1l341t1029r568b1069],

1	The	DT	O	the	det	2	SENT_7	[p1l586t1029r655b1060],
2	association	NN	O	association	nsubj	17	SENT_7	[p1l673t1029r867b1060],
3	of	IN	O	of	_	0	SENT_7	[p1l884t1029r921b1060],
4	IMPDH2	NN	O	impdh2	nn	5	SENT_7	[p1l932t1030r1094b1059],
5	3757T	NN	O	3757t	prep_of	2	SENT_7	[p1l1112t1029r1285b1060],
6	>	JJR	O	>	amod	8	SENT_7	[p1l1112t1029r1285b1060],
7	C	NN	O	c	nn	8	SENT_7	[p1l1112t1029r1285b1060],
8	SNP	NN	O	snp	dep	5	SENT_7	[p1l1302t1029r1380b1060],
9	with	IN	O	with	_	0	SENT_7	[p1l1395t1029r1472b1060],
10	posttransplant	JJ	O	posttransplant	amod	11	SENT_7	[p1l1487t1029r1742b1069],
11	courses	NNS	O	course	prep_with	8	SENT_7	[p1l1758t1039r1888b1060],
12	of	IN	O	of	_	0	SENT_7	[p1l1906t1029r1943b1060],
13	kidney	NN	O	kidney	nn	15	SENT_7	[p1l341t1078r459b1118],
14	allograft	NN	O	allograft	nn	15	SENT_7	[p1l471t1078r619b1118],
15	recipients	NNS	O	recipient	prep_of	11	SENT_7	[p1l631t1078r802b1118],
16	remains	VBZ	O	remain	cop	17	SENT_7	[p1l815t1078r955b1109],
17	unclear	JJ	O	unclear	_	0	SENT_7	[p1l967t1078r1107b1109],
18	.	.	O	.	_	0	SENT_7	[p1l967t1078r1107b1109],

1	Therefore	RB	O	therefore	advmod	9	SENT_8	[p1l1121t1078r1309b1115],
2	,	,	O	,	_	0	SENT_8	[p1l1121t1078r1309b1115],
3	the	DT	O	the	det	4	SENT_8	[p1l1323t1078r1378b1109],
4	aim	NN	O	aim	nsubj	9	SENT_8	[p1l1392t1078r1456b1109],
5	of	IN	O	of	_	0	SENT_8	[p1l1468t1078r1505b1109],
6	the	DT	O	the	det	8	SENT_8	[p1l1515t1078r1570b1109],
7	present	JJ	DATE	present	amod	8	SENT_8	[p1l1582t1082r1714b1118],
8	study	NN	O	study	prep_of	4	SENT_8	[p1l1726t1078r1819b1118],
9	was	VBD	O	be	_	0	SENT_8	[p1l1829t1088r1893b1109],
10	to	TO	O	to	aux	11	SENT_8	[p1l1906t1082r1940b1109],
11	evaluate	VB	O	evaluate	xcomp	9	SENT_8	[p1l342t1127r488b1158],
12	associations	NNS	O	association	dobj	11	SENT_8	[p1l500t1127r710b1158],
13	between	IN	O	between	_	0	SENT_8	[p1l720t1127r868b1158],
14	this	DT	O	this	det	17	SENT_8	[p1l879t1127r941b1158],
15	single	JJ	O	single	amod	17	SENT_8	[p1l952t1127r1052b1167],
16	nucleotide	NN	O	nucleotide	nn	17	SENT_8	[p1l1063t1127r1249b1158],
17	polymorphism	NN	O	polymorphism	prep_between	12	SENT_8	[p1l1259t1127r1514b1167],
18	and	CC	O	and	_	0	SENT_8	[p1l1526t1127r1589b1158],
19	common	JJ	O	common	amod	21	SENT_8	[p1l1600t1137r1754b1158],
20	posttransplant	JJ	O	posttransplant	amod	21	SENT_8	[p1l1764t1131r1940b1167, p1l341t1176r431b1216],
21	complications	NNS	O	complication	prep_between	12	SENT_8	[p1l446t1176r690b1216],
22	among	IN	O	among	_	0	SENT_8	[p1l707t1186r825b1216],
23	Polish	JJ	MISC	polish	amod	26	SENT_8	[p1l840t1176r948b1207],
24	kidney	NN	O	kidney	nn	26	SENT_8	[p1l963t1176r1081b1216],
25	allotransplant	NN	O	allotransplant	nn	26	SENT_8	[p1l1096t1176r1340b1216],
26	recipients	NNS	O	recipient	prep_among	11	SENT_8	[p1l1355t1176r1535b1216],
27	.	.	O	.	_	0	SENT_8	[p1l1355t1176r1535b1216],

1	We	PRP	O	we	nsubj	2	SENT_9	[p1l1552t1177r1612b1207],
2	observed	VBD	O	observe	dep	20	SENT_9	[p1l1628t1176r1786b1207],
3	that	IN	O	that	_	0	SENT_9	[p1l1801t1176r1870b1207],
4	the	DT	O	the	det	5	SENT_9	[p1l1885t1176r1940b1207],
5	frequency	NN	O	frequency	prep_that	2	SENT_9	[p1l341t1226r517b1266],
6	of	IN	O	of	_	0	SENT_9	[p1l528t1226r565b1256],
7	IMPDH2	NN	O	impdh2	nn	9	SENT_9	[p1l572t1226r734b1256],
8	3757C	NN	O	3757c	nn	9	SENT_9	[p1l747t1226r858b1256],
9	allele	NN	O	allele	prep_of	5	SENT_9	[p1l871t1225r963b1256],
10	in	IN	O	in	_	0	SENT_9	[p1l976t1225r1008b1256],
11	this	DT	O	this	det	14	SENT_9	[p1l1021t1225r1082b1256],
12	group	NN	O	group	nn	14	SENT_9	[p1l1095t1235r1197b1266],
13	(	CD	NUMBER	(	num	14	SENT_9	[p1l1211t1225r1245b1266],
14	n	NN	O	n	prep_in	2	SENT_9	[p1l1211t1225r1245b1266],
15	=	JJ	O	=	amod	17	SENT_9	[p1l1263t1237r1288b1247],
16	177	CD	NUMBER	177	tmod	15	SENT_9	[p1l1306t1225r1379b1266],
17	)	NN	O	)	dep	2	SENT_9	[p1l1306t1225r1379b1266],
18	did	VBD	O	do	aux	20	SENT_9	[p1l1393t1225r1448b1256],
19	not	RB	O	not	neg	20	SENT_9	[p1l1460t1230r1518b1256],
20	differ	VB	O	differ	_	0	SENT_9	[p1l1530t1225r1623b1256],
21	signiﬁcantly	RB	O	signiﬁcantly	advmod	20	SENT_9	[p1l1635t1225r1845b1265],
22	from	IN	O	from	_	0	SENT_9	[p1l1855t1226r1941b1256],
23	a	DT	O	a	det	25	SENT_9	[p1l342t1285r361b1306],
24	control	NN	O	control	nn	25	SENT_9	[p1l372t1275r498b1306],
25	cohort	NN	O	cohort	prep_from	20	SENT_9	[p1l510t1275r625b1306],
26	representing	VBG	O	represent	partmod	25	SENT_9	[p1l637t1275r859b1316],
27	the	DT	O	the	det	29	SENT_9	[p1l870t1275r925b1306],
28	background	NN	O	background	nn	29	SENT_9	[p1l937t1275r1147b1315],
29	population	NN	O	population	dobj	26	SENT_9	[p1l1158t1275r1351b1316],
30	of	IN	O	of	_	0	SENT_9	[p1l1363t1275r1400b1306],
31	Poland	NNP	LOCATION	Poland	prep_of	29	SENT_9	[p1l1409t1275r1533b1306],
32	(	CD	NUMBER	(	num	31	SENT_9	[p1l1547t1274r1581b1316],
33	11	CD	NUMBER	11	num	36	SENT_9	[p1l1547t1274r1581b1316],
34	=	JJ	O	=	amod	36	SENT_9	[p1l1598t1287r1624b1297],
35	550	CD	NUMBER	550	tmod	34	SENT_9	[p1l1639t1274r1725b1316],
36	)	NN	O	)	nsubj	20	SENT_9	[p1l1639t1274r1725b1316],
37	.	.	O	.	_	0	SENT_9	[p1l1639t1274r1725b1316],

1	There	EX	O	there	expl	2	SENT_10	[p1l1739t1275r1844b1306],
2	were	VBD	O	be	_	0	SENT_10	[p1l1855t1285r1940b1306],
3	no	DT	O	no	det	5	SENT_10	[p1l341t1335r385b1356],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_10	[p1l414t1325r593b1365],
5	differences	NNS	O	difference	nsubj	2	SENT_10	[p1l622t1325r812b1356],
6	between	IN	O	between	_	0	SENT_10	[p1l840t1325r988b1356],
7	patients	NNS	O	patient	prep_between	5	SENT_10	[p1l1015t1325r1155b1365],
8	carrying	VBG	O	carry	partmod	7	SENT_10	[p1l1184t1325r1327b1365],
9	the	DT	O	the	det	11	SENT_10	[p1l1355t1325r1410b1356],
10	IMPDH2	NN	O	impdh2	nn	11	SENT_10	[p1l1436t1326r1598b1355],
11	3757CT	NN	O	3757ct	dobj	8	SENT_10	[p1l1627t1325r1766b1356],
12	and	CC	O	and	_	0	SENT_10	[p1l1795t1325r1859b1356],
13	TT	NN	O	tt	nn	14	SENT_10	[p1l1887t1326r1941b1355],
14	genotypes	NNS	O	genotype	conj_and	11	SENT_10	[p1l341t1378r517b1414],
15	with	IN	O	with	_	0	SENT_10	[p1l539t1374r616b1405],
16	respect	NN	O	respect	prep_with	8	SENT_10	[p1l639t1378r765b1414],
17	to	TO	O	to	_	0	SENT_10	[p1l789t1378r823b1405],
18	acute	JJ	O	acute	amod	20	SENT_10	[p1l848t1378r941b1405],
19	rejection	NN	O	rejection	nn	20	SENT_10	[p1l965t1374r1121b1414],
20	risk	NN	O	risk	prep_to	8	SENT_10	[p1l1144t1374r1217b1411],
21	,	,	O	,	_	0	SENT_10	[p1l1144t1374r1217b1411],
22	neutropenia	NN	O	neutropenia	prep_to	8	SENT_10	[p1l1241t1374r1466b1414],
23	,	,	O	,	_	0	SENT_10	[p1l1241t1374r1466b1414],
24	or	CC	O	or	_	0	SENT_10	[p1l1491t1384r1528b1405],
25	incidences	NNS	O	incidence	conj_or	20	SENT_10	[p1l1551t1374r1734b1405],
26	of	IN	O	of	_	0	SENT_10	[p1l1759t1374r1796b1405],
27	serious	JJ	O	serious	amod	28	SENT_10	[p1l1817t1374r1940b1405],
28	infections	NNS	O	infection	prep_of	25	SENT_10	[p1l341t1423r513b1454],
29	or	CC	O	or	_	0	SENT_10	[p1l531t1433r569b1454],
30	gastrointestinal	JJ	O	gastrointestinal	amod	32	SENT_10	[p1l586t1423r858b1463],
31	side	JJ	O	side	amod	32	SENT_10	[p1l877t1423r945b1454],
32	effects	NNS	O	effect	conj_or	28	SENT_10	[p1l964t1423r1083b1454],
33	.	.	O	.	_	0	SENT_10	[p1l964t1423r1083b1454],

1	However	RB	O	however	advmod	4	SENT_11	[p1l1103t1424r1271b1460],
2	,	,	O	,	_	0	SENT_11	[p1l1103t1424r1271b1460],
3	we	PRP	O	we	nsubj	4	SENT_11	[p1l1289t1433r1338b1454],
4	noted	VBD	O	note	_	0	SENT_11	[p1l1356t1423r1457b1454],
5	that	IN	O	that	complm	10	SENT_11	[p1l1475t1423r1544b1454],
6	the	DT	O	the	det	8	SENT_11	[p1l1562t1423r1617b1454],
7	3757C	NN	O	3757c	nn	8	SENT_11	[p1l1636t1423r1748b1454],
8	allele	NN	O	allele	nsubjpass	10	SENT_11	[p1l1766t1423r1859b1454],
9	was	VBD	O	be	auxpass	10	SENT_11	[p1l1876t1433r1940b1454],
10	associated	VBN	O	associate	ccomp	4	SENT_11	[p1l342t1472r522b1503],
11	with	IN	O	with	_	0	SENT_11	[p1l533t1472r609b1503],
12	higher	JJR	O	higher	amod	14	SENT_11	[p1l621t1472r734b1512],
13	lymphocyte	NN	O	lymphocyte	nn	14	SENT_11	[p1l746t1472r948b1512],
14	counts	NNS	O	count	prep_with	10	SENT_11	[p1l961t1476r1076b1503],
15	and	CC	O	and	_	0	SENT_11	[p1l1089t1472r1153b1503],
16	a	DT	O	a	det	18	SENT_11	[p1l1166t1482r1185b1503],
17	reduced	VBN	O	reduce	amod	18	SENT_11	[p1l1197t1472r1340b1503],
18	incidence	NN	O	incidence	prep_with	10	SENT_11	[p1l1352t1472r1519b1503],
19	of	IN	O	of	_	0	SENT_11	[p1l1533t1472r1570b1503],
20	lymphopenia	NN	O	lymphopenia	prep_of	18	SENT_11	[p1l1579t1472r1809b1512],
21	among	IN	O	among	_	0	SENT_11	[p1l1822t1482r1940b1512],
22	kidney	NN	O	kidney	nn	24	SENT_11	[p1l341t1521r459b1561],
23	allograft	NN	O	allograft	nn	24	SENT_11	[p1l487t1521r634b1561],
24	recipients	NNS	O	recipient	prep_among	18	SENT_11	[p1l662t1521r843b1561],
25	.	.	O	.	_	0	SENT_11	[p1l662t1521r843b1561],

1	Our	PRP$	O	we	poss	2	SENT_12	[p1l874t1521r945b1552],
2	ﬁndings	NNS	O	ﬁndings	nsubj	4	SENT_12	[p1l972t1521r1110b1561],
3	may	MD	O	may	aux	4	SENT_12	[p1l1139t1531r1212b1561],
4	be	VB	O	be	_	0	SENT_12	[p1l1238t1521r1280b1552],
5	of	IN	O	of	_	0	SENT_12	[p1l1309t1521r1346b1552],
6	practical	JJ	O	practical	amod	7	SENT_12	[p1l1371t1521r1523b1561],
7	signiﬁcance	NN	O	signiﬁcance	prep_of	4	SENT_12	[p1l1551t1521r1755b1561],
8	to	TO	O	to	aux	9	SENT_12	[p1l1783t1525r1818b1552],
9	tailor	VB	O	tailor	xcomp	4	SENT_12	[p1l1846t1521r1941b1552],
10	immunosuppressive	JJ	O	immunosuppressive	amod	11	SENT_12	[p1l341t1571r691b1611],
11	regimens	NNS	O	regimen	dobj	9	SENT_12	[p1l707t1571r867b1611],
12	in	IN	O	in	_	0	SENT_12	[p1l883t1571r916b1601],
13	kidney	NN	O	kidney	nn	15	SENT_12	[p1l930t1571r1048b1611],
14	transplant	NN	O	transplant	nn	15	SENT_12	[p1l1063t1571r1241b1611],
15	recipients	NNS	O	recipient	prep_in	9	SENT_12	[p1l1256t1571r1437b1611],
16	.	.	O	.	_	0	SENT_12	[p1l1256t1571r1437b1611],

1	N	NN	O	n	nn	3	SENT_13	[p1l101t1799r164b1858],
2	OSINE	NN	O	osine	nn	3	SENT_13	[p1l168t1798r435b1859],
3	monophosphate	NN	O	monophosphate	nsubj	11	SENT_13	[p1l463t1797r1042b1878],
4	dehydrogenase	NN	O	dehydrogenase	nn	7	SENT_13	[p1l1073t1797r1609b1878],
5	(	CD	NUMBER	(	num	7	SENT_13	[p1l1642t1796r1999b1880],
6	IMPDH	NN	O	impdh	nn	7	SENT_13	[p1l1642t1796r1999b1880],
7	)	NN	O	)	dep	3	SENT_13	[p1l1642t1796r1999b1880],
8	is	VBZ	O	be	cop	11	SENT_13	[p1l2030t1797r2082b1859],
9	a	DT	O	a	det	11	SENT_13	[p1l2113t1817r2150b1859],
10	key	JJ	O	key	amod	11	SENT_13	[p1l143t1903r266b1984],
11	enzyme	NN	O	enzyme	_	0	SENT_13	[p1l293t1922r561b1984],
12	responsible	JJ	O	responsible	amod	11	SENT_13	[p1l590t1903r997b1984],
13	for	IN	O	for	_	0	SENT_13	[p1l1025t1903r1129b1965],
14	de	FW	O	de	nn	16	SENT_13	[p1l1157t1903r1239b1965],
15	novo	FW	O	novo	nn	16	SENT_13	[p1l1267t1922r1440b1965],
16	purine	NN	O	purine	prep_for	12	SENT_13	[p1l1468t1903r1701b1984],
17	synthesis	NN	O	synthesis	dep	16	SENT_13	[p1l1731t1892r2150b1984],
18	.	.	O	.	_	0	SENT_13	[p1l1731t1892r2150b1984],

1	”	NN	O	”	nsubj	16	SENT_14	[p1l1731t1892r2150b1984],
2	This	DT	O	this	det	3	SENT_14	[p1l8t2008r162b2071],
3	enzyme	NN	O	enzyme	nsubj	4	SENT_14	[p1l202t2028r471b2090],
4	exists	VBZ	O	exist	rcmod	1	SENT_14	[p1l511t2009r701b2071],
5	in	IN	O	in	_	0	SENT_14	[p1l740t2009r806b2071],
6	two	CD	NUMBER	two	num	7	SENT_14	[p1l844t2017r971b2072],
7	isoforms	NNS	O	isoform	prep_in	4	SENT_14	[p1l1011t2009r1335b2072],
8	:	:	O	:	_	0	SENT_14	[p1l1011t2009r1335b2072],
9	IMPDH	NN	O	impdh	nn	10	SENT_14	[p1l1379t2011r1677b2071],
10	type	NN	O	type	dep	7	SENT_14	[p1l1714t2017r1864b2091],
11	1	CD	NUMBER	1	number	12	SENT_14	[p1l1908t2010r1938b2071],
12	(	CD	NUMBER	(	num	14	SENT_14	[p1l1984t2007r2148b2092, p1l9t2113r265b2198],
13	IMPDH1	NN	O	impdh1	nn	14	SENT_14	[p1l1984t2007r2148b2092, p1l9t2113r265b2198],
14	)	NN	O	)	dep	10	SENT_14	[p1l1984t2007r2148b2092, p1l9t2113r265b2198],
15	constitutively	RB	O	constitutively	advmod	16	SENT_14	[p1l304t2114r781b2196],
16	expressed	VBN	O	express	_	0	SENT_14	[p1l815t2114r1163b2196],
17	in	IN	O	in	_	0	SENT_14	[p1l1198t2114r1264b2176],
18	all	DT	O	all	det	19	SENT_14	[p1l1301t2114r1384b2177],
19	tissues	NNS	O	tissue	prep_in	16	SENT_14	[p1l1418t2114r1650b2177],
20	and	CC	O	and	_	0	SENT_14	[p1l1687t2114r1817b2177],
21	IMPDH	NN	O	impdh	nn	22	SENT_14	[p1l1853t2116r2150b2176],
22	type	NN	O	type	conj_and	19	SENT_14	[p1l8t2228r157b2300],
23	2	CD	NUMBER	2	number	24	SENT_14	[p1l188t2220r227b2280],
24	(	CD	NUMBER	(	num	26	SENT_14	[p1l258t2218r656b2301],
25	IMPDH2	NN	O	impdh2	nn	26	SENT_14	[p1l258t2218r656b2301],
26	)	NN	O	)	dobj	16	SENT_14	[p1l258t2218r656b2301],
27	expressed	VBN	O	express	partmod	26	SENT_14	[p1l689t2219r1037b2300],
28	by	IN	O	by	_	0	SENT_14	[p1l1064t2219r1147b2300],
29	T	NN	O	t	nn	32	SENT_14	[p1l1173t2221r1227b2280],
30	and	CC	O	and	_	0	SENT_14	[p1l1256t2219r1386b2281],
31	B	NN	O	b	nn	32	SENT_14	[p1l1414t2221r1467b2280],
32	lymphocytes	NNS	O	lymphocyte	agent	27	SENT_14	[p1l1496t2219r1938b2300],
33	upon	IN	O	upon	_	0	SENT_14	[p1l1967t2238r2150b2300],
34	activation	NN	O	activation	prep_upon	27	SENT_14	[p1l10t2324r376b2386],
35	.	.	O	.	_	0	SENT_14	[p1l10t2324r376b2386],

1	Both	DT	O	both	det	2	SENT_15	[p1l408t2324r582b2386],
2	isoforms	NNS	O	isoform	nsubjpass	5	SENT_15	[p1l611t2324r916b2386],
3	are	VBP	O	be	auxpass	5	SENT_15	[p1l947t2343r1057b2386],
4	selectively	RB	O	selectively	advmod	5	SENT_15	[p1l1087t2324r1453b2405],
5	inhibited	VBN	O	inhibit	_	0	SENT_15	[p1l1479t2324r1799b2386],
6	by	IN	O	by	_	0	SENT_15	[p1l1825t2324r1908b2405],
7	mycophenolic	JJ	O	mycophenolic	amod	8	SENT_15	[p1l1934t2343r2148b2405, p1l7t2429r317b2512],
8	acid	NN	O	acid	agent	5	SENT_15	[p1l373t2430r517b2492],
9	(	CD	NUMBER	(	num	11	SENT_15	[p1l576t2428r849b2513],
10	MPA	NN	ORGANIZATION	mpa	nn	11	SENT_15	[p1l576t2428r849b2513],
11	)	NN	O	)	tmod	5	SENT_15	[p1l576t2428r849b2513],
12	,	,	O	,	_	0	SENT_15	[p1l576t2428r849b2513],
13	an	DT	O	a	det	14	SENT_15	[p1l910t2450r993b2492],
14	immunosuppressant	JJ	O	immunosuppressant	appos	11	SENT_15	[p1l1049t2430r1773b2512],
15	routinely	RB	O	routinely	advmod	16	SENT_15	[p1l1828t2429r2152b2511],
16	used	VBN	O	use	dep	14	SENT_15	[p1l7t2534r172b2597],
17	for	IN	O	for	_	0	SENT_15	[p1l195t2535r298b2597],
18	the	DT	O	the	det	19	SENT_15	[p1l321t2534r433b2597],
19	prophylaxis	NN	O	prophylaxis	prep_for	16	SENT_15	[p1l455t2534r865b2616],
20	of	IN	O	of	_	0	SENT_15	[p1l890t2535r965b2597],
21	acute	JJ	O	acute	amod	24	SENT_15	[p1l984t2543r1173b2597],
22	kidney	NN	O	kidney	nn	24	SENT_15	[p1l1196t2534r1435b2616],
23	allograft	NN	O	allograft	nn	24	SENT_15	[p1l1458t2534r1757b2616],
24	rejection	NN	O	rejection	prep_of	19	SENT_15	[p1l1780t2524r2147b2616],
25	}	CD	NUMBER	}	num	27	SENT_15	[p1l1780t2524r2147b2616],
26	MPA	NN	O	mpa	nn	27	SENT_15	[p1l9t2642r204b2702],
27	therapy	NN	O	therapy	nsubjpass	30	SENT_15	[p1l227t2641r500b2722],
28	may	MD	O	may	aux	30	SENT_15	[p1l523t2661r671b2722],
29	be	VB	O	be	auxpass	30	SENT_15	[p1l692t2641r777b2703],
30	associated	VBN	O	associate	rcmod	24	SENT_15	[p1l805t2641r1170b2703],
31	with	IN	O	with	_	0	SENT_15	[p1l1191t2641r1346b2703],
32	a	DT	O	a	det	33	SENT_15	[p1l1373t2661r1411b2703],
33	variety	NN	O	variety	prep_with	30	SENT_15	[p1l1432t2641r1677b2722],
34	of	IN	O	of	_	0	SENT_15	[p1l1701t2641r1776b2703],
35	undesired	JJ	O	undesired	amod	36	SENT_15	[p1l1795t2641r2150b2703],
36	effects	NNS	O	effect	prep_of	33	SENT_15	[p1l9t2746r233b2808],
37	as	RB	O	as	_	0	SENT_15	[p1l262t2765r330b2808],
38	well	RB	O	well	_	0	SENT_15	[p1l353t2746r499b2808],
39	as	IN	O	as	_	0	SENT_15	[p1l527t2765r595b2808],
40	sometimes	RB	O	sometimes	advmod	43	SENT_15	[p1l623t2746r1002b2808],
41	be	VB	O	be	cop	43	SENT_15	[p1l1027t2746r1111b2808],
42	ineifective	JJ	O	ineifective	amod	43	SENT_15	[p1l1138t2735r1556b2808],
43	.3	NN	NUMBER	.3	conj_and	30	SENT_15	[p1l1138t2735r1556b2808],
44	The	DT	O	the	det	45	SENT_15	[p1l1583t2746r1724b2808],
45	reasons	NNS	O	reason	nsubjpass	52	SENT_15	[p1l1751t2765r2020b2808],
46	for	IN	O	for	_	0	SENT_15	[p1l2047t2746r2151b2808],
47	these	DT	O	these	det	48	SENT_15	[p1l8t2850r194b2913],
48	phenomena	NNS	O	phenomenon	prep_for	45	SENT_15	[p1l246t2850r671b2932],
49	are	VBP	O	be	auxpass	52	SENT_15	[p1l723t2870r833b2913],
50	still	RB	O	still	advmod	52	SENT_15	[p1l887t2850r1012b2913],
51	poorly	RB	O	poorly	advmod	52	SENT_15	[p1l1063t2850r1294b2932],
52	understood	VBN	O	understand	rcmod	43	SENT_15	[p1l1343t2850r1772b2926],
53	;	:	O	;	_	0	SENT_15	[p1l1343t2850r1772b2926],
54	however	RB	O	however	advmod	58	SENT_15	[p1l1827t2851r2147b2926],
55	,	,	O	,	_	0	SENT_15	[p1l1827t2851r2147b2926],
56	growing	VBG	O	grow	amod	57	SENT_15	[p1l8t2955r294b3036],
57	evidence	NN	O	evidence	nsubj	58	SENT_15	[p1l318t2955r629b3018],
58	suggests	VBZ	O	suggest	parataxis	52	SENT_15	[p1l654t2964r945b3036],
59	that	IN	O	that	complm	66	SENT_15	[p1l968t2955r1108b3017],
60	they	PRP	O	they	nsubj	66	SENT_15	[p1l1132t2955r1284b3036],
61	may	MD	O	may	aux	66	SENT_15	[p1l1304t2975r1453b3036],
62	be	VB	O	be	cop	66	SENT_15	[p1l1472t2955r1556b3017],
63	at	IN	O	at	advmod	66	SENT_15	[p1l1582t2964r1647b3017],
64	least	JJS	O	least	pobj	63	SENT_15	[p1l1669t2955r1833b3017],
65	partially	RB	O	partially	advmod	66	SENT_15	[p1l1855t2955r2151b3036],
66	related	JJ	O	related	ccomp	58	SENT_15	[p1l9t3062r260b3125],
67	to	TO	O	to	_	0	SENT_15	[p1l291t3071r360b3125],
68	genetic	JJ	O	genetic	amod	69	SENT_15	[p1l393t3062r650b3144],
69	factors	NNS	O	factor	prep_to	66	SENT_15	[p1l680t3051r1024b3125],
70	.4	CD	NUMBER	.4	dobj	30	SENT_15	[p1l680t3051r1024b3125],
71	’	CD	NUMBER	’	number	72	SENT_15	[p1l680t3051r1024b3125],
72	5	CD	NUMBER	5	num	14	SENT_15	[p1l680t3051r1024b3125],

1	One	CD	NUMBER	one	nsubj	21	SENT_16	[p1l95t3168r246b3229],
2	of	IN	O	of	_	0	SENT_16	[p1l274t3167r349b3229],
3	the	DT	O	the	det	5	SENT_16	[p1l370t3167r482b3229],
4	possible	JJ	O	possible	amod	5	SENT_16	[p1l509t3167r796b3248],
5	candidate	NN	O	candidate	prep_of	1	SENT_16	[p1l824t3167r1171b3229],
6	allelic	JJ	O	allelic	amod	7	SENT_16	[p1l1201t3167r1410b3229],
7	variants	NNS	O	variant	nsubj	16	SENT_16	[p1l1432t3167r1715b3229],
8	responsible	JJ	O	responsible	amod	7	SENT_16	[p1l1742t3167r2149b3248],
9	for	IN	O	for	_	0	SENT_16	[p1l8t3272r112b3334],
10	the	DT	O	the	det	12	SENT_16	[p1l168t3271r280b3334],
11	clinical	JJ	O	clinical	amod	12	SENT_16	[p1l338t3271r589b3334],
12	efﬁcacy	NN	O	efﬁcacy	prep_for	8	SENT_16	[p1l648t3271r908b3352],
13	of	IN	O	of	_	0	SENT_16	[p1l964t3272r1039b3334],
14	MPA	NN	ORGANIZATION	mpa	nn	15	SENT_16	[p1l1091t3273r1286b3333],
15	therapy	NN	O	therapy	prep_of	12	SENT_16	[p1l1340t3271r1613b3353],
16	seems	VBZ	O	seem	rcmod	1	SENT_16	[p1l1669t3291r1881b3334],
17	to	TO	O	to	aux	19	SENT_16	[p1l1939t3280r2008b3334],
18	be	VB	O	be	cop	19	SENT_16	[p1l2064t3272r2149b3334],
19	3757T	JJ	O	3757t	xcomp	16	SENT_16	[p1l9t3376r362b3439],
20	>	JJR	O	>	amod	21	SENT_16	[p1l9t3376r362b3439],
21	C	NN	O	c	_	0	SENT_16	[p1l9t3376r362b3439],
22	single	JJ	O	single	amod	27	SENT_16	[p1l385t3376r588b3457],
23	nucleotide	NN	O	nucleotide	nn	27	SENT_16	[p1l612t3376r988b3438],
24	polymorphism	NN	O	polymorphism	nn	27	SENT_16	[p1l1011t3376r1528b3457],
25	(	CD	NUMBER	(	num	27	SENT_16	[p1l1555t3375r1773b3458],
26	SNP	NN	O	snp	nn	27	SENT_16	[p1l1555t3375r1773b3458],
27	)	NN	O	)	dobj	21	SENT_16	[p1l1555t3375r1773b3458],
28	located	JJ	O	located	amod	27	SENT_16	[p1l1799t3376r2060b3438],
29	in	IN	O	in	_	0	SENT_16	[p1l2084t3376r2150b3437],
30	the	DT	O	the	det	33	SENT_16	[p1l8t3482r120b3545],
31	5	CD	NUMBER	5	num	33	SENT_16	[p1l154t3482r215b3545],
32	’	NN	O	’	nn	33	SENT_16	[p1l154t3482r215b3545],
33	end	NN	O	end	prep_in	28	SENT_16	[p1l256t3482r386b3545],
34	of	IN	O	of	_	0	SENT_16	[p1l420t3482r495b3545],
35	intron	NN	O	intron	prep_of	33	SENT_16	[p1l523t3482r742b3545],
36	7	CD	NUMBER	7	num	35	SENT_16	[p1l775t3484r814b3545],
37	in	IN	O	in	_	0	SENT_16	[p1l847t3482r913b3544],
38	the	DT	O	the	det	40	SENT_16	[p1l946t3482r1058b3545],
39	IMPDH2	NN	O	impdh2	nn	40	SENT_16	[p1l1086t3483r1415b3544],
40	gene	NN	O	gene	prep_in	21	SENT_16	[p1l1449t3502r1635b3564],
41	.	.	O	.	_	0	SENT_16	[p1l1449t3502r1635b3564],

1	Grinyo	NNP	O	Grinyo	nsubj	5	SENT_17	[p1l1674t3482r1921b3564],
2	et	FW	O	et	nn	3	SENT_17	[p1l1957t3491r2022b3545],
3	al5	FW	O	al5	dep	1	SENT_17	[p1l2057t3471r2148b3545],
4	have	VBP	O	have	aux	5	SENT_17	[p1l8t3587r173b3649],
5	suggested	VBN	O	suggest	_	0	SENT_17	[p1l216t3587r562b3667],
6	that	IN	O	that	complm	14	SENT_17	[p1l604t3587r744b3649],
7	the	DT	O	the	det	8	SENT_17	[p1l784t3586r896b3649],
8	presence	NN	O	presence	nsubj	14	SENT_17	[p1l937t3606r1254b3668],
9	of	IN	O	of	_	0	SENT_17	[p1l1297t3587r1371b3649],
10	21	CD	NUMBER	21	num	13	SENT_17	[p1l1413t3587r1512b3648],
11	IMPDH2	NN	O	impdh2	nn	13	SENT_17	[p1l1553t3588r1881b3648],
12	3757C	NN	O	3757c	nn	13	SENT_17	[p1l1924t3587r2150b3649],
13	allele	NN	O	allele	prep_of	8	SENT_17	[p1l10t3692r198b3754],
14	tripled	VBD	O	triple	ccomp	5	SENT_17	[p1l257t3692r494b3773],
15	the	DT	O	the	det	16	SENT_17	[p1l552t3692r663b3754],
16	odds	NNS	O	odds	nsubj	26	SENT_17	[p1l722t3692r888b3754],
17	of	IN	O	of	_	0	SENT_17	[p1l947t3693r1022b3754],
18	developing	VBG	O	develop	prepc_of	16	SENT_17	[p1l1075t3692r1466b3773],
19	an	DT	O	a	det	24	SENT_17	[p1l1525t3712r1608b3754],
20	acute	JJ	O	acute	amod	24	SENT_17	[p1l1667t3701r1855b3754],
21	kidney	NN	O	kidney	nn	24	SENT_17	[p1l1913t3692r2151b3773],
22	allograft	NN	O	allograft	nn	24	SENT_17	[p2l10t19r310b100],
23	rejection	NN	O	rejection	nn	24	SENT_17	[p2l334t19r650b100],
24	episodes	NNS	O	episode	dobj	18	SENT_17	[p2l676t19r1000b100],
25	,	,	O	,	_	0	SENT_17	[p2l676t19r1000b100],
26	results	VBZ	O	result	ccomp	14	SENT_17	[p2l1028t19r1260b81],
27	that	IN	O	that	complm	30	SENT_17	[p2l1285t19r1426b81],
28	were	VBD	O	be	auxpass	30	SENT_17	[p2l1446t38r1619b81],
29	not	RB	O	not	neg	30	SENT_17	[p2l1644t28r1762b81],
30	conﬁrmed	VBN	O	conﬁrmed	ccomp	26	SENT_17	[p2l1786t18r2150b81],

1	©	RB	O	©	dep	2	SENT_18	[p2l8t221r66b278],
2	2011	CD	DATE	2011	_	0	SENT_18	[p2l94t222r245b277],
3	Published	VBN	O	publish	partmod	2	SENT_18	[p2l290t222r613b277],
4	by	IN	O	by	_	0	SENT_18	[p2l647t222r724b292],
5	Elsevier	NNP	ORGANIZATION	Elsevier	nn	6	SENT_18	[p2l755t222r1011b277],
6	Inc.	NNP	ORGANIZATION	Inc.	agent	3	SENT_18	[p2l1041t222r1152b277],
7	360	CD	NUMBER	360	num	10	SENT_18	[p2l9t305r129b361],
8	Park	NNP	O	Park	nn	10	SENT_18	[p2l163t305r310b361],
9	Avenue	NNP	O	Avenue	nn	10	SENT_18	[p2l335t305r585b361],
10	South	NNP	O	South	dep	6	SENT_18	[p2l614t304r826b371],
11	,	,	O	,	_	0	SENT_18	[p2l614t304r826b371],
12	New	NNP	LOCATION	New	nn	13	SENT_18	[p2l862t305r1007b361],
13	York	NNP	LOCATION	York	appos	6	SENT_18	[p2l1034t305r1204b370],
14	,	,	O	,	_	0	SENT_18	[p2l1034t305r1204b370],
15	NY	NNP	LOCATION	NY	appos	13	SENT_18	[p2l1241t305r1339b360],
16	10010-1710	CD	NUMBER	10010-1710	num	15	SENT_18	[p2l1370t305r1766b361],

1	Transplantation	NN	O	transplantation	nn	2	SENT_19	[p2l11t541r518b610],
2	Proceedings	NNP	O	Proceedings	dep	9	SENT_19	[p2l548t541r980b611],
3	,	,	O	,	_	0	SENT_19	[p2l548t541r980b611],
4	43	CD	NUMBER	43	appos	2	SENT_19	[p2l1016t541r1113b606],
5	,	,	O	,	_	0	SENT_19	[p2l1016t541r1113b606],
6	2943-2945	CD	DATE	2943-2945	appos	2	SENT_19	[p2l1145t541r1512b596],
7	(	CD	NUMBER	(	dep	9	SENT_19	[p2l1544t540r1744b610],
8	2011	CD	DATE	2011	num	9	SENT_19	[p2l1544t540r1744b610],
9	)	NN	O	)	dep	13	SENT_19	[p2l1544t540r1744b610],
10	by	IN	O	by	_	0	SENT_19	[p2l7t645r90b727],
11	Gensburger	NNP	PERSON	Gensburger	prep_by	9	SENT_19	[p2l132t645r556b727],
12	et	FW	O	et	nn	13	SENT_19	[p2l598t654r664b708],
13	al.	FW	O	al.	_	0	SENT_19	[p2l707t634r821b708],
14	4	CD	NUMBER	4	tmod	13	SENT_19	[p2l707t634r821b708],
15	Therefore	RB	O	therefore	advmod	14	SENT_19	[p2l862t645r1245b721],
16	,	,	O	,	_	0	SENT_19	[p2l862t645r1245b721],
17	the	DT	O	the	det	18	SENT_19	[p2l1289t645r1401b708],
18	aim	NN	O	aim	nsubj	23	SENT_19	[p2l1446t645r1575b708],
19	of	IN	O	of	_	0	SENT_19	[p2l1618t645r1693b708],
20	the	DT	O	the	det	22	SENT_19	[p2l1730t645r1841b708],
21	present	JJ	DATE	present	amod	22	SENT_19	[p2l1883t654r2150b727],
22	study	NN	O	study	prep_of	18	SENT_19	[p2l10t752r198b833],
23	was	VBD	O	be	dep	13	SENT_19	[p2l217t771r348b814],
24	to	TO	O	to	aux	25	SENT_19	[p2l374t761r443b814],
25	evaluate	VB	O	evaluate	xcomp	23	SENT_19	[p2l471t752r768b814],
26	the	DT	O	the	det	27	SENT_19	[p2l794t752r906b814],
27	association	NN	O	association	nn	33	SENT_19	[p2l934t752r1327b814],
28	of	IN	O	of	_	0	SENT_19	[p2l1353t752r1428b814],
29	IMPDH2	NN	O	impdh2	nn	30	SENT_19	[p2l1442t753r1771b813],
30	3757T	NN	O	3757t	prep_of	27	SENT_19	[p2l1798t752r2151b814],
31	>	JJR	O	>	dep	32	SENT_19	[p2l1798t752r2151b814],
32	C	NN	O	c	amod	33	SENT_19	[p2l1798t752r2151b814],
33	SNP	NN	O	snp	dobj	25	SENT_19	[p2l10t860r167b921],
34	with	IN	O	with	_	0	SENT_19	[p2l207t859r362b921],
35	key	JJ	O	key	amod	37	SENT_19	[p2l405t859r528b940],
36	clinical	JJ	O	clinical	amod	37	SENT_19	[p2l570t859r821b921],
37	indicators	NNS	O	indicator	prep_with	25	SENT_19	[p2l865t859r1236b934],
38	,	,	O	,	_	0	SENT_19	[p2l865t859r1236b934],
39	such	JJ	O	such	_	0	SENT_19	[p2l1283t859r1441b921],
40	as	IN	O	as	_	0	SENT_19	[p2l1486t878r1555b921],
41	acute	JJ	O	acute	amod	43	SENT_19	[p2l1601t868r1790b921],
42	rejection	NN	O	rejection	nn	43	SENT_19	[p2l1834t859r2150b940],
43	episodes	NNS	O	episode	prep_such_as	13	SENT_19	[p2l10t965r334b1047],
44	,	,	O	,	_	0	SENT_19	[p2l10t965r334b1047],
45	leukopenia	NN	O	leukopenia	appos	43	SENT_19	[p2l392t965r807b1047],
46	,	,	O	,	_	0	SENT_19	[p2l392t965r807b1047],
47	infectious	JJ	O	infectious	amod	48	SENT_19	[p2l866t966r1213b1028],
48	complications	NNS	O	complication	appos	45	SENT_19	[p2l1269t965r1765b1047],
49	requiring	VBG	O	require	partmod	48	SENT_19	[p2l1820t966r2150b1047],
50	in-hospital	JJ	O	in-hospital	amod	51	SENT_19	[p2l9t1072r390b1153],
51	treatment	NN	O	treatment	dobj	49	SENT_19	[p2l421t1081r792b1148],
52	,	,	O	,	_	0	SENT_19	[p2l421t1081r792b1148],
53	and	CC	O	and	_	0	SENT_19	[p2l828t1072r957b1134],
54	gastrointestinal	JJ	O	gastrointestinal	amod	56	SENT_19	[p2l989t1072r1540b1153],
55	side	NN	O	side	nn	56	SENT_19	[p2l1573t1072r1711b1134],
56	eifects	NNS	O	eifect	dobj	49	SENT_19	[p2l1745t1073r1968b1134],
57	during	IN	O	during	_	0	SENT_19	[p2l2001t1072r2148b1134, p2l9t1180r117b1261],
58	the	DT	O	the	det	60	SENT_19	[p2l142t1180r254b1242],
59	posttransplant	JJ	O	posttransplant	amod	60	SENT_19	[p2l280t1180r796b1261],
60	courses	NNS	O	course	prep_during	49	SENT_19	[p2l823t1200r1087b1242],
61	of	IN	O	of	_	0	SENT_19	[p2l1115t1181r1190b1242],
62	kidney	NN	O	kidney	nn	64	SENT_19	[p2l1210t1180r1449b1261],
63	allograft	NN	O	allograft	nn	64	SENT_19	[p2l1475t1180r1775b1261],
64	recipients	NNS	O	recipient	prep_of	60	SENT_19	[p2l1801t1180r2149b1261],

1	From	IN	O	from	dep	59	SENT_20	[p2l88t1429r253b1484],
2	the	DT	O	the	det	3	SENT_20	[p2l288t1429r392b1484],
3	Departments	NNP	O	Departments	pobj	1	SENT_20	[p2l429t1429r856b1498],
4	of	IN	O	of	_	0	SENT_20	[p2l890t1428r954b1484],
5	Transplantation	NNP	ORGANIZATION	Transplantation	nn	6	SENT_20	[p2l983t1429r1500b1498],
6	Medicine	NNP	ORGANIZATION	Medicine	prep_of	3	SENT_20	[p2l1540t1429r1840b1484],
7	and	CC	O	and	_	0	SENT_20	[p2l1873t1429r1993b1484],
8	Nephrology	NNP	O	Nephrology	conj_and	6	SENT_20	[p2l2032t1429r2148b1484, p2l11t1522r302b1592],
9	(	CD	NUMBER	(	num	8	SENT_20	[p2l344t1521r505b1591],
10	J.P.	NNP	LOCATION	J.P.	dep	30	SENT_20	[p2l344t1521r505b1591],
11	,	,	O	,	_	0	SENT_20	[p2l344t1521r505b1591],
12	E.S.	NNP	LOCATION	E.S.	appos	10	SENT_20	[p2l555t1521r701b1587],
13	,	,	O	,	_	0	SENT_20	[p2l555t1521r701b1587],
14	M.D.	NNP	O	M.D.	nn	15	SENT_20	[p2l752t1521r941b1591],
15	)	NNP	O	)	appos	10	SENT_20	[p2l752t1521r941b1591],
16	,	,	O	,	_	0	SENT_20	[p2l752t1521r941b1591],
17	Histology	NNP	O	Histology	nn	21	SENT_20	[p2l991t1522r1301b1592],
18	and	CC	O	and	_	0	SENT_20	[p2l1343t1522r1463b1577],
19	Embryology	NNP	MISC	Embryology	nn	21	SENT_20	[p2l1512t1522r1907b1592],
20	(	CD	NUMBER	(	num	21	SENT_20	[p2l1950t1521r2145b1591],
21	M.O.	NNP	O	M.O.	appos	10	SENT_20	[p2l1950t1521r2145b1591],
22	,	,	O	,	_	0	SENT_20	[p2l1950t1521r2145b1591],
23	M.P.	NNP	LOCATION	M.P.	appos	10	SENT_20	[p2l13t1615r178b1681],
24	,	,	O	,	_	0	SENT_20	[p2l13t1615r178b1681],
25	J.M.	NNP	O	J.M.	nn	26	SENT_20	[p2l214t1614r393b1685],
26	)	NNP	O	)	appos	10	SENT_20	[p2l214t1614r393b1685],
27	,	,	O	,	_	0	SENT_20	[p2l214t1614r393b1685],
28	Epidemiology	NNP	O	Epidemiology	appos	10	SENT_20	[p2l433t1615r885b1685],
29	(	CD	NUMBER	(	dep	30	SENT_20	[p2l917t1614r1097b1685],
30	Z.L.	NNP	O	Z.L.	dep	3	SENT_20	[p2l917t1614r1097b1685],
31	)	CD	NUMBER	)	num	30	SENT_20	[p2l917t1614r1097b1685],
32	,	,	O	,	_	0	SENT_20	[p2l917t1614r1097b1685],
33	Medical	NNP	O	Medical	nn	37	SENT_20	[p2l1137t1615r1392b1671],
34	Genetics	NNP	O	Genetics	nn	37	SENT_20	[p2l1428t1614r1721b1671],
35	(	NNP	O	(	nn	37	SENT_20	[p2l1755t1614r1948b1685],
36	R.P.	NNP	LOCATION	R.P.	nn	37	SENT_20	[p2l1755t1614r1948b1685],
37	)	NNP	O	)	conj_and	30	SENT_20	[p2l1755t1614r1948b1685],
38	,	,	O	,	_	0	SENT_20	[p2l1755t1614r1948b1685],
39	General	NNP	O	General	conj_and	30	SENT_20	[p2l1985t1614r2148b1671, p2l9t1708r144b1773],
40	,	,	O	,	_	0	SENT_20	[p2l1985t1614r2148b1671, p2l9t1708r144b1773],
41	Vascular	JJ	O	vascular	amod	42	SENT_20	[p2l179t1708r469b1763],
42	Surgery	NN	O	surgery	conj_and	30	SENT_20	[p2l500t1707r759b1778],
43	and	CC	O	and	_	0	SENT_20	[p2l791t1708r911b1763],
44	Transplantology	NN	O	transplantology	nn	47	SENT_20	[p2l946t1708r1484b1778],
45	(	CD	NUMBER	(	num	47	SENT_20	[p2l1518t1707r1698b1777],
46	J.S.	NNP	LOCATION	J.S.	nn	47	SENT_20	[p2l1518t1707r1698b1777],
47	)	NNP	O	)	conj_and	30	SENT_20	[p2l1518t1707r1698b1777],
48	,	,	O	,	_	0	SENT_20	[p2l1518t1707r1698b1777],
49	and	CC	O	and	_	0	SENT_20	[p2l1736t1708r1855b1763],
50	General	NNP	O	General	nn	51	SENT_20	[p2l1893t1707r2147b1763],
51	Surgery	NNP	O	Surgery	pobj	1	SENT_20	[p2l9t1800r268b1871],
52	and	CC	O	and	_	0	SENT_20	[p2l298t1801r418b1856],
53	Transplantology	NNP	O	Transplantology	nn	56	SENT_20	[p2l448t1801r987b1871],
54	(	CD	NUMBER	(	num	56	SENT_20	[p2l1018t1800r1213b1870],
55	A.C.	NNP	ORGANIZATION	A.C.	nn	56	SENT_20	[p2l1018t1800r1213b1870],
56	)	NNP	O	)	conj_and	51	SENT_20	[p2l1018t1800r1213b1870],
57	,	,	O	,	_	0	SENT_20	[p2l1018t1800r1213b1870],
58	Medical	NNP	ORGANIZATION	Medical	nn	59	SENT_20	[p2l1251t1801r1506b1856],
59	University	NNP	ORGANIZATION	University	_	0	SENT_20	[p2l1542t1801r1868b1871],
60	of	IN	ORGANIZATION	of	_	0	SENT_20	[p2l1897t1800r1961b1856],
61	Warsaw	NNP	ORGANIZATION	Warsaw	nn	63	SENT_20	[p2l1988t1801r2148b1856, p2l9t1909r157b1960],
62	,	,	O	,	_	0	SENT_20	[p2l1988t1801r2148b1856, p2l9t1909r157b1960],
63	Warsaw	NNP	LOCATION	Warsaw	prep_of	59	SENT_20	[p2l189t1894r473b1960],
64	,	,	O	,	_	0	SENT_20	[p2l189t1894r473b1960],
65	Poland	NNP	LOCATION	Poland	nn	68	SENT_20	[p2l509t1894r735b1950],
66	(	NNP	O	(	nn	68	SENT_20	[p2l767t1893r963b1964],
67	A.C.	NNP	PERSON	A.C.	nn	68	SENT_20	[p2l767t1893r963b1964],
68	)	NNP	O	)	dep	59	SENT_20	[p2l767t1893r963b1964],
69	.	.	O	.	_	0	SENT_20	[p2l767t1893r963b1964],

1	J.	NNP	PERSON	J.	nn	2	SENT_21	[p2l84t1987r136b2042],
2	Pazik	NNP	PERSON	Pazik	nsubj	6	SENT_21	[p2l173t1987r348b2042],
3	and	CC	O	and	_	0	SENT_21	[p2l376t1987r495b2042],
4	M.	NNP	PERSON	M.	nn	5	SENT_21	[p2l530t1987r605b2041],
5	Oldak	NNP	PERSON	Oldak	nsubj	6	SENT_21	[p2l639t1986r834b2042],
6	contributed	VBD	O	contribute	_	0	SENT_21	[p2l862t1987r1241b2042],
7	equally	RB	O	equally	advmod	6	SENT_21	[p2l1273t1987r1508b2057],
8	to	TO	O	to	_	0	SENT_21	[p2l1534t1990r1598b2042],
9	this	DT	O	this	det	10	SENT_21	[p2l1626t1987r1744b2042],
10	study	NN	O	study	prep_to	6	SENT_21	[p2l1773t1987r1971b2057],
11	.	.	O	.	_	0	SENT_21	[p2l1773t1987r1971b2057],

1	Supported	VBN	O	support	_	0	SENT_22	[p2l85t2079r434b2149],
2	by	IN	O	by	_	0	SENT_22	[p2l469t2080r546b2150],
3	grants	NNS	O	grant	prep_by	1	SENT_22	[p2l574t2083r781b2150],
4	from	IN	O	from	_	0	SENT_22	[p2l809t2079r959b2135],
5	the	DT	O	the	det	7	SENT_22	[p2l989t2080r1093b2135],
6	Polish	NNP	ORGANIZATION	Polish	nn	7	SENT_22	[p2l1125t2080r1320b2135],
7	Ministry	NNP	ORGANIZATION	Ministry	prep_from	3	SENT_22	[p2l1355t2080r1614b2150],
8	of	IN	ORGANIZATION	of	_	0	SENT_22	[p2l1642t2079r1705b2135],
9	Science	NNP	ORGANIZATION	Science	prep_of	7	SENT_22	[p2l1733t2079r1998b2136],
10	and	CC	ORGANIZATION	and	_	0	SENT_22	[p2l2027t2080r2147b2135],
11	Higher	JJR	ORGANIZATION	higher	amod	14	SENT_22	[p2l12t2173r229b2243],
12	Education	NN	ORGANIZATION	education	nn	14	SENT_22	[p2l269t2173r597b2229],
13	N	NN	ORGANIZATION	n	nn	14	SENT_22	[p2l641t2173r685b2228],
14	N402	NN	O	n402	prep_from	3	SENT_22	[p2l730t2173r900b2229],
15	4266	CD	DATE	4266	number	16	SENT_22	[p2l941t2174r1104b2229],
16	33	CD	DATE	33	dep	14	SENT_22	[p2l1143t2174r1221b2229],
17	and	CC	O	and	_	0	SENT_22	[p2l1262t2173r1381b2229],
18	Medical	NNP	ORGANIZATION	Medical	nn	19	SENT_22	[p2l1426t2173r1680b2229],
19	University	NNP	ORGANIZATION	University	conj_and	3	SENT_22	[p2l1725t2173r2051b2243],
20	of	IN	ORGANIZATION	of	_	0	SENT_22	[p2l2088t2173r2152b2229],
21	Warsaw	NNP	ORGANIZATION	Warsaw	nn	22	SENT_22	[p2l8t2265r276b2320],
22	1M15/N/2010	NNP	O	1M15/N/2010	prep_of	19	SENT_22	[p2l308t2264r780b2320],
23	.	.	O	.	_	0	SENT_22	[p2l308t2264r780b2320],

1	Address	NN	O	address	nsubj	2	SENT_23	[p2l81t2358r359b2413],
2	reprint	VB	O	reprint	_	0	SENT_23	[p2l391t2358r602b2427],
3	requests	NNS	O	request	dobj	2	SENT_23	[p2l634t2361r919b2427],
4	to	TO	O	to	_	0	SENT_23	[p2l947t2361r1011b2413],
5	Joanna	NNP	PERSON	Joanna	nn	12	SENT_23	[p2l1040t2358r1285b2414],
6	Pazik	NNP	PERSON	Pazik	nn	12	SENT_23	[p2l1317t2358r1508b2423],
7	,	,	O	,	_	0	SENT_23	[p2l1317t2358r1508b2423],
8	MD	NNP	O	MD	appos	12	SENT_23	[p2l1545t2358r1673b2423],
9	,	,	O	,	_	0	SENT_23	[p2l1545t2358r1673b2423],
10	PhD	NNP	O	PhD	appos	12	SENT_23	[p2l1710t2358r1863b2423],
11	,	,	O	,	_	0	SENT_23	[p2l1710t2358r1863b2423],
12	Department	NNP	ORGANIZATION	Department	prep_to	2	SENT_23	[p2l1900t2358r2148b2427, p2l11t2454r175b2507],
13	of	IN	ORGANIZATION	of	_	0	SENT_23	[p2l210t2451r273b2507],
14	Transplantation	NNP	ORGANIZATION	Transplantation	nn	15	SENT_23	[p2l303t2451r820b2521],
15	Medicine	NNP	ORGANIZATION	Medicine	prep_of	12	SENT_23	[p2l861t2451r1160b2507],
16	and	CC	O	and	_	0	SENT_23	[p2l1194t2451r1314b2507],
17	Nephrology	NNP	O	Nephrology	conj_and	12	SENT_23	[p2l1354t2451r1754b2521],
18	,	,	O	,	_	0	SENT_23	[p2l1354t2451r1754b2521],
19	Transplantation	NN	O	transplantation	nn	20	SENT_23	[p2l1790t2451r2148b2521, p2l7t2544r192b2599],
20	lnstitute	NN	O	lnstitute	appos	17	SENT_23	[p2l222t2544r500b2609],
21	,	,	O	,	_	0	SENT_23	[p2l222t2544r500b2609],
22	Medical	NNP	ORGANIZATION	Medical	nn	23	SENT_23	[p2l531t2544r786b2599],
23	University	NNP	ORGANIZATION	University	appos	17	SENT_23	[p2l815t2544r1141b2614],
24	of	IN	ORGANIZATION	of	_	0	SENT_23	[p2l1164t2543r1227b2599],
25	Warsaw	NNP	ORGANIZATION	Warsaw	prep_of	23	SENT_23	[p2l1247t2544r1532b2609],
26	,	,	O	,	_	0	SENT_23	[p2l1247t2544r1532b2609],
27	Nowogrodzka	NNP	ORGANIZATION	Nowogrodzka	appos	17	SENT_23	[p2l1563t2544r2026b2614],
28	59	CD	NUMBER	59	num	27	SENT_23	[p2l2049t2544r2145b2609],
29	,	,	O	,	_	0	SENT_23	[p2l2049t2544r2145b2609],
30	02-006	CD	NUMBER	02-006	num	27	SENT_23	[p2l10t2637r243b2692],
31	Warsaw	NNP	LOCATION	Warsaw	nn	33	SENT_23	[p2l271t2637r556b2702],
32	,	,	O	,	_	0	SENT_23	[p2l271t2637r556b2702],
33	Poland	NNP	LOCATION	Poland	dep	27	SENT_23	[p2l592t2637r837b2692],
34	.	.	O	.	_	0	SENT_23	[p2l592t2637r837b2692],

1	E	NN	O	e	_	0	SENT_24	[p2l873t2637r1096b2692],
2	—	CD	NUMBER	—	num	1	SENT_24	[p2l873t2637r1096b2692],
3	mai	FW	O	mai	nn	4	SENT_24	[p2l873t2637r1096b2692],
4	|	FW	O	|	dep	1	SENT_24	[p2l873t2637r1096b2692],
5	:	:	O	:	_	0	SENT_24	[p2l873t2637r1096b2692],
6	jpazik@poczta.fm	NN	O	jpazik@poczta.fm	dep	4	SENT_24	[p2l1125t2636r1712b2706],

1	0041	CD	DURATION	0041	num	2	SENT_25	[p2l1186t2834r1336b2889],
2	-1345	CD	DURATION	-1345	nsubj	3	SENT_25	[p2l1354t2833r1727b2889],
3	/	:	O	/	_	0	SENT_25	[p2l1354t2833r1727b2889],
4	.	.	O	.	_	0	SENT_25	[p2l1354t2833r1727b2889],

1	—	NN	O	—	_	0	SENT_26	[p2l1354t2833r1727b2889],
2	.	.	O	.	_	0	SENT_26	[p2l1354t2833r1727b2889],

1	see	VB	O	see	_	0	SENT_27	[p2l1354t2833r1727b2889],
2	front	JJ	O	front	amod	3	SENT_27	[p2l1754t2833r1907b2889],
3	matter	NN	O	matter	dobj	1	SENT_27	[p2l1939t2837r2152b2889],
4	doi	FW	O	doi	nsubj	1	SENT_27	[p2l808t2917r2149b2987],
5	:10.1016	CD	NUMBER	:10.1016	dep	4	SENT_27	[p2l808t2917r2149b2987],
6	/	:	O	/	punct	5	SENT_27	[p2l808t2917r2149b2987],
7	j.	NN	O	j.	nsubj	8	SENT_27	[p2l808t2917r2149b2987],
8	transproceed	VBD	O	transproceed	dep	5	SENT_27	[p2l808t2917r2149b2987],
9	.2011.08.037	CD	NUMBER	.2011.08.037	dobj	8	SENT_27	[p2l808t2917r2149b2987],

1	2944	CD	DATE	2944	num	4	SENT_28	[p2l93t3287r165b3312],
2	PAZIK	NNP	PERSON	PAZIK	nn	4	SENT_28	[p2l1512t3287r1611b3316],
3	,	,	O	,	_	0	SENT_28	[p2l1512t3287r1611b3316],
4	OLDAK	NNP	LOCATION	OLDAK	_	0	SENT_28	[p2l1626t3286r1742b3316],
5	,	,	O	,	_	0	SENT_28	[p2l1626t3286r1742b3316],
6	PODGORSKA	NNP	O	PODGORSKA	nn	8	SENT_28	[p2l1758t3286r1966b3312],
7	ET	NNP	O	ET	nn	8	SENT_28	[p2l1979t3287r2016b3311],
8	AL	NNP	O	AL	appos	4	SENT_28	[p2l2027t3287r2067b3311],

1	Table	NNP	O	Table	_	0	SENT_29	[p2l157t3387r239b3410],
2	1	CD	NUMBER	1	dep	1	SENT_29	[p2l252t3387r274b3410],
3	.	.	O	.	_	0	SENT_29	[p2l252t3387r274b3410],

1	The	DT	O	the	det	2	SENT_30	[p2l291t3387r346b3410],
2	Frequency	NN	O	frequency	_	0	SENT_30	[p2l359t3387r514b3416],
3	of	IN	O	of	_	0	SENT_30	[p2l526t3387r554b3410],
4	Cases	NNS	O	case	prep_of	2	SENT_30	[p2l565t3386r656b3410],
5	With	IN	O	with	dep	2	SENT_30	[p2l668t3387r733b3410],
6	Posttransplant	NN	O	posttransplant	nn	7	SENT_30	[p2l747t3387r963b3416],
7	Complications	NNS	O	complication	pobj	5	SENT_30	[p2l975t3386r1189b3415],
8	in	IN	O	in	_	0	SENT_30	[p2l1201t3387r1225b3410],
9	Patient	NN	O	patient	nn	10	SENT_30	[p2l1239t3387r1342b3410],
10	Groups	NNS	O	group	prep_in	7	SENT_30	[p2l1353t3386r1461b3416],
11	Carrying	VBG	O	carry	partmod	10	SENT_30	[p2l1473t3386r1598b3416],
12	the	DT	O	the	det	13	SENT_30	[p2l1610t3387r1657b3410],
13	lMPDH2	NN	O	lmpdh2	dobj	11	SENT_30	[p2l1668t3387r1790b3410],
14	3757TC	NN	O	3757tc	rcmod	13	SENT_30	[p2l1801t3386r1911b3410],
15	or	CC	O	or	_	0	SENT_30	[p2l1923t3392r1954b3410],
16	1	CD	NUMBER	1	conj_or	14	SENT_30	[p2l1964t3387r2002b3410],
17	'	''	O	'	_	0	SENT_30	[p2l1964t3387r2002b3410],
18	l'	SYM	O	l'	dep	13	SENT_30	[p2l1964t3387r2002b3410],

1	Genotype	NN	O	genotype	_	0	SENT_31	[p2l1004t3425r1145b3454],

1	IMPHD2	NN	O	imphd2	nn	2	SENT_32	[p2l1086t3501r1187b3522],
2	3757T	NN	O	3757t	_	0	SENT_32	[p2l1198t3501r1314b3522],
3	>	JJR	O	>	amod	5	SENT_32	[p2l1198t3501r1314b3522],
4	C	NN	O	c	nn	5	SENT_32	[p2l1198t3501r1314b3522],
5	Genotype	NN	O	genotype	dep	2	SENT_32	[p2l1325t3501r1442b3527],

1	Posttransplant	JJ	O	posttransplant	amod	2	SENT_33	[p3l321t17r495b43],
2	Complications	NNS	O	complication	nsubj	3	SENT_33	[p3l505t17r678b43],
3	CT	NN	O	ct	_	0	SENT_33	[p3l1091t17r1125b38],
4	‘	CD	NUMBER	‘	dobj	3	SENT_33	[p3l1402t17r1434b38],
5	IT	PRP	O	it	dep	11	SENT_33	[p3l1402t17r1434b38],
6	OR	NN	O	or	nn	10	SENT_33	[p3l1636t17r1674b38],
7	95	CD	PERCENT	95	number	8	SENT_33	[p3l1808t17r1862b38],
8	%	NN	PERCENT	%	amod	10	SENT_33	[p3l1808t17r1862b38],
9	CI	NN	O	ci	nn	10	SENT_33	[p3l1874t17r1898b38],
10	P	NN	O	p	dep	11	SENT_33	[p3l2035t17r2052b38],
11	Lymphopenia	NNP	O	Lymphopenia	dep	16	SENT_33	[p3l94t77r282b107],
12	<	JJR	O	<	dep	11	SENT_33	[p3l295t78r330b101],
13	1	CD	NUMBER	1	dep	14	SENT_33	[p3l295t78r330b101],
14	>	JJR	O	>	npadvmod	15	SENT_33	[p3l350t81r368b99],
15	<	JJR	O	<	amod	12	SENT_33	[p3l350t81r368b99],
16	103	CD	NUMBER	103	dep	3	SENT_33	[p3l385t74r479b107],
17	/	:	O	/	punct	16	SENT_33	[p3l385t74r479b107],
18	;	:	O	;	_	0	SENT_33	[p3l385t74r479b107],
19	.	.	O	.	_	0	SENT_33	[p3l385t74r479b107],

1	tL	NN	O	tl	dep	131	SENT_34	[p3l385t74r479b107],
2	(	CD	NUMBER	(	dep	131	SENT_34	[p3l490t77r526b107],
3	all	DT	O	all	dep	131	SENT_34	[p3l490t77r526b107],
4	patients	NNS	O	patient	dep	131	SENT_34	[p3l540t77r657b107],
5	)	IN	O	)	dep	131	SENT_34	[p3l540t77r657b107],
6	7/17	CD	PERCENT	7/17	dep	131	SENT_34	[p3l1019t77r1079b101],
7	(	CD	PERCENT	(	dep	131	SENT_34	[p3l1090t77r1196b107],
8	41.1	CD	PERCENT	41.1	dep	131	SENT_34	[p3l1090t77r1196b107],
9	%	NN	PERCENT	%	dep	131	SENT_34	[p3l1090t77r1196b107],
10	)	CD	NUMBER	)	dep	131	SENT_34	[p3l1090t77r1196b107],
11	73/106	CD	NUMBER	73/106	dep	131	SENT_34	[p3l1312t77r1407b101],
12	(	NN	O	(	dep	131	SENT_34	[p3l1418t77r1524b107],
13	68.8	CD	PERCENT	68.8	dep	131	SENT_34	[p3l1418t77r1524b107],
14	%	NN	PERCENT	%	dep	131	SENT_34	[p3l1418t77r1524b107],
15	)	CD	NUMBER	)	dep	131	SENT_34	[p3l1418t77r1524b107],
16	0.32	CD	NUMBER	0.32	dep	131	SENT_34	[p3l1626t78r1684b101],
17	0.11-0	CD	NUMBER	0.11-0	dep	131	SENT_34	[p3l1786t78r1921b101],
18	.90	CD	NUMBER	.90	dep	131	SENT_34	[p3l1786t78r1921b101],
19	.03	CD	NUMBER	.03	dep	131	SENT_34	[p3l2024t78r2064b101],
20	Lymphopenia	NNP	O	Lymphopenia	dep	131	SENT_34	[p3l94t118r282b148],
21	<	JJR	O	<	dep	131	SENT_34	[p3l295t119r330b142],
22	1	CD	NUMBER	1	dep	131	SENT_34	[p3l295t119r330b142],
23	>	JJR	O	>	dep	131	SENT_34	[p3l350t122r368b141],
24	<	JJR	O	<	dep	131	SENT_34	[p3l350t122r368b141],
25	103/ML	CD	NUMBER	103/ml	dep	131	SENT_34	[p3l385t115r479b148],
26	(	NN	O	(	dep	131	SENT_34	[p3l490t118r608b148],
27	patients	NNS	O	patient	dep	131	SENT_34	[p3l490t118r608b148],
28	untreated	JJ	O	untreated	dep	131	SENT_34	[p3l621t118r751b142],
29	with	IN	O	with	dep	131	SENT_34	[p3l764t118r819b142],
30	ATG	NN	ORGANIZATION	atg	dep	131	SENT_34	[p3l831t118r900b148],
31	)	CD	NUMBER	)	dep	131	SENT_34	[p3l831t118r900b148],
32	7/17	CD	NUMBER	7/17	dep	131	SENT_34	[p3l1019t118r1079b142],
33	(	NN	O	(	dep	131	SENT_34	[p3l1090t118r1196b148],
34	41.2	CD	PERCENT	41.2	dep	131	SENT_34	[p3l1090t118r1196b148],
35	%	NN	PERCENT	%	dep	131	SENT_34	[p3l1090t118r1196b148],
36	)	CD	NUMBER	)	dep	131	SENT_34	[p3l1090t118r1196b148],
37	60/93	CD	NUMBER	60/93	dep	131	SENT_34	[p3l1329t118r1407b142],
38	(	NN	O	(	dep	131	SENT_34	[p3l1418t118r1524b148],
39	64.5	CD	PERCENT	64.5	dep	131	SENT_34	[p3l1418t118r1524b148],
40	%	NN	PERCENT	%	dep	131	SENT_34	[p3l1418t118r1524b148],
41	)	CD	NUMBER	)	dep	131	SENT_34	[p3l1418t118r1524b148],
42	0.38	CD	NUMBER	0.38	dep	131	SENT_34	[p3l1626t119r1684b142],
43	0.13-1	CD	NUMBER	0.13-1	dep	131	SENT_34	[p3l1786t119r1921b142],
44	.09	CD	NUMBER	.09	dep	131	SENT_34	[p3l1786t119r1921b142],
45	.07	CD	NUMBER	.07	dep	131	SENT_34	[p3l2024t119r2064b142],
46	Early	JJ	O	early	dep	131	SENT_34	[p3l94t160r161b189],
47	acute	JJ	O	acute	dep	131	SENT_34	[p3l172t161r248b183],
48	rejection	NN	O	rejection	dep	131	SENT_34	[p3l261t160r377b189],
49	(	NN	O	(	dep	131	SENT_34	[p3l391t159r440b189],
50	53	CD	DURATION	53	dep	131	SENT_34	[p3l391t159r440b189],
51	months	NNS	NUMBER	month	dep	131	SENT_34	[p3l453t160r555b183],
52	after	IN	O	after	dep	131	SENT_34	[p3l567t159r630b183],
53	transplantation	NN	O	transplantation	dep	131	SENT_34	[p3l640t159r855b189],
54	)	CD	NUMBER	)	dep	131	SENT_34	[p3l640t159r855b189],
55	3/24	CD	NUMBER	3/24	dep	131	SENT_34	[p3l1018t159r1079b183],
56	(	NN	O	(	dep	131	SENT_34	[p3l1090t159r1196b189],
57	12.5	CD	PERCENT	12.5	dep	131	SENT_34	[p3l1090t159r1196b189],
58	%	NN	PERCENT	%	dep	131	SENT_34	[p3l1090t159r1196b189],
59	)	CD	NUMBER	)	dep	131	SENT_34	[p3l1090t159r1196b189],
60	30/140	CD	NUMBER	30/140	dep	131	SENT_34	[p3l1312t159r1407b183],
61	(	NN	O	(	dep	131	SENT_34	[p3l1418t159r1524b189],
62	21.4	CD	PERCENT	21.4	dep	131	SENT_34	[p3l1418t159r1524b189],
63	%	NN	PERCENT	%	dep	131	SENT_34	[p3l1418t159r1524b189],
64	)	CD	NUMBER	)	dep	131	SENT_34	[p3l1418t159r1524b189],
65	0.52	CD	NUMBER	0.52	dep	131	SENT_34	[p3l1626t160r1684b183],
66	0.15-1	CD	NUMBER	0.15-1	dep	131	SENT_34	[p3l1786t160r1921b183],
67	.88	CD	NUMBER	.88	dep	131	SENT_34	[p3l1786t160r1921b183],
68	.32	CD	NUMBER	.32	dep	131	SENT_34	[p3l2024t160r2063b183],
69	Late	JJ	O	late	dep	131	SENT_34	[p3l94t200r152b223],
70	acute	JJ	O	acute	dep	131	SENT_34	[p3l164t202r240b223],
71	rejection	NN	O	rejection	dep	131	SENT_34	[p3l253t200r369b229],
72	(	CD	NUMBER	(	dep	131	SENT_34	[p3l383t200r432b229],
73	>	JJR	O	>	dep	131	SENT_34	[p3l383t200r432b229],
74	3	CD	DURATION	3	dep	131	SENT_34	[p3l383t200r432b229],
75	months	NNS	NUMBER	month	dep	131	SENT_34	[p3l445t200r547b223],
76	after	IN	O	after	dep	131	SENT_34	[p3l559t200r622b223],
77	transplantation	NN	O	transplantation	dep	131	SENT_34	[p3l632t200r847b229],
78	)	CD	NUMBER	)	dep	131	SENT_34	[p3l632t200r847b229],
79	3/24	CD	NUMBER	3/24	dep	131	SENT_34	[p3l1018t200r1079b224],
80	(	NN	O	(	dep	131	SENT_34	[p3l1090t200r1196b229],
81	12.5	CD	PERCENT	12.5	dep	131	SENT_34	[p3l1090t200r1196b229],
82	%	NN	PERCENT	%	dep	131	SENT_34	[p3l1090t200r1196b229],
83	)	CD	NUMBER	)	dep	131	SENT_34	[p3l1090t200r1196b229],
84	15/135	CD	NUMBER	15/135	dep	131	SENT_34	[p3l1314t200r1407b224],
85	(	NN	O	(	dep	131	SENT_34	[p3l1418t200r1524b229],
86	11.1	CD	PERCENT	11.1	dep	131	SENT_34	[p3l1418t200r1524b229],
87	%	NN	PERCENT	%	dep	131	SENT_34	[p3l1418t200r1524b229],
88	)	CD	NUMBER	)	dep	131	SENT_34	[p3l1418t200r1524b229],
89	1.14	CD	NUMBER	1.14	dep	131	SENT_34	[p3l1627t201r1684b223],
90	0.30-4	CD	NUMBER	0.30-4	dep	131	SENT_34	[p3l1786t201r1921b223],
91	.29	CD	NUMBER	.29	dep	131	SENT_34	[p3l1786t201r1921b223],
92	.84	CD	NUMBER	.84	dep	131	SENT_34	[p3l2024t201r2064b223],
93	Serious	JJ	O	serious	dep	131	SENT_34	[p3l93t241r196b265],
94	infection	NN	O	infection	dep	131	SENT_34	[p3l210t241r325b265],
95	3/26	CD	PERCENT	3/26	dep	131	SENT_34	[p3l1018t241r1079b265],
96	(	CD	PERCENT	(	dep	131	SENT_34	[p3l1090t241r1196b271],
97	11.5	CD	PERCENT	11.5	dep	131	SENT_34	[p3l1090t241r1196b271],
98	%	NN	PERCENT	%	dep	131	SENT_34	[p3l1090t241r1196b271],
99	)	CD	NUMBER	)	dep	131	SENT_34	[p3l1090t241r1196b271],
100	22/145	CD	NUMBER	22/145	dep	131	SENT_34	[p3l1312t241r1407b265],
101	(	NN	O	(	dep	131	SENT_34	[p3l1418t241r1524b271],
102	15.7	CD	PERCENT	15.7	dep	131	SENT_34	[p3l1418t241r1524b271],
103	%	NN	PERCENT	%	dep	131	SENT_34	[p3l1418t241r1524b271],
104	)	CD	NUMBER	)	dep	131	SENT_34	[p3l1418t241r1524b271],
105	0.73	CD	NUMBER	0.73	dep	131	SENT_34	[p3l1626t242r1684b265],
106	0.20-2	CD	NUMBER	0.20-2	dep	131	SENT_34	[p3l1786t242r1921b265],
107	.64	CD	NUMBER	.64	dep	131	SENT_34	[p3l1786t242r1921b265],
108	.63	CD	NUMBER	.63	dep	131	SENT_34	[p3l2024t242r2064b265],
109	GI	NN	O	gi	dep	131	SENT_34	[p3l93t282r121b306],
110	side	NN	O	side	dep	131	SENT_34	[p3l135t283r191b306],
111	effects	NNS	O	effect	dep	131	SENT_34	[p3l203t282r293b306],
112	3/15	CD	PERCENT	3/15	dep	131	SENT_34	[p3l1018t282r1079b306],
113	(	CD	PERCENT	(	dep	131	SENT_34	[p3l1090t282r1170b312],
114	20	CD	PERCENT	20	dep	131	SENT_34	[p3l1090t282r1170b312],
115	%	NN	PERCENT	%	dep	131	SENT_34	[p3l1090t282r1170b312],
116	)	CD	NUMBER	)	dep	131	SENT_34	[p3l1090t282r1170b312],
117	27/95	CD	NUMBER	27/95	dep	131	SENT_34	[p3l1329t282r1407b306],
118	(	NN	O	(	dep	131	SENT_34	[p3l1418t282r1524b312],
119	28.4	CD	PERCENT	28.4	dep	131	SENT_34	[p3l1418t282r1524b312],
120	%	NN	PERCENT	%	dep	131	SENT_34	[p3l1418t282r1524b312],
121	)	CD	NUMBER	)	dep	131	SENT_34	[p3l1418t282r1524b312],
122	0.63	CD	NUMBER	0.63	dep	131	SENT_34	[p3l1626t283r1684b306],
123	0.17-2	CD	NUMBER	0.17-2	dep	131	SENT_34	[p3l1786t283r1916b306],
124	.41	CD	NUMBER	.41	dep	131	SENT_34	[p3l1786t283r1916b306],
125	.50	CD	NUMBER	.50	dep	131	SENT_34	[p3l2024t283r2064b306],
126	Neutropenia	NN	O	neutropenia	dep	131	SENT_34	[p3l94t324r263b354],
127	<	JJR	O	<	dep	131	SENT_34	[p3l276t324r311b347],
128	1	CD	NUMBER	1	dep	131	SENT_34	[p3l276t324r311b347],
129	>	JJR	O	>	dep	131	SENT_34	[p3l331t328r350b346],
130	<	JJR	O	<	dep	131	SENT_34	[p3l331t328r350b346],
131	103/p	CD	NUMBER	103/p	_	0	SENT_34	[p3l366t321r460b354],
132	.	.	O	.	_	0	SENT_34	[p3l366t321r460b354],

1	L	NN	O	l	dep	10	SENT_35	[p3l366t321r460b354],
2	2/15	CD	PERCENT	2/15	num	1	SENT_35	[p3l1018t324r1079b348],
3	(	CD	PERCENT	(	number	4	SENT_35	[p3l1090t324r1196b354],
4	13.3	CD	PERCENT	13.3	num	5	SENT_35	[p3l1090t324r1196b354],
5	%	NN	PERCENT	%	dep	1	SENT_35	[p3l1090t324r1196b354],
6	)	CD	NUMBER	)	dep	5	SENT_35	[p3l1090t324r1196b354],
7	11/78	CD	NUMBER	11/78	num	8	SENT_35	[p3l1331t324r1407b348],
8	(	NN	O	(	dep	10	SENT_35	[p3l1418t324r1524b354],
9	14.1	CD	PERCENT	14.1	num	10	SENT_35	[p3l1418t324r1524b354],
10	%	NN	PERCENT	%	dep	15	SENT_35	[p3l1418t324r1524b354],
11	)	CD	NUMBER	)	number	12	SENT_35	[p3l1418t324r1524b354],
12	0.94	CD	NUMBER	0.94	dep	10	SENT_35	[p3l1626t325r1684b348],
13	0.19-4	CD	NUMBER	0.19-4	dep	12	SENT_35	[p3l1786t325r1921b348],
14	.73	CD	NUMBER	.73	num	15	SENT_35	[p3l1786t325r1921b348],
15	.94	CD	NUMBER	.94	_	0	SENT_35	[p3l2024t325r2064b348],

1	undergoing	VBG	O	undergo	_	0	SENT_36	[p3l10t554r419b635],
2	immunosuppressive	JJ	O	immunosuppressive	amod	3	SENT_36	[p3l461t555r1170b636],
3	treatment	NN	O	treatment	dobj	1	SENT_36	[p3l1212t563r1565b617],
4	with	IN	O	with	_	0	SENT_36	[p3l1603t554r1758b617],
5	mycophenolate	JJ	O	mycophenolate	amod	6	SENT_36	[p3l1799t554r2146b636, p3l10t656r233b718],
6	mofetil	NN	O	mofetil	prep_with	1	SENT_36	[p3l265t656r521b718],
7	(	CD	NUMBER	(	num	9	SENT_36	[p3l555t655r844b738],
8	MMF	NN	O	mmf	nn	9	SENT_36	[p3l555t655r844b738],
9	)	NN	O	)	tmod	1	SENT_36	[p3l555t655r844b738],
10	,	,	O	,	_	0	SENT_36	[p3l555t655r844b738],
11	a	DT	O	a	det	12	SENT_36	[p3l880t676r917b718],
12	prodrug	NN	O	prodrug	appos	9	SENT_36	[p3l947t656r1236b737],
13	of	IN	O	of	_	0	SENT_36	[p3l1268t657r1342b718],
14	MPA	NNP	O	MPA	prep_of	12	SENT_36	[p3l1370t657r1579b718],
15	.	.	O	.	_	0	SENT_36	[p3l1370t657r1579b718],

1	PATIENTS	NNS	O	patient	_	0	SENT_37	[p3l15t878r380b938],
2	AND	CC	O	and	_	0	SENT_37	[p3l422t879r585b937],
3	METHODS	NNS	O	method	conj_and	1	SENT_37	[p3l634t878r1016b938],

1	The	DT	O	the	det	2	SENT_38	[p3l10t1014r135b1069],
2	study	NN	O	study	nsubj	3	SENT_38	[p3l162t1014r329b1086],
3	included	VBD	O	include	_	0	SENT_38	[p3l353t1014r626b1069],
4	177	CD	NUMBER	177	num	7	SENT_38	[p3l656t1015r761b1069],
5	kidney	NN	O	kidney	nn	7	SENT_38	[p3l786t1014r999b1086],
6	allograft	NN	O	allograft	nn	7	SENT_38	[p3l1024t1014r1290b1086],
7	recipients	NNS	O	recipient	nsubj	8	SENT_38	[p3l1316t1014r1625b1086],
8	(	VBP	O	(	ccomp	3	SENT_38	[p3l1654t1013r1752b1087],
9	70	CD	NUMBER	70	num	10	SENT_38	[p3l1654t1013r1752b1087],
10	women	NNS	O	woman	nsubj	17	SENT_38	[p3l1774t1031r2007b1069],
11	and	CC	O	and	_	0	SENT_38	[p3l2034t1014r2149b1069],
12	107	CD	NUMBER	107	num	13	SENT_38	[p3l15t1107r120b1161],
13	men	NNS	O	man	nsubj	17	SENT_38	[p3l158t1105r322b1179],
14	)	CD	NUMBER	)	dep	13	SENT_38	[p3l158t1105r322b1179],
15	of	IN	O	of	_	0	SENT_38	[p3l364t1106r430b1161],
16	overall	JJ	O	overall	prep_of	14	SENT_38	[p3l465t1106r680b1161],
17	mean	VB	O	mean	ccomp	8	SENT_38	[p3l718t1124r893b1161],
18	age	NN	O	age	dobj	17	SENT_38	[p3l932t1124r1038b1178],
19	of	IN	O	of	_	0	SENT_38	[p3l1078t1106r1144b1161],
20	40.1	CD	NUMBER	40.1	prep_of	18	SENT_38	[p3l1178t1107r1303b1161],
21	:	:	O	:	_	0	SENT_38	[p3l1352t1114r1397b1158],
22	12.2	CD	DURATION	12.2	num	23	SENT_38	[p3l1447t1107r1572b1161],
23	years	NNS	NUMBER	year	dep	18	SENT_38	[p3l1606t1124r1788b1178],
24	,	,	O	,	_	0	SENT_38	[p3l1606t1124r1788b1178],
25	who	WP	O	who	nsubjpass	27	SENT_38	[p3l1825t1106r1958b1161],
26	were	VBD	O	be	auxpass	27	SENT_38	[p3l1994t1124r2147b1161],
27	engrafted	VBN	O	engraft	rcmod	23	SENT_38	[p3l12t1197r316b1269],
28	between	IN	O	between	_	0	SENT_38	[p3l342t1197r609b1252],
29	1997	CD	DATE	1997	prep_between	27	SENT_38	[p3l640t1198r783b1253],
30	and	CC	DATE	and	_	0	SENT_38	[p3l812t1197r927b1252],
31	2009	CD	DATE	2009	prep_between	27	SENT_38	[p3l955t1198r1118b1252],
32	.	.	O	.	_	0	SENT_38	[p3l955t1198r1118b1252],

1	The	DT	O	the	det	2	SENT_39	[p3l1148t1197r1272b1252],
2	patients	NNS	O	patient	nsubjpass	4	SENT_39	[p3l1300t1197r1552b1269],
3	were	VBD	O	be	auxpass	4	SENT_39	[p3l1577t1215r1731b1252],
4	subjected	VBN	O	subject	_	0	SENT_39	[p3l1760t1197r2059b1269],
5	to	TO	O	to	_	0	SENT_39	[p3l2086t1205r2148b1252],
6	immunosuppressive	JJ	O	immunosuppressive	amod	7	SENT_39	[p3l10t1290r641b1362],
7	therapy	NN	O	therapy	prep_to	4	SENT_39	[p3l688t1290r930b1362],
8	with	IN	O	with	_	0	SENT_39	[p3l971t1290r1109b1345],
9	MMF	NN	MISC	mmf	prep_with	4	SENT_39	[p3l1156t1291r1358b1357],
10	,	,	O	,	_	0	SENT_39	[p3l1156t1291r1358b1357],
11	glucocorticoids	NNS	O	glucocorticoid	prep_with	4	SENT_39	[p3l1406t1290r1903b1362],
12	,	,	O	,	_	0	SENT_39	[p3l1406t1290r1903b1362],
13	and	CC	O	and	_	0	SENT_39	[p3l1954t1290r2069b1345],
14	a	DT	O	a	det	16	SENT_39	[p3l2117t1308r2149b1345],
15	calcineurin	NN	O	calcineurin	nn	16	SENT_39	[p3l11t1382r362b1437],
16	inhibitor	NN	O	inhibitor	conj_and	9	SENT_39	[p3l384t1382r675b1437],
17	.	.	O	.	_	0	SENT_39	[p3l384t1382r675b1437],

1	Seventeen	CD	NUMBER	seventeen	num	2	SENT_40	[p3l702t1383r1029b1437],
2	patients	NNS	O	patient	nsubjpass	5	SENT_40	[p3l1050t1382r1302b1454],
3	were	VBD	O	be	auxpass	5	SENT_40	[p3l1321t1400r1475b1437],
4	additionally	RB	O	additionally	advmod	5	SENT_40	[p3l1500t1382r1876b1454],
5	induced	VBN	O	induce	_	0	SENT_40	[p3l1896t1382r2149b1437],
6	using	VBG	O	use	xcomp	5	SENT_40	[p3l10t1473r176b1545],
7	antithymocyte	JJ	O	antithymocyte	amod	8	SENT_40	[p3l205t1473r653b1545],
8	globulin	NN	O	globulin	dobj	6	SENT_40	[p3l682t1473r941b1545],
9	(	CD	NUMBER	(	num	11	SENT_40	[p3l971t1472r1207b1546],
10	ATG	NN	ORGANIZATION	atg	nn	11	SENT_40	[p3l971t1472r1207b1546],
11	)	NN	O	)	dep	8	SENT_40	[p3l971t1472r1207b1546],
12	.	.	O	.	_	0	SENT_40	[p3l971t1472r1207b1546],

1	The	DT	O	the	det	3	SENT_41	[p3l85t1566r210b1621],
2	clinical	JJ	O	clinical	amod	3	SENT_41	[p3l231t1566r453b1621],
3	status	NN	O	status	nsubjpass	8	SENT_41	[p3l474t1574r654b1621],
4	of	IN	O	of	_	0	SENT_41	[p3l675t1566r742b1621],
5	the	DT	O	the	det	6	SENT_41	[p3l756t1566r855b1621],
6	patients	NNS	O	patient	prep_of	3	SENT_41	[p3l875t1566r1127b1638],
7	was	VBD	O	be	auxpass	8	SENT_41	[p3l1144t1583r1260b1621],
8	analyzed	VBN	O	analyze	_	0	SENT_41	[p3l1282t1566r1557b1638],
9	at	IN	O	at	_	0	SENT_41	[p3l1579t1574r1636b1621],
10	1	CD	NUMBER	1	prep_at	8	SENT_41	[p3l1659t1567r1706b1633],
11	,	,	O	,	_	0	SENT_41	[p3l1659t1567r1706b1633],
12	2	CD	NUMBER	2	conj_and	10	SENT_41	[p3l1729t1567r1779b1633],
13	,	,	O	,	_	0	SENT_41	[p3l1729t1567r1779b1633],
14	4	CD	NUMBER	4	conj_and	10	SENT_41	[p3l1801t1567r1852b1633],
15	,	,	O	,	_	0	SENT_41	[p3l1801t1567r1852b1633],
16	8	CD	NUMBER	8	prep_at	8	SENT_41	[p3l1876t1567r1925b1633],
17	,	,	O	,	_	0	SENT_41	[p3l1876t1567r1925b1633],
18	12	CD	NUMBER	12	conj_and	10	SENT_41	[p3l1951t1567r2036b1633],
19	,	,	O	,	_	0	SENT_41	[p3l1951t1567r2036b1633],
20	24	CD	NUMBER	24	prep_at	8	SENT_41	[p3l2058t1567r2146b1633],
21	,	,	O	,	_	0	SENT_41	[p3l2058t1567r2146b1633],
22	and	CC	DURATION	and	_	0	SENT_41	[p3l12t1658r127b1713],
23	48	CD	DURATION	48	num	24	SENT_41	[p3l149t1659r220b1713],
24	weeks	NNS	NUMBER	week	conj_and	10	SENT_41	[p3l240t1658r433b1713],
25	after	IN	O	after	_	0	SENT_41	[p3l458t1658r606b1713],
26	transplantation	NN	O	transplantation	prep_after	8	SENT_41	[p3l627t1658r1128b1730],
27	.	.	O	.	_	0	SENT_41	[p3l627t1658r1128b1730],

1	The	DT	O	the	det	3	SENT_42	[p3l1154t1658r1278b1713],
2	following	VBG	O	follow	amod	3	SENT_42	[p3l1300t1658r1595b1730],
3	parameters	NNS	O	parameter	nsubjpass	5	SENT_42	[p3l1616t1666r1975b1730],
4	were	VBD	O	be	auxpass	5	SENT_42	[p3l1994t1676r2148b1713],
5	evaluated	VBN	O	evaluate	_	0	SENT_42	[p3l12t1749r334b1804],
6	:	:	O	:	_	0	SENT_42	[p3l12t1749r334b1804],
7	Biopsy-proven	JJ	O	biopsy-proven	amod	10	SENT_42	[p3l373t1749r834b1822],
8	acute	JJ	O	acute	amod	10	SENT_42	[p3l871t1757r1038b1804],
9	rejection	NN	O	rejection	nn	10	SENT_42	[p3l1074t1749r1355b1821],
10	episodes	NNS	O	episode	dobj	5	SENT_42	[p3l1391t1749r1679b1821],
11	,	,	O	,	_	0	SENT_42	[p3l1391t1749r1679b1821],
12	infections	NNS	O	infection	appos	10	SENT_42	[p3l1716t1749r2025b1804],
13	requiring	VBG	O	require	partmod	12	SENT_42	[p3l2061t1767r2147b1804, p3l12t1842r238b1914],
14	hospitalization	NN	O	hospitalization	dobj	13	SENT_42	[p3l267t1842r753b1914],
15	,	,	O	,	_	0	SENT_42	[p3l267t1842r753b1914],
16	gastrointestinal	JJ	O	gastrointestinal	amod	17	SENT_42	[p3l785t1842r1275b1914],
17	symptoms	NNS	O	symptom	conj_and	14	SENT_42	[p3l1306t1850r1640b1914],
18	,	,	O	,	_	0	SENT_42	[p3l1306t1850r1640b1914],
19	and	CC	O	and	_	0	SENT_42	[p3l1674t1842r1788b1897],
20	peripheral	JJ	O	peripheral	amod	22	SENT_42	[p3l1818t1842r2149b1914],
21	blood	NN	O	blood	nn	22	SENT_42	[p3l9t1934r191b1989],
22	neutrophil	NN	O	neutrophil	conj_and	14	SENT_42	[p3l219t1934r553b2006],
23	and	CC	O	and	_	0	SENT_42	[p3l583t1934r697b1989],
24	lymphocyte	NN	O	lymphocyte	nn	25	SENT_42	[p3l725t1934r1088b2006],
25	counts	NNS	O	count	conj_and	14	SENT_42	[p3l1117t1942r1339b1989],
26	.	.	O	.	_	0	SENT_42	[p3l1117t1942r1339b1989],

1	The	DT	O	the	det	3	SENT_43	[p3l85t2025r210b2080],
2	control	NN	O	control	nn	3	SENT_43	[p3l240t2025r467b2080],
3	group	NN	O	group	_	0	SENT_43	[p3l496t2043r681b2097],
4	for	IN	O	for	_	0	SENT_43	[p3l711t2026r803b2080],
5	the	DT	O	the	det	7	SENT_43	[p3l832t2025r931b2080],
6	genetic	JJ	O	genetic	amod	7	SENT_43	[p3l961t2025r1190b2097],
7	analysis	NN	O	analysis	prep_for	3	SENT_43	[p3l1219t2025r1461b2097],
8	of	IN	O	of	_	0	SENT_43	[p3l1492t2026r1559b2080],
9	the	DT	O	the	det	10	SENT_43	[p3l1584t2025r1682b2080],
10	prevalence	NN	O	prevalence	prep_of	7	SENT_43	[p3l1712t2025r2056b2097],
11	of	IN	O	of	_	0	SENT_43	[p3l2086t2026r2153b2080],
12	IMPDH2	NN	O	impdh2	nn	13	SENT_43	[p3l6t2119r298b2172],
13	3757T	NN	O	3757t	prep_of	10	SENT_43	[p3l319t2118r631b2173],
14	>	JJR	O	>	amod	16	SENT_43	[p3l319t2118r631b2173],
15	C	NN	O	c	nn	16	SENT_43	[p3l319t2118r631b2173],
16	variants	NNS	O	variant	nsubj	17	SENT_43	[p3l647t2118r898b2173],
17	consisted	VBD	O	consist	rcmod	3	SENT_43	[p3l918t2118r1211b2173],
18	of	IN	O	of	_	0	SENT_43	[p3l1231t2118r1298b2173],
19	550	CD	NUMBER	550	prep_of	3	SENT_43	[p3l1312t2118r1422b2173],
20	anonymous	JJ	O	anonymous	amod	21	SENT_43	[p3l1443t2135r1804b2190],
21	unrelated	JJ	O	unrelated	amod	19	SENT_43	[p3l1824t2118r2146b2185],
22	,	,	O	,	_	0	SENT_43	[p3l1824t2118r2146b2185],
23	randomly	RB	O	randomly	advmod	24	SENT_43	[p3l10t2210r315b2282],
24	selected	VBN	O	select	partmod	19	SENT_43	[p3l351t2210r622b2277],
25	,	,	O	,	_	0	SENT_43	[p3l351t2210r622b2277],
26	age	NN	O	age	npadvmod	24	SENT_43	[p3l664t2228r793b2282],
27	-	:	O	-	_	0	SENT_43	[p3l664t2228r793b2282],
28	and	CC	O	and	_	0	SENT_43	[p3l834t2210r949b2265],
29	gender-matched	JJ	O	gender-matched	amod	30	SENT_43	[p3l986t2210r1505b2282],
30	individuals	NNS	O	individual	npadvmod	24	SENT_43	[p3l1543t2210r1886b2265],
31	from	IN	O	from	_	0	SENT_43	[p3l1923t2210r2078b2265],
32	a	DT	O	a	det	34	SENT_43	[p3l2116t2228r2149b2265],
33	cohort	NN	O	cohort	nn	34	SENT_43	[p3l11t2301r217b2356],
34	representative	NN	O	representative	prep_from	24	SENT_43	[p3l250t2301r704b2373],
35	of	IN	O	of	_	0	SENT_43	[p3l739t2302r806b2356],
36	Central	NNP	LOCATION	Central	nn	37	SENT_43	[p3l837t2301r1074b2357],
37	Poland	NNP	LOCATION	Poland	prep_of	34	SENT_43	[p3l1108t2301r1348b2368],
38	,	,	O	,	_	0	SENT_43	[p3l1108t2301r1348b2368],
39	as	RB	O	as	advmod	41	SENT_43	[p3l1385t2319r1446b2356],
40	been	VBN	O	be	auxpass	41	SENT_43	[p3l1478t2301r1633b2356],
41	described	VBN	O	describe	dep	37	SENT_43	[p3l1667t2301r1970b2356],
42	elsewhere	RB	O	elsewhere	advmod	41	SENT_43	[p3l2004t2301r2147b2356, p3l7t2384r249b2449],
43	.6	CD	NUMBER	.6	pobj	42	SENT_43	[p3l2004t2301r2147b2356, p3l7t2384r249b2449],

1	The	DT	O	the	det	2	SENT_44	[p3l85t2486r210b2541],
2	study	NN	O	study	nsubjpass	12	SENT_44	[p3l246t2486r413b2558],
3	has	VBZ	O	have	aux	5	SENT_44	[p3l444t2486r548b2541],
4	been	VBN	O	be	auxpass	5	SENT_44	[p3l581t2486r735b2541],
5	approved	VBN	O	approve	_	0	SENT_44	[p3l771t2486r1067b2558],
6	by	IN	O	by	_	0	SENT_44	[p3l1099t2486r1173b2558],
7	our	PRP$	O	we	poss	10	SENT_44	[p3l1206t2504r1314b2541],
8	local	JJ	O	local	amod	10	SENT_44	[p3l1347t2486r1497b2541],
9	Ethical	NNP	ORGANIZATION	Ethical	nn	10	SENT_44	[p3l1530t2486r1757b2541],
10	Committee	NNP	ORGANIZATION	Committee	agent	5	SENT_44	[p3l1792t2486r2148b2541],
11	and	CC	O	and	_	0	SENT_44	[p3l12t2577r127b2632],
12	conducted	VBN	O	conduct	conj_and	5	SENT_44	[p3l156t2577r485b2632],
13	strictly	RB	O	strictly	advmod	12	SENT_44	[p3l514t2577r726b2649],
14	according	VBG	O	accord	_	0	SENT_44	[p3l754t2577r1062b2649],
15	to	TO	O	to	prepc_according_to	12	SENT_44	[p3l1089t2585r1150b2632],
16	the	DT	O	the	det	18	SENT_44	[p3l1179t2577r1278b2632],
17	approved	VBN	O	approve	amod	18	SENT_44	[p3l1309t2577r1606b2649],
18	protocols	NNS	O	protocol	pobj	12	SENT_44	[p3l1632t2577r1945b2649],
19	.	.	O	.	_	0	SENT_44	[p3l1632t2577r1945b2649],

1	DNA	NN	O	dna	nsubjpass	3	SENT_45	[p3l86t2671r262b2724],
2	was	VBD	O	be	auxpass	3	SENT_45	[p3l276t2687r393b2725],
3	extracted	VBN	O	extract	_	0	SENT_45	[p3l415t2670r707b2725],
4	from	IN	O	from	_	0	SENT_45	[p3l728t2670r881b2725],
5	blood	NN	O	blood	nn	6	SENT_45	[p3l900t2670r1082b2725],
6	samples	NNS	O	sample	prep_from	3	SENT_45	[p3l1104t2670r1354b2742],
7	by	IN	O	by	_	0	SENT_45	[p3l1373t2670r1448b2742],
8	a	DT	O	a	det	9	SENT_45	[p3l1468t2688r1501b2725],
9	standard	JJ	O	standard	agent	3	SENT_45	[p3l1522t2670r1797b2725],
10	salting	VBG	O	salt	partmod	9	SENT_45	[p3l1819t2670r2025b2742],
11	out	RP	O	out	prt	10	SENT_45	[p3l2046t2678r2149b2725],
12	method	NN	O	method	nn	15	SENT_45	[p3l10t2753r301b2817],
13	.7	CD	NUMBER	.7	num	15	SENT_45	[p3l10t2753r301b2817],
14	IMPDH2	NN	O	impdh2	nn	15	SENT_45	[p3l332t2763r625b2816],
15	3757T	NN	O	3757t	dobj	10	SENT_45	[p3l662t2762r975b2817],
16	>	JJR	O	>	amod	18	SENT_45	[p3l662t2762r975b2817],
17	C	NN	O	c	nn	18	SENT_45	[p3l662t2762r975b2817],
18	SNP	NN	O	snp	nsubj	21	SENT_45	[p3l1011t2763r1151b2817],
19	genetic	JJ	O	genetic	amod	20	SENT_45	[p3l1187t2762r1416b2834],
20	variants	NNS	O	variant	dep	18	SENT_45	[p3l1448t2762r1699b2817],
21	(	VBP	O	(	rcmod	15	SENT_45	[p3l1739t2761r2145b2835],
22	rs11706052	NN	O	rs11706052	nn	23	SENT_45	[p3l1739t2761r2145b2835],
23	)	NN	O	)	nsubjpass	25	SENT_45	[p3l1739t2761r2145b2835],
24	were	VBD	O	be	auxpass	25	SENT_45	[p3l7t2871r161b2908],
25	genotyped	VBN	O	genotype	ccomp	21	SENT_45	[p3l201t2853r531b2925],
26	by	IN	O	by	_	0	SENT_45	[p3l569t2853r643b2925],
27	a	DT	O	a	det	34	SENT_45	[p3l682t2871r715b2908],
28	speciﬁc	JJ	O	speciﬁc	amod	34	SENT_45	[p3l755t2853r987b2925],
29	polymerase	NN	O	polymerase	nn	34	SENT_45	[p3l1025t2853r1388b2925],
30	chain	NN	O	chain	nn	34	SENT_45	[p3l1429t2853r1599b2908],
31	reaction	NN	O	reaction	nn	34	SENT_45	[p3l1638t2853r1898b2908],
32	(	CD	NUMBER	(	num	34	SENT_45	[p3l1940t2852r2145b2926],
33	PCR	NN	O	pcr	nn	34	SENT_45	[p3l1940t2852r2145b2926],
34	)	NN	O	)	agent	25	SENT_45	[p3l1940t2852r2145b2926],
35	sequence	NN	O	sequence	nn	36	SENT_45	[p3l11t2963r303b3018],
36	ampliﬁcation	NN	O	ampliﬁcation	dep	34	SENT_45	[p3l351t2946r766b3018],
37	followed	VBN	O	follow	partmod	34	SENT_45	[p3l811t2946r1085b3001],
38	by	IN	O	by	_	0	SENT_45	[p3l1129t2946r1202b3018],
39	restriction	NN	O	restriction	nn	43	SENT_45	[p3l1246t2946r1572b3001],
40	fragment	NN	O	fragment	nn	43	SENT_45	[p3l1617t2946r1905b3018],
41	length	NN	O	length	nn	43	SENT_45	[p3l1950t2946r2149b3018],
42	polymorphism	NN	O	polymorphism	nn	43	SENT_45	[p3l9t3038r468b3110],
43	analysis	NN	O	analysis	agent	37	SENT_45	[p3l514t3038r772b3110],
44	,	,	O	,	_	0	SENT_45	[p3l514t3038r772b3110],
45	employing	VBG	O	employ	partmod	43	SENT_45	[p3l820t3038r1149b3110],
46	a	DT	O	a	det	50	SENT_45	[p3l1194t3056r1227b3093],
47	5	CD	NUMBER	5	num	50	SENT_45	[p3l1271t3038r2147b3093, p3l13t3130r497b3185],
48	’	NN	O	’	nn	50	SENT_45	[p3l1271t3038r2147b3093, p3l13t3130r497b3185],
49	GTAGTGGTTTTGGTGAGCGGC-3	NN	O	gtagtggttttggtgagcggc-3	nn	50	SENT_45	[p3l1271t3038r2147b3093, p3l13t3130r497b3185],
50	’	NN	O	’	dobj	45	SENT_45	[p3l1271t3038r2147b3093, p3l13t3130r497b3185],
51	and	CC	O	and	_	0	SENT_45	[p3l571t3129r686b3184],
52	5	CD	NUMBER	5	conj_and	50	SENT_45	[p3l753t3130r785b3184],
53	’	SYM	O	’	dep	50	SENT_45	[p3l796t3130r807b3152],
54	-	:	O	-	_	0	SENT_45	[p3l817t3130r2143b3185],
55	CTGGAAGATGGAATTTCCCTGG-3	NN	O	ctggaagatggaatttccctgg-3	nn	56	SENT_45	[p3l817t3130r2143b3185],
56	’	NN	O	’	dep	9	SENT_45	[p3l817t3130r2143b3185],

1	PCR	NN	O	pcr	nn	3	SENT_46	[p4l11t26r165b81],
2	primer	NN	O	primer	nn	3	SENT_46	[p4l198t26r415b98],
3	pair	NN	O	pair	dep	14	SENT_46	[p4l448t26r574b98],
4	and	CC	O	and	_	0	SENT_46	[p4l610t26r725b81],
5	BsuRI	NN	O	bsurus	nn	7	SENT_46	[p4l759t27r964b81],
6	restriction	NN	O	restriction	nn	7	SENT_46	[p4l999t26r1325b81],
7	enzyme	NN	O	enzyme	conj_and	3	SENT_46	[p4l1361t43r1599b98],
8	(	CD	NUMBER	(	num	10	SENT_46	[p4l1638t25r2048b99],
9	Fermentas	NNP	O	Fermentas	nn	10	SENT_46	[p4l1638t25r2048b99],
10	)	NN	O	)	dep	3	SENT_46	[p4l1638t25r2048b99],
11	,	,	O	,	_	0	SENT_46	[p4l1638t25r2048b99],
12	as	IN	O	as	_	0	SENT_46	[p4l2087t43r2148b81],
13	reference	NN	O	reference	prep_as	14	SENT_46	[p4l10t118r311b173],
14	served	VBD	O	serve	_	0	SENT_46	[p4l339t118r541b173],
15	the	DT	O	the	det	18	SENT_46	[p4l567t118r665b173],
16	N	NN	O	n	nn	18	SENT_46	[p4l691t120r747b172],
17	CBI	NNP	O	CBI	nn	18	SENT_46	[p4l751t119r879b173],
18	NG_012091	NN	O	ng_012091	dobj	14	SENT_46	[p4l905t119r1336b190],
19	.1	CD	NUMBER	.1	num	21	SENT_46	[p4l905t119r1336b190],
20	genomic	JJ	O	genomic	amod	21	SENT_46	[p4l1364t118r1634b190],
21	sequence	NN	O	sequence	nsubj	14	SENT_46	[p4l1659t135r1967b190],
22	.	.	O	.	_	0	SENT_46	[p4l1659t135r1967b190],

1	Individual	JJ	O	individual	amod	3	SENT_47	[p4l1996t118r2147b173, p4l7t209r202b264],
2	PCR	NN	O	pcr	nn	3	SENT_47	[p4l236t210r390b265],
3	products	NNS	O	product	nsubjpass	5	SENT_47	[p4l422t209r699b281],
4	were	VBD	O	be	auxpass	5	SENT_47	[p4l730t227r884b264],
5	sequenced	VBN	O	sequence	_	0	SENT_47	[p4l919t209r1253b282],
6	using	VBG	O	use	xcomp	5	SENT_47	[p4l1286t209r1452b281],
7	an	DT	O	a	det	12	SENT_47	[p4l1487t227r1561b264],
8	ABI	NNP	O	ABI	nn	12	SENT_47	[p4l1593t210r1729b264],
9	PRISM	NN	O	prism	nn	12	SENT_47	[p4l1763t210r2004b265],
10	377	CD	NUMBER	377	num	12	SENT_47	[p4l2039t210r2148b264],
11	DNA	NN	O	dna	nn	12	SENT_47	[p4l10t303r186b356],
12	sequencer	NN	O	sequencer	nsubj	16	SENT_47	[p4l213t319r534b374],
13	(	CD	NUMBER	(	num	16	SENT_47	[p4l564t301r846b375],
14	Applied	NNP	O	Applied	nn	16	SENT_47	[p4l564t301r846b375],
15	Biosystems	NNP	O	Biosystems	nn	16	SENT_47	[p4l874t301r1271b375],
16	)	NN	O	)	xcomp	6	SENT_47	[p4l874t301r1271b375],
17	.	.	O	.	_	0	SENT_47	[p4l874t301r1271b375],

1	Statistical	JJ	O	statistical	amod	4	SENT_48	[p4l87t395r395b450],
2	analysis	NN	O	analysis	nn	4	SENT_48	[p4l419t395r661b467],
3	(	NN	O	(	nn	4	SENT_48	[p4l687t394r1112b468],
4	comparisons	NNS	O	comparison	nsubj	25	SENT_48	[p4l687t394r1112b468],
5	of	IN	O	of	_	0	SENT_48	[p4l1136t395r1202b450],
6	groups	NNS	O	group	prep_of	4	SENT_48	[p4l1220t394r1461b468],
7	)	CD	NUMBER	)	nsubjpass	9	SENT_48	[p4l1220t394r1461b468],
8	was	VBD	O	be	auxpass	9	SENT_48	[p4l1483t412r1599b450],
9	performed	VBN	O	perform	rcmod	6	SENT_48	[p4l1621t395r1960b467],
10	using	VBG	O	use	xcomp	9	SENT_48	[p4l1983t395r2149b467],
11	Fisher	NNP	PERSON	Fisher	poss	14	SENT_48	[p4l10t486r257b541],
12	’s	POS	O	’s	_	0	SENT_48	[p4l10t486r257b541],
13	exact	JJ	O	exact	amod	14	SENT_48	[p4l286t494r447b541],
14	test	NN	O	test	dobj	10	SENT_48	[p4l474t494r586b541],
15	for	IN	O	for	_	0	SENT_48	[p4l612t487r705b541],
16	qualitative	JJ	O	qualitative	amod	17	SENT_48	[p4l732t486r1065b558],
17	variables	NNS	O	variable	prep_for	14	SENT_48	[p4l1089t486r1372b541],
18	and	CC	O	and	_	0	SENT_48	[p4l1402t486r1517b541],
19	WilcoXon	NNP	PERSON	WilcoXon	poss	21	SENT_48	[p4l1542t486r1892b542],
20	’s	POS	O	’s	_	0	SENT_48	[p4l1542t486r1892b542],
21	test	NN	O	test	dobj	10	SENT_48	[p4l1919t494r2031b541],
22	for	IN	O	for	_	0	SENT_48	[p4l2057t487r2150b541],
23	quantitative	JJ	O	quantitative	amod	24	SENT_48	[p4l12t579r389b651],
24	variables	NNS	O	variable	prep_for	21	SENT_48	[p4l415t579r698b634],
25	(	VBP	O	(	_	0	SENT_48	[p4l730t578r909b652],
26	SAS	NNP	ORGANIZATION	SAS	dobj	25	SENT_48	[p4l730t578r909b652],
27	,	,	ORGANIZATION	,	_	0	SENT_48	[p4l730t578r909b652],
28	Inc.	NNP	ORGANIZATION	Inc.	nn	32	SENT_48	[p4l940t580r1074b645],
29	,	,	O	,	_	0	SENT_48	[p4l940t580r1074b645],
30	Chicago	NNP	LOCATION	Chicago	appos	32	SENT_48	[p4l1106t579r1380b651],
31	,	,	O	,	_	0	SENT_48	[p4l1106t579r1380b651],
32	Ill	NNP	O	Ill	appos	26	SENT_48	[p4l1412t578r1522b652],
33	)	CD	NUMBER	)	num	32	SENT_48	[p4l1412t578r1522b652],
34	.	.	O	.	_	0	SENT_48	[p4l1412t578r1522b652],

1	RESULTS	NNS	O	result	_	0	SENT_49	[p4l15t789r361b850],

1	The	DT	O	the	det	2	SENT_50	[p4l10t932r150b995],
2	frequency	NN	O	frequency	nsubj	14	SENT_50	[p4l200t933r556b1014],
3	of	IN	O	of	_	0	SENT_50	[p4l603t933r678b995],
4	IMPDH2	NN	O	impdh2	nn	5	SENT_50	[p4l716t934r1045b994],
5	3757T	NN	O	3757t	prep_of	2	SENT_50	[p4l1094t933r1316b995],
6	and	CC	O	and	_	0	SENT_50	[p4l1366t933r1495b994],
7	C	NN	O	c	nn	8	SENT_50	[p4l1546t933r1601b995],
8	alleles	NNS	O	allele	prep_of	2	SENT_50	[p4l1651t932r1871b995],
9	in	IN	O	in	_	0	SENT_50	[p4l1921t933r1987b994],
10	the	DT	O	the	det	12	SENT_50	[p4l2036t933r2147b995],
11	patient	NN	O	patient	nn	12	SENT_50	[p4l9t1035r262b1116],
12	group	NN	O	group	prep_in	2	SENT_50	[p4l313t1055r521b1116],
13	was	VBD	O	be	cop	14	SENT_50	[p4l569t1055r700b1097],
14	327/354	CD	PERCENT	327/354	_	0	SENT_50	[p4l753t1035r1025b1104],
15	(	CD	PERCENT	(	number	16	SENT_50	[p4l1079t1034r1362b1117],
16	92.4	CD	PERCENT	92.4	dep	17	SENT_50	[p4l1079t1034r1362b1117],
17	%	NN	PERCENT	%	dep	14	SENT_50	[p4l1079t1034r1362b1117],
18	)	CD	NUMBER	)	number	22	SENT_50	[p4l1079t1034r1362b1117],
19	and	CC	O	and	_	0	SENT_50	[p4l1418t1035r1547b1097],
20	27/354	CD	PERCENT	27/354	num	23	SENT_50	[p4l1599t1035r1829b1104],
21	(	CD	PERCENT	(	number	22	SENT_50	[p4l1884t1034r2144b1117],
22	7.6	CD	PERCENT	7.6	num	23	SENT_50	[p4l1884t1034r2144b1117],
23	%	NN	PERCENT	%	dep	14	SENT_50	[p4l1884t1034r2144b1117],
24	)	CD	NUMBER	)	dep	23	SENT_50	[p4l1884t1034r2144b1117],
25	.	.	O	.	_	0	SENT_50	[p4l1884t1034r2144b1117],

1	Among	IN	O	among	_	0	SENT_51	[p4l8t1139r276b1219],
2	the	DT	O	the	det	4	SENT_51	[p4l310t1138r422b1200],
3	control	NN	O	control	nn	4	SENT_51	[p4l458t1138r712b1200],
4	group	NN	O	group	prep_among	10	SENT_51	[p4l747t1157r955b1219],
5	the	DT	O	the	det	7	SENT_51	[p4l990t1138r1102b1200],
6	respective	JJ	O	respective	amod	7	SENT_51	[p4l1138t1138r1495b1219],
7	frequencies	NNS	O	frequency	nsubj	10	SENT_51	[p4l1531t1138r1943b1219],
8	were	VBD	O	be	cop	10	SENT_51	[p4l1975t1157r2147b1200],
9	1023/1100	CD	PERCENT	1023/1100	number	10	SENT_51	[p4l16t1240r355b1309],
10	(	CD	PERCENT	(	_	0	SENT_51	[p4l388t1238r600b1322],
11	93	CD	PERCENT	93	num	12	SENT_51	[p4l388t1238r600b1322],
12	%	NN	PERCENT	%	dep	10	SENT_51	[p4l388t1238r600b1322],
13	)	CD	NUMBER	)	dep	10	SENT_51	[p4l388t1238r600b1322],
14	and	CC	O	and	_	0	SENT_51	[p4l635t1239r761b1301],
15	77/1100	CD	PERCENT	77/1100	number	16	SENT_51	[p4l791t1240r1053b1309],
16	(	CD	PERCENT	(	conj_and	10	SENT_51	[p4l1087t1238r1338b1322],
17	7.0	CD	PERCENT	7.0	num	18	SENT_51	[p4l1087t1238r1338b1322],
18	%	NN	PERCENT	%	dep	16	SENT_51	[p4l1087t1238r1338b1322],
19	)	CD	NUMBER	)	dep	16	SENT_51	[p4l1087t1238r1338b1322],
20	.	.	O	.	_	0	SENT_51	[p4l1087t1238r1338b1322],

1	There	EX	O	there	expl	2	SENT_52	[p4l1370t1240r1578b1302],
2	were	VBD	O	be	dep	19	SENT_52	[p4l1604t1259r1772b1302],
3	no	DT	O	no	det	5	SENT_52	[p4l1802t1259r1888b1302],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_52	[p4l1921t1239r2146b1320, p4l11t1352r155b1405],
5	differences	NNS	O	difference	nsubj	2	SENT_52	[p4l191t1343r559b1405],
6	in	IN	O	in	_	0	SENT_52	[p4l594t1343r658b1404],
7	the	DT	O	the	det	8	SENT_52	[p4l692t1343r800b1405],
8	distributions	NNS	O	distribution	prep_in	5	SENT_52	[p4l836t1343r1262b1405],
9	of	IN	O	of	_	0	SENT_52	[p4l1298t1344r1371b1405],
10	these	DT	O	these	det	11	SENT_52	[p4l1400t1343r1579b1405],
11	alleles	NNS	O	allele	prep_of	8	SENT_52	[p4l1616t1343r1826b1405],
12	between	IN	O	between	_	0	SENT_52	[p4l1859t1343r2149b1405],
13	the	DT	O	the	det	14	SENT_52	[p4l10t1445r119b1507],
14	patient	NN	O	patient	prep_between	11	SENT_52	[p4l156t1445r398b1526],
15	and	CC	O	and	_	0	SENT_52	[p4l436t1445r562b1507],
16	the	DT	O	the	det	18	SENT_52	[p4l598t1445r707b1507],
17	control	NN	O	control	nn	18	SENT_52	[p4l745t1445r990b1507],
18	groups	NNS	O	group	prep_between	11	SENT_52	[p4l1026t1464r1259b1526],
19	(	VBP	O	(	_	0	SENT_52	[p4l1299t1443r1377b1527],
20	P	NN	O	p	nsubj	21	SENT_52	[p4l1299t1443r1377b1527],
21	=	JJ	O	=	xcomp	19	SENT_52	[p4l1419t1469r1470b1488],
22	.689	CD	NUMBER	.689	num	23	SENT_52	[p4l1519t1444r1701b1527],
23	)	NN	O	)	nsubj	19	SENT_52	[p4l1519t1444r1701b1527],
24	.	.	O	.	_	0	SENT_52	[p4l1519t1444r1701b1527],

1	Analysis	NN	O	analysis	nsubj	5	SENT_53	[p4l1739t1445r2038b1526],
2	of	IN	O	of	_	0	SENT_53	[p4l2078t1445r2153b1507],
3	genotype	NN	O	genotype	nn	4	SENT_53	[p4l10t1555r335b1627],
4	distribution	NN	O	distribution	prep_of	1	SENT_53	[p4l382t1546r796b1609],
5	revealed	VBD	O	reveal	_	0	SENT_53	[p4l840t1546r1144b1609],
6	150	CD	PERCENT	150	dobj	5	SENT_53	[p4l1193t1547r1311b1609],
7	(	CD	PERCENT	(	number	8	SENT_53	[p4l1359t1545r1641b1629],
8	84.7	CD	PERCENT	84.7	num	9	SENT_53	[p4l1359t1545r1641b1629],
9	%	NN	PERCENT	%	dep	6	SENT_53	[p4l1359t1545r1641b1629],
10	)	CD	NUMBER	)	num	12	SENT_53	[p4l1359t1545r1641b1629],
11	TT	NN	ORGANIZATION	tt	nn	12	SENT_53	[p4l1689t1548r1798b1608],
12	homozygotes	NNS	O	homozygote	dep	6	SENT_53	[p4l1841t1546r2146b1627, p4l10t1658r195b1730],
13	and	CC	O	and	_	0	SENT_53	[p4l250t1649r379b1711],
14	27	CD	PERCENT	27	number	15	SENT_53	[p4l432t1650r512b1711],
15	(	CD	PERCENT	(	conj_and	6	SENT_53	[p4l567t1648r849b1731],
16	15.3	CD	PERCENT	15.3	num	17	SENT_53	[p4l567t1648r849b1731],
17	%	NN	PERCENT	%	dep	15	SENT_53	[p4l567t1648r849b1731],
18	)	CD	NUMBER	)	num	20	SENT_53	[p4l567t1648r849b1731],
19	TC	NN	O	tc	nn	20	SENT_53	[p4l903t1650r1017b1712],
20	heterozygotes	NNS	O	heterozygote	tmod	5	SENT_53	[p4l1067t1649r1563b1730],
21	in	IN	O	in	_	0	SENT_53	[p4l1615t1649r1681b1710],
22	the	DT	O	the	det	24	SENT_53	[p4l1733t1649r1844b1711],
23	patient	NN	O	patient	nn	24	SENT_53	[p4l1896t1649r2148b1730],
24	group	NN	O	group	prep_in	20	SENT_53	[p4l10t1770r237b1832],
25	.	.	O	.	_	0	SENT_53	[p4l10t1770r237b1832],

1	The	DT	O	the	det	3	SENT_54	[p4l285t1751r425b1813],
2	control	NN	O	control	nn	3	SENT_54	[p4l471t1751r726b1813],
3	group	NN	O	group	nsubj	4	SENT_54	[p4l771t1770r979b1832],
4	included	VBD	O	include	_	0	SENT_54	[p4l1025t1751r1332b1813],
5	476	CD	PERCENT	476	number	6	SENT_54	[p4l1377t1752r1499b1813],
6	(	CD	PERCENT	(	dobj	4	SENT_54	[p4l1548t1749r1830b1833],
7	86.6	CD	PERCENT	86.6	num	8	SENT_54	[p4l1548t1749r1830b1833],
8	%	NN	PERCENT	%	dep	6	SENT_54	[p4l1548t1749r1830b1833],
9	)	CD	NUMBER	)	num	11	SENT_54	[p4l1548t1749r1830b1833],
10	TT	NN	ORGANIZATION	tt	nn	11	SENT_54	[p4l1877t1753r1987b1812],
11	homozygotes	NNS	O	homozygote	dep	6	SENT_54	[p4l2031t1751r2146b1813, p4l12t1861r407b1933],
12	,	,	O	,	_	0	SENT_54	[p4l2031t1751r2146b1813, p4l12t1861r407b1933],
13	71	CD	PERCENT	71	number	14	SENT_54	[p4l436t1854r513b1915],
14	(	CD	PERCENT	(	conj_and	6	SENT_54	[p4l546t1851r828b1935],
15	12.9	CD	PERCENT	12.9	num	16	SENT_54	[p4l546t1851r828b1935],
16	%	NN	PERCENT	%	dep	14	SENT_54	[p4l546t1851r828b1935],
17	)	CD	NUMBER	)	num	19	SENT_54	[p4l546t1851r828b1935],
18	TC	NN	O	tc	nn	19	SENT_54	[p4l857t1853r971b1915],
19	heterozygotes	NNS	O	heterozygote	dep	14	SENT_54	[p4l996t1852r1511b1933],
20	,	,	O	,	_	0	SENT_54	[p4l996t1852r1511b1933],
21	and	CC	O	and	_	0	SENT_54	[p4l1541t1852r1670b1914],
22	3	CD	PERCENT	3	num	23	SENT_54	[p4l1697t1853r1733b1914],
23	(	NN	PERCENT	(	dobj	4	SENT_54	[p4l1765t1851r2005b1935],
24	0.5	CD	PERCENT	0.5	number	25	SENT_54	[p4l1765t1851r2005b1935],
25	%	NN	PERCENT	%	amod	23	SENT_54	[p4l1765t1851r2005b1935],
26	)	CD	NUMBER	)	num	28	SENT_54	[p4l1765t1851r2005b1935],
27	CC	NN	O	cc	nn	28	SENT_54	[p4l2036t1853r2152b1915],
28	homozygotes	NNS	O	homozygote	dep	23	SENT_54	[p4l13t1956r498b2037],
29	.	.	O	.	_	0	SENT_54	[p4l13t1956r498b2037],

1	The	DT	O	the	det	2	SENT_55	[p4l529t1956r669b2018],
2	distribution	NN	O	distribution	nsubj	13	SENT_55	[p4l700t1956r1114b2018],
3	of	IN	O	of	_	0	SENT_55	[p4l1142t1956r1217b2018],
4	genotypes	NNS	O	genotype	prep_of	2	SENT_55	[p4l1240t1965r1597b2037],
5	in	IN	O	in	_	0	SENT_55	[p4l1626t1956r1692b2017],
6	both	DT	O	both	det	7	SENT_55	[p4l1718t1956r1882b2018],
7	groups	NNS	O	group	prep_in	4	SENT_55	[p4l1909t1975r2150b2037],
8	was	VBD	O	be	cop	13	SENT_55	[p4l9t2077r140b2120],
9	in	IN	O	in	_	0	SENT_55	[p4l173t2058r239b2119],
10	Hardy-Weinberg	JJ	LOCATION	hardy-weinberg	amod	11	SENT_55	[p4l272t2058r878b2139],
11	equilibrium	NN	O	equilibrium	prep_in	13	SENT_55	[p4l912t2058r1327b2139],
12	(	CD	NUMBER	(	num	13	SENT_55	[p4l1362t2056r1441b2140],
13	P	NN	O	p	_	0	SENT_55	[p4l1362t2056r1441b2140],
14	=	JJ	O	=	amod	13	SENT_55	[p4l1479t2082r1530b2101],
15	.27	CD	NUMBER	.27	tmod	14	SENT_55	[p4l1574t2059r1672b2120],
16	and	CC	O	and	_	0	SENT_55	[p4l1707t2058r1836b2120],
17	P	NN	O	p	nn	19	SENT_55	[p4l1862t2060r1919b2119],
18	=	JJ	O	=	amod	19	SENT_55	[p4l1957t2082r2007b2101],
19	.84	NN	NUMBER	.84	conj_and	13	SENT_55	[p4l2051t2059r2150b2120],
20	for	IN	O	for	_	0	SENT_55	[p4l12t2160r116b2221],
21	patient	NN	O	patient	nn	24	SENT_55	[p4l146t2159r398b2240],
22	and	CC	O	and	_	0	SENT_55	[p4l431t2159r560b2221],
23	control	NN	O	control	nn	24	SENT_55	[p4l592t2159r847b2221],
24	groups	NNS	O	group	prep_for	19	SENT_55	[p4l878t2179r1138b2240],
25	,	,	O	,	_	0	SENT_55	[p4l878t2179r1138b2240],
26	respectively	RB	O	respectively	advmod	27	SENT_55	[p4l1172t2158r1642b2241],
27	)	CD	NUMBER	)	rcmod	19	SENT_55	[p4l1172t2158r1642b2241],
28	.	.	O	.	_	0	SENT_55	[p4l1172t2158r1642b2241],

1	We	PRP	O	we	nsubj	4	SENT_56	[p4l96t2265r218b2325],
2	did	VBD	O	do	aux	4	SENT_56	[p4l262t2263r373b2325],
3	not	RB	O	not	neg	4	SENT_56	[p4l414t2272r531b2325],
4	observe	VB	O	observe	_	0	SENT_56	[p4l573t2263r846b2325],
5	any	DT	O	any	det	7	SENT_56	[p4l890t2283r1012b2344],
6	signiﬁcant	NN	O	signiﬁcant	nn	7	SENT_56	[p4l1053t2263r1415b2344],
7	difference	NN	O	difference	dobj	4	SENT_56	[p4l1458t2263r1811b2325],
8	between	IN	O	between	_	0	SENT_56	[p4l1851t2263r2151b2325],
9	patients	NNS	O	patient	prep_between	7	SENT_56	[p4l11t2365r295b2446],
10	carrying	VBG	O	carry	partmod	9	SENT_56	[p4l335t2365r623b2445],
11	3757C	NN	O	3757c	nn	14	SENT_56	[p4l662t2365r888b2427],
12	and	CC	O	and	_	0	SENT_56	[p4l927t2364r1056b2426],
13	T	NN	O	t	conj_and	11	SENT_56	[p4l1094t2367r1148b2426],
14	alleles	NNS	O	allele	dobj	10	SENT_56	[p4l1187t2364r1407b2427],
15	with	IN	O	with	_	0	SENT_56	[p4l1442t2364r1598b2427],
16	respect	NN	O	respect	prep_with	10	SENT_56	[p4l1636t2373r1892b2446],
17	to	TO	O	to	_	0	SENT_56	[p4l1930t2373r1999b2427],
18	the	DT	O	the	det	19	SENT_56	[p4l2038t2364r2150b2427],
19	risk	NN	O	risk	prep_to	10	SENT_56	[p4l13t2467r143b2529],
20	of	IN	O	of	_	0	SENT_56	[p4l172t2468r247b2529],
21	acute	JJ	O	acute	amod	23	SENT_56	[p4l275t2476r463b2530],
22	rejection	NN	O	rejection	nn	23	SENT_56	[p4l494t2467r810b2548],
23	episodes	NNS	O	episode	prep_of	19	SENT_56	[p4l842t2467r1165b2548],
24	,	,	O	,	_	0	SENT_56	[p4l842t2467r1165b2548],
25	incidence	NN	O	incidence	prep_to	10	SENT_56	[p4l1199t2467r1537b2529],
26	of	IN	O	of	_	0	SENT_56	[p4l1569t2468r1644b2529],
27	serious	JJ	O	serious	amod	28	SENT_56	[p4l1670t2467r1919b2529],
28	infections	NNS	O	infection	prep_of	25	SENT_56	[p4l1951t2467r2150b2529, p4l13t2570r203b2645],
29	,	,	O	,	_	0	SENT_56	[p4l1951t2467r2150b2529, p4l13t2570r203b2645],
30	gastrointestinal	JJ	O	gastrointestinal	amod	32	SENT_56	[p4l233t2570r783b2651],
31	side	JJ	O	side	amod	32	SENT_56	[p4l812t2570r950b2632],
32	effects	NNS	O	effect	appos	28	SENT_56	[p4l979t2570r1202b2632],
33	or	CC	O	or	_	0	SENT_56	[p4l1230t2590r1306b2632],
34	neutropenia	NN	O	neutropenia	nn	36	SENT_56	[p4l1332t2570r1769b2651],
35	(	CD	NUMBER	(	num	36	SENT_56	[p4l1799t2569r2030b2652],
36	Table	NNP	O	Table	conj_or	19	SENT_56	[p4l1799t2569r2030b2652],
37	1	CD	NUMBER	1	number	38	SENT_56	[p4l2063t2569r2147b2652],
38	)	CD	NUMBER	)	dep	36	SENT_56	[p4l2063t2569r2147b2652],
39	.	.	O	.	_	0	SENT_56	[p4l2063t2569r2147b2652],

1	At	IN	O	at	_	0	SENT_57	[p4l95t2673r187b2734],
2	4	CD	DURATION	4	num	3	SENT_57	[p4l222t2673r261b2733],
3	weeks	NNS	NUMBER	week	tmod	4	SENT_57	[p4l293t2671r510b2734],
4	posttransplant	JJ	O	posttransplant	prep_at	9	SENT_57	[p4l545t2672r1078b2753],
5	,	,	O	,	_	0	SENT_57	[p4l545t2672r1078b2753],
6	lymphocyte	NN	O	lymphocyte	nn	7	SENT_57	[p4l1116t2671r1525b2753],
7	counts	NNS	O	count	nsubjpass	9	SENT_57	[p4l1562t2680r1793b2734],
8	were	VBD	O	be	auxpass	9	SENT_57	[p4l1825t2691r1998b2734],
9	observed	VBN	O	observe	_	0	SENT_57	[p4l2036t2671r2149b2734, p4l14t2774r242b2836],
10	to	TO	O	to	aux	13	SENT_57	[p4l271t2783r340b2836],
11	be	VB	O	be	cop	13	SENT_57	[p4l367t2774r452b2836],
12	signiﬁcantly	RB	O	signiﬁcantly	advmod	13	SENT_57	[p4l482t2774r906b2855],
13	higher	JJR	O	higher	xcomp	9	SENT_57	[p4l933t2774r1161b2855],
14	(	CD	NUMBER	(	num	15	SENT_57	[p4l1192t2773r1271b2856],
15	P	NN	O	p	nsubj	16	SENT_57	[p4l1192t2773r1271b2856],
16	=	JJ	O	=	ccomp	13	SENT_57	[p4l1305t2798r1356b2818],
17	.040	CD	NUMBER	.040	num	18	SENT_57	[p4l1396t2773r1566b2856],
18	)	NN	O	)	dobj	16	SENT_57	[p4l1396t2773r1566b2856],
19	among	IN	O	among	_	0	SENT_57	[p4l1600t2794r1839b2855],
20	patients	NNS	O	patient	prep_among	18	SENT_57	[p4l1866t2774r2150b2855],
21	carrying	VBG	O	carry	partmod	20	SENT_57	[p4l14t2876r302b2957],
22	the	DT	O	the	det	28	SENT_57	[p4l353t2876r465b2938],
23	3757C	NN	O	3757c	nn	28	SENT_57	[p4l518t2876r744b2938],
24	allele	NN	O	allele	nn	28	SENT_57	[p4l796t2876r984b2938],
25	(	CD	NUMBER	(	num	28	SENT_57	[p4l1040t2875r1183b2958],
26	Fig	NN	O	fig	nn	28	SENT_57	[p4l1040t2875r1183b2958],
27	1A	NN	O	1a	nn	28	SENT_57	[p4l1239t2875r1388b2958],
28	)	NN	O	)	dobj	21	SENT_57	[p4l1239t2875r1388b2958],
29	.	.	O	.	_	0	SENT_57	[p4l1239t2875r1388b2958],

1	This	DT	O	this	det	2	SENT_58	[p4l1443t2876r1597b2938],
2	tendency	NN	O	tendency	nsubjpass	4	SENT_58	[p4l1649t2876r1973b2957],
3	was	VBD	O	be	auxpass	4	SENT_58	[p4l2019t2895r2150b2938],
4	observed	VBN	O	observe	_	0	SENT_58	[p4l14t2978r333b3041],
5	also	RB	O	also	advmod	4	SENT_58	[p4l363t2978r499b3041],
6	after	IN	O	after	_	0	SENT_58	[p4l531t2979r698b3041],
7	8	CD	DURATION	8	num	8	SENT_58	[p4l726t2980r762b3041],
8	weeks	NNS	NUMBER	week	prep_after	4	SENT_58	[p4l788t2979r1025b3053],
9	;	:	O	;	_	0	SENT_58	[p4l788t2979r1025b3053],
10	however	RB	O	however	advmod	22	SENT_58	[p4l1056t2978r1375b3053],
11	,	,	O	,	_	0	SENT_58	[p4l1056t2978r1375b3053],
12	the	DT	O	the	det	13	SENT_58	[p4l1406t2979r1517b3041],
13	difference	NN	O	difference	nsubj	22	SENT_58	[p4l1548t2978r1900b3041],
14	was	VBD	O	be	cop	22	SENT_58	[p4l1925t2998r2056b3041],
15	at	IN	O	at	_	0	SENT_58	[p4l2087t2987r2151b3040],
16	the	DT	O	the	det	17	SENT_58	[p4l13t3080r124b3142],
17	borderline	NN	O	borderline	prep_at	22	SENT_58	[p4l151t3080r527b3142],
18	of	IN	O	of	_	0	SENT_58	[p4l556t3081r631b3142],
19	signiﬁcance	NN	O	signiﬁcance	nn	21	SENT_58	[p4l655t3080r1067b3161],
20	(	CD	NUMBER	(	num	21	SENT_58	[p4l1099t3079r1178b3162],
21	P	NN	O	p	prep_of	17	SENT_58	[p4l1099t3079r1178b3162],
22	=	JJ	O	=	parataxis	4	SENT_58	[p4l1211t3104r1262b3124],
23	.068	CD	NUMBER	.068	num	24	SENT_58	[p4l1301t3079r1493b3162],
24	)	NN	O	)	dep	22	SENT_58	[p4l1301t3079r1493b3162],
25	.	.	O	.	_	0	SENT_58	[p4l1301t3079r1493b3162],

1	Furthermore	RB	O	furthermore	advmod	7	SENT_59	[p4l1524t3080r2008b3155],
2	,	,	O	,	_	0	SENT_59	[p4l1524t3080r2008b3155],
3	the	DT	O	the	det	4	SENT_59	[p4l2038t3080r2149b3142],
4	incidence	NN	O	incidence	nsubj	7	SENT_59	[p4l13t3182r352b3244],
5	of	IN	O	of	_	0	SENT_59	[p4l393t3182r468b3244],
6	lymphopenia	NN	O	lymphopenia	prep_of	4	SENT_59	[p4l502t3182r967b3263],
7	deﬁned	VBN	O	deﬁned	_	0	SENT_59	[p4l1008t3181r1273b3244],
8	as	IN	O	as	_	0	SENT_59	[p4l1315t3201r1383b3244],
9	a	DT	O	a	det	11	SENT_59	[p4l1425t3202r1462b3244],
10	lymphocyte	NN	O	lymphocyte	nn	11	SENT_59	[p4l1501t3182r1910b3263],
11	count	NN	O	count	prep_as	7	SENT_59	[p4l1951t3191r2151b3244],
12	<	JJR	O	<	npadvmod	15	SENT_59	[p4l18t3284r118b3345],
13	1	CD	NUMBER	1	number	14	SENT_59	[p4l18t3284r118b3345],
14	>	JJR	O	>	amod	12	SENT_59	[p4l167t3292r217b3342],
15	<	JJR	O	<	amod	11	SENT_59	[p4l167t3292r217b3342],
16	103/p	CD	NUMBER	103/p	tmod	7	SENT_59	[p4l267t3273r512b3363],
17	.	.	O	.	_	0	SENT_59	[p4l267t3273r512b3363],

1	L	NN	O	l	nsubj	4	SENT_60	[p4l267t3273r512b3363],
2	was	VBD	O	be	cop	4	SENT_60	[p4l542t3304r673b3346],
3	signiﬁcantly	RB	O	signiﬁcantly	advmod	4	SENT_60	[p4l711t3284r1135b3365],
4	lower	JJR	O	lower	_	0	SENT_60	[p4l1169t3284r1367b3346],
5	among	IN	O	among	_	0	SENT_60	[p4l1405t3304r1644b3365],
6	patients	NNS	O	patient	prep_among	4	SENT_60	[p4l1679t3284r1963b3365],
7	with	IN	O	with	_	0	SENT_60	[p4l1995t3284r2151b3346],
8	the	DT	O	the	det	11	SENT_60	[p4l13t3385r124b3448],
9	3757	CD	DATE	3757	num	11	SENT_60	[p4l151t3386r317b3448],
10	C	NN	O	c	nn	11	SENT_60	[p4l322t3386r378b3448],
11	allele	NN	O	allele	prep_with	6	SENT_60	[p4l404t3385r592b3448],
12	compared	VBN	O	compare	_	0	SENT_60	[p4l619t3386r976b3467],
13	with	IN	O	with	prepc_compared_with	4	SENT_60	[p4l997t3386r1152b3448],
14	those	DT	O	those	pobj	4	SENT_60	[p4l1177t3385r1367b3448],
15	encoding	VBG	O	encode	partmod	14	SENT_60	[p4l1395t3385r1719b3466],
16	the	DT	O	the	det	18	SENT_60	[p4l1744t3386r1856b3448],
17	T	NN	O	t	nn	18	SENT_60	[p4l1881t3388r1936b3447],
18	allele	NN	O	allele	dobj	15	SENT_60	[p4l1961t3385r2150b3448],
19	(	CD	NUMBER	(	num	20	SENT_60	[p4l16t3487r95b3570],
20	P	NN	O	p	dep	18	SENT_60	[p4l16t3487r95b3570],
21	=	JJ	O	=	amod	20	SENT_60	[p4l159t3512r209b3532],
22	.032	CD	NUMBER	.032	tmod	21	SENT_60	[p4l278t3489r439b3563],
23	;	:	O	;	_	0	SENT_60	[p4l278t3489r439b3563],
24	odds	NNS	O	odds	nn	25	SENT_60	[p4l501t3488r667b3550],
25	ratio	NN	O	ratio	dep	20	SENT_60	[p4l725t3488r911b3563],
26	,	,	O	,	_	0	SENT_60	[p4l725t3488r911b3563],
27	0.32	CD	NUMBER	0.32	appos	25	SENT_60	[p4l971t3489r1136b3563],
28	;	:	O	;	_	0	SENT_60	[p4l971t3489r1136b3563],
29	95	CD	PERCENT	95	number	30	SENT_60	[p4l1198t3488r1353b3552],
30	%	NN	PERCENT	%	amod	32	SENT_60	[p4l1198t3488r1353b3552],
31	conﬁdence	NN	O	conﬁdence	nn	32	SENT_60	[p4l1415t3488r1800b3550],
32	interval	NN	O	interval	dep	20	SENT_60	[p4l1859t3488r2148b3563],
33	,	,	O	,	_	0	SENT_60	[p4l1859t3488r2148b3563],
34	0.11-0	CD	NUMBER	0.11-0	num	35	SENT_60	[p4l14t3591r378b3665],
35	.90	CD	NUMBER	.90	appos	32	SENT_60	[p4l14t3591r378b3665],
36	;	:	O	;	_	0	SENT_60	[p4l14t3591r378b3665],
37	Table	NNP	O	Table	dep	20	SENT_60	[p4l417t3590r620b3652],
38	1	CD	NUMBER	1	number	39	SENT_60	[p4l662t3588r746b3672],
39	)	CD	NUMBER	)	dep	37	SENT_60	[p4l662t3588r746b3672],
40	.	.	O	.	_	0	SENT_60	[p4l662t3588r746b3672],

1	After	IN	O	after	_	0	SENT_61	[p4l783t3590r977b3652],
2	excluding	VBG	O	exclude	prepc_after	11	SENT_61	[p4l1014t3590r1352b3671],
3	patients	NNS	O	patient	dobj	2	SENT_61	[p4l1387t3590r1670b3671],
4	subjected	VBN	O	subject	partmod	3	SENT_61	[p4l1708t3590r2044b3671],
5	to	TO	O	to	_	0	SENT_61	[p4l2080t3599r2150b3652],
6	ATG	NN	ORGANIZATION	atg	nn	7	SENT_61	[p4l11t3692r200b3754],
7	treatment	NN	O	treatment	prep_to	4	SENT_61	[p4l229t3700r600b3767],
8	,	,	O	,	_	0	SENT_61	[p4l229t3700r600b3767],
9	the	DT	O	the	det	10	SENT_61	[p4l633t3691r744b3754],
10	lymphocyte	NN	O	lymphocyte	nsubj	11	SENT_61	[p4l775t3691r1184b3773],
11	counts	VBZ	O	count	_	0	SENT_61	[p4l1215t3700r1447b3754],
12	in	IN	O	in	_	0	SENT_61	[p4l1478t3692r1544b3753],
13	the	DT	O	the	det	15	SENT_61	[p4l1574t3692r1685b3754],
14	same	JJ	O	same	amod	15	SENT_61	[p4l1718t3711r1897b3754],
15	observation	NN	O	observation	prep_in	11	SENT_61	[p4l1929t3692r2149b3754, p5l9t18r233b80],

1	points	NNS	O	point	nsubj	4	SENT_62	[p5l260t18r479b99],
2	were	VBD	O	be	cop	4	SENT_62	[p5l505t38r677b80],
3	also	RB	O	also	advmod	4	SENT_62	[p5l709t18r845b80],
4	higher	JJR	O	higher	_	0	SENT_62	[p5l875t18r1103b99],
5	among	IN	O	among	_	0	SENT_62	[p5l1133t38r1373b99],
6	C	NN	O	c	nn	8	SENT_62	[p5l1404t19r1459b81],
7	allele	NN	O	allele	nn	8	SENT_62	[p5l1489t18r1677b80],
8	carriers	NNS	O	carrier	prep_among	4	SENT_62	[p5l1707t18r1975b80],
9	(	VBP	O	(	dep	8	SENT_62	[p5l2008t17r2151b100],
10	Fig	NN	O	fig	nn	12	SENT_62	[p5l2008t17r2151b100],
11	1B	NN	O	1b	nn	12	SENT_62	[p5l18t118r160b202],
12	)	NN	O	)	dobj	9	SENT_62	[p5l18t118r160b202],
13	.	.	O	.	_	0	SENT_62	[p5l18t118r160b202],

1	Accordingly	RB	O	accordingly	advmod	9	SENT_63	[p5l184t120r636b201],
2	,	,	O	,	_	0	SENT_63	[p5l184t120r636b201],
3	analysis	NN	O	analysis	nsubj	9	SENT_63	[p5l664t120r936b201],
4	of	IN	O	of	_	0	SENT_63	[p5l960t120r1035b182],
5	AT	IN	O	at	dep	6	SENT_63	[p5l1050t121r1171b181],
6	G-untreated	JJ	MISC	g-untreated	amod	7	SENT_63	[p5l1175t120r1617b182],
7	recipients	NNS	O	recipient	prep_of	3	SENT_63	[p5l1640t120r1988b201],
8	also	RB	O	also	advmod	9	SENT_63	[p5l2013t120r2149b182],
9	revealed	VBD	O	reveal	_	0	SENT_63	[p5l13t222r317b285],
10	a	DT	O	a	det	12	SENT_63	[p5l348t242r386b284],
11	decreased	VBN	O	decrease	amod	12	SENT_63	[p5l416t222r773b284],
12	incidence	NN	O	incidence	dobj	9	SENT_63	[p5l803t222r1141b284],
13	of	IN	O	of	_	0	SENT_63	[p5l1173t223r1248b284],
14	lymphopenia	NN	O	lymphopenia	prep_of	12	SENT_63	[p5l1272t222r1738b303],
15	among	IN	O	among	_	0	SENT_63	[p5l1769t242r2009b303],
16	the	DT	O	the	det	17	SENT_63	[p5l2039t222r2150b284],
17	group	NN	O	group	prep_among	12	SENT_63	[p5l13t345r221b406],
18	carrying	VBG	O	carry	partmod	17	SENT_63	[p5l273t325r561b406],
19	the	DT	O	the	det	20	SENT_63	[p5l611t325r723b387],
20	C	NN	O	c	dobj	18	SENT_63	[p5l776t326r832b388],
21	allele	NN	O	allele	nn	23	SENT_63	[p5l883t325r1071b387],
22	(	CD	NUMBER	(	num	23	SENT_63	[p5l1126t324r1357b407],
23	Table	NNP	O	Table	dep	20	SENT_63	[p5l1126t324r1357b407],
24	1	CD	NUMBER	1	number	25	SENT_63	[p5l1414t324r1498b407],
25	)	CD	NUMBER	)	dep	23	SENT_63	[p5l1414t324r1498b407],
26	.	.	O	.	_	0	SENT_63	[p5l1414t324r1498b407],

1	The	DT	O	the	det	2	SENT_64	[p5l1551t325r1691b387],
2	differences	NNS	O	difference	nsubj	6	SENT_64	[p5l1744t325r2148b400],
3	,	,	O	,	_	0	SENT_64	[p5l1744t325r2148b400],
4	however	RB	O	however	advmod	6	SENT_64	[p5l13t427r332b502],
5	,	,	O	,	_	0	SENT_64	[p5l13t427r332b502],
6	were	VBD	O	be	_	0	SENT_64	[p5l362t446r534b489],
7	at	IN	O	at	_	0	SENT_64	[p5l569t436r633b489],
8	the	DT	O	the	det	9	SENT_64	[p5l664t427r776b489],
9	borderline	NN	O	borderline	prep_at	6	SENT_64	[p5l806t427r1181b489],
10	of	IN	O	of	_	0	SENT_64	[p5l1214t427r1289b489],
11	signiﬁcance	NN	O	signiﬁcance	prep_of	9	SENT_64	[p5l1317t426r1748b508],
12	.	.	O	.	_	0	SENT_64	[p5l1317t426r1748b508],

1	DISCUSSION	NN	O	discussion	_	0	SENT_65	[p5l17t611r492b672],

1	In	IN	O	in	_	0	SENT_66	[p5l14t757r88b816],
2	our	PRP$	O	we	poss	3	SENT_66	[p5l122t774r243b817],
3	study	NN	O	study	prep_in	16	SENT_66	[p5l276t754r480b835],
4	,	,	O	,	_	0	SENT_66	[p5l276t754r480b835],
5	the	DT	O	the	det	6	SENT_66	[p5l515t755r626b817],
6	distribution	NN	O	distribution	nsubj	24	SENT_66	[p5l660t755r1075b817],
7	of	IN	O	of	_	0	SENT_66	[p5l1108t755r1183b817],
8	IMPDH2	NN	O	impdh2	nn	9	SENT_66	[p5l1204t756r1533b816],
9	3757C	NN	O	3757c	prep_of	6	SENT_66	[p5l1567t755r1793b817],
10	among	IN	O	among	_	0	SENT_66	[p5l1826t774r2066b835],
11	T	NN	O	t	nn	12	SENT_66	[p5l2098t757r2152b816],
12	alleles	NNS	O	allele	prep_among	9	SENT_66	[p5l15t858r236b920],
13	and	CC	O	and	_	0	SENT_66	[p5l269t858r398b920],
14	genotypes	NNS	O	genotype	conj_and	12	SENT_66	[p5l429t867r786b939],
15	was	VBD	O	be	cop	16	SENT_66	[p5l813t878r944b920],
16	comparable	JJ	O	comparable	_	0	SENT_66	[p5l977t858r1396b939],
17	between	IN	O	between	_	0	SENT_66	[p5l1426t858r1726b920],
18	the	DT	O	the	det	22	SENT_66	[p5l1756t858r1868b920],
19	patient	NN	O	patient	nn	22	SENT_66	[p5l1898t858r2151b939],
20	and	CC	O	and	_	0	SENT_66	[p5l15t961r144b1023],
21	control	NN	O	control	conj_and	19	SENT_66	[p5l174t961r429b1023],
22	groups	NNS	O	group	prep_between	16	SENT_66	[p5l459t980r699b1042],
23	and	CC	O	and	_	0	SENT_66	[p5l732t961r861b1023],
24	similar	JJ	O	similar	conj_and	16	SENT_66	[p5l892t961r1133b1023],
25	to	TO	O	to	_	0	SENT_66	[p5l1162t970r1231b1023],
26	previously	RB	DATE	previously	advmod	27	SENT_66	[p5l1262t961r1628b1042],
27	reported	VBN	O	report	amod	28	SENT_66	[p5l1656t961r1967b1042],
28	data	NNS	O	datum	prep_to	24	SENT_66	[p5l1998t961r2151b1023],
29	from	IN	O	from	_	0	SENT_66	[p5l13t1064r185b1127],
30	other	JJ	O	other	amod	32	SENT_66	[p5l217t1064r408b1127],
31	populations	NNS	O	population	nn	32	SENT_66	[p5l437t1052r978b1146],
32	.3	NN	NUMBER	.3	prep_from	28	SENT_66	[p5l437t1052r978b1146],
33	‘	CD	NUMBER	‘	number	34	SENT_66	[p5l437t1052r978b1146],
34	5	CD	NUMBER	5	num	32	SENT_66	[p5l437t1052r978b1146],

1	We	PRP	O	we	nsubj	4	SENT_67	[p5l97t1169r218b1230],
2	did	VBD	O	do	aux	4	SENT_67	[p5l252t1167r363b1229],
3	not	RB	O	not	neg	4	SENT_67	[p5l394t1176r512b1229],
4	observe	VB	O	observe	ccomp	39	SENT_67	[p5l543t1167r816b1229],
5	a	DT	O	a	det	7	SENT_67	[p5l850t1187r887b1229],
6	signiﬁcant	JJ	O	signiﬁcant	amod	7	SENT_67	[p5l919t1167r1281b1248],
7	association	NN	O	association	dobj	4	SENT_67	[p5l1314t1167r1707b1229],
8	of	IN	O	of	_	0	SENT_67	[p5l1738t1168r1813b1229],
9	C	NN	O	c	nn	10	SENT_67	[p5l1842t1168r1897b1230],
10	alleles	NNS	O	allele	prep_of	7	SENT_67	[p5l1930t1167r2150b1229],
11	with	IN	O	with	_	0	SENT_67	[p5l9t1270r164b1332],
12	an	DT	O	a	det	14	SENT_67	[p5l197t1289r280b1332],
13	increased	VBN	O	increase	amod	14	SENT_67	[p5l311t1270r650b1332],
14	rate	NN	O	rate	prep_with	4	SENT_67	[p5l681t1279r820b1332],
15	of	IN	O	of	_	0	SENT_67	[p5l853t1270r928b1332],
16	acute	JJ	O	acute	amod	18	SENT_67	[p5l956t1279r1144b1332],
17	rejection	NN	O	rejection	nn	18	SENT_67	[p5l1176t1270r1492b1351],
18	episodes	NNS	O	episode	prep_of	14	SENT_67	[p5l1524t1270r1848b1351],
19	,	,	O	,	_	0	SENT_67	[p5l1524t1270r1848b1351],
20	a	DT	O	a	det	21	SENT_67	[p5l1883t1290r1920b1332],
21	result	NN	O	result	appos	18	SENT_67	[p5l1951t1270r2151b1332],
22	that	IN	O	that	_	0	SENT_67	[p5l13t1371r153b1434],
23	conﬁrms	NNS	O	conﬁrms	prep_that	21	SENT_67	[p5l194t1371r500b1434],
24	previous	JJ	O	previous	amod	25	SENT_67	[p5l540t1372r843b1453],
25	ﬁndings	NNS	O	ﬁndings	dep	18	SENT_67	[p5l884t1371r1163b1452],
26	of	IN	O	of	_	0	SENT_67	[p5l1205t1372r1280b1434],
27	Gensburger	NNP	O	Gensburger	prep_of	25	SENT_67	[p5l1317t1372r1740b1452],
28	et	FW	O	et	nn	29	SENT_67	[p5l1780t1380r1846b1434],
29	al4	FW	O	al4	dep	25	SENT_67	[p5l1887t1361r1980b1433],
30	and	CC	O	and	_	0	SENT_67	[p5l2021t1371r2151b1433],
31	Wang	NNP	PERSON	Wang	conj_and	18	SENT_67	[p5l12t1476r222b1555],
32	et	FW	O	et	nn	33	SENT_67	[p5l273t1483r337b1536],
33	al.	FW	O	al.	dep	31	SENT_67	[p5l388t1464r501b1536],
34	8	CD	NUMBER	8	tmod	14	SENT_67	[p5l388t1464r501b1536],
35	However	RB	O	however	advmod	34	SENT_67	[p5l550t1476r892b1550],
36	,	,	O	,	_	0	SENT_67	[p5l550t1476r892b1550],
37	we	PRP	O	we	nsubj	39	SENT_67	[p5l939t1494r1038b1536],
38	did	VBD	O	do	aux	39	SENT_67	[p5l1089t1474r1200b1536],
39	show	VB	O	show	_	0	SENT_67	[p5l1250t1474r1429b1536],
40	that	IN	O	that	complm	48	SENT_67	[p5l1477t1474r1617b1536],
41	the	DT	O	the	det	43	SENT_67	[p5l1665t1474r1776b1536],
42	IMPDH2	NN	O	impdh2	nn	43	SENT_67	[p5l1821t1476r2150b1535],
43	3757C	NN	O	3757c	nsubjpass	48	SENT_67	[p5l14t1577r239b1639],
44	allelic	JJ	O	allelic	amod	45	SENT_67	[p5l264t1577r472b1639],
45	variant	NN	O	variant	dep	43	SENT_67	[p5l490t1577r742b1639],
46	may	MD	O	may	aux	48	SENT_67	[p5l765t1597r912b1658],
47	be	VB	O	be	auxpass	48	SENT_67	[p5l932t1577r1016b1639],
48	associated	VBN	O	associate	ccomp	39	SENT_67	[p5l1042t1577r1406b1639],
49	with	IN	O	with	_	0	SENT_67	[p5l1425t1577r1580b1639],
50	a	DT	O	a	det	52	SENT_67	[p5l1605t1597r1642b1639],
51	low	JJ	O	low	amod	52	SENT_67	[p5l1665t1577r1789b1639],
52	incidence	NN	O	incidence	prep_with	48	SENT_67	[p5l1811t1577r2149b1639],
53	of	IN	O	of	_	0	SENT_67	[p5l14t1679r89b1741],
54	lymphopenia	NN	O	lymphopenia	prep_of	52	SENT_67	[p5l110t1678r575b1760],
55	among	IN	O	among	_	0	SENT_67	[p5l603t1698r843b1759],
56	kidney	NN	O	kidney	nn	58	SENT_67	[p5l869t1679r1107b1759],
57	transplant	NN	O	transplant	nn	58	SENT_67	[p5l1132t1678r1494b1760],
58	recipients	NNS	O	recipient	prep_among	48	SENT_67	[p5l1520t1679r1868b1760],
59	treated	VBN	O	treat	partmod	58	SENT_67	[p5l1895t1678r2151b1741],
60	with	IN	O	with	_	0	SENT_67	[p5l9t1782r164b1844],
61	MMF	NN	O	mmf	prep_with	59	SENT_67	[p5l221t1784r447b1844],
62	.	.	O	.	_	0	SENT_67	[p5l221t1784r447b1844],

1	Although	IN	O	although	mark	9	SENT_68	[p5l504t1782r845b1863],
2	the	DT	O	the	det	4	SENT_68	[p5l901t1782r1012b1844],
3	functional	JJ	O	functional	amod	4	SENT_68	[p5l1069t1782r1431b1844],
4	role	NN	O	role	nsubj	9	SENT_68	[p5l1487t1782r1626b1844],
5	of	IN	O	of	_	0	SENT_68	[p5l1684t1783r1759b1844],
6	this	DT	O	this	det	7	SENT_68	[p5l1810t1782r1935b1844],
7	SNP	NN	O	snp	prep_of	4	SENT_68	[p5l1993t1783r2150b1845],
8	remains	VBZ	O	remain	cop	9	SENT_68	[p5l13t1885r296b1947],
9	unknown	JJ	O	unknown	advcl	18	SENT_68	[p5l331t1885r680b1960],
10	,	,	O	,	_	0	SENT_68	[p5l331t1885r680b1960],
11	the	DT	O	the	det	13	SENT_68	[p5l718t1885r829b1947],
12	low	JJ	O	low	amod	13	SENT_68	[p5l865t1885r990b1947],
13	incidence	NN	O	incidence	nsubjpass	18	SENT_68	[p5l1024t1885r1363b1947],
14	of	IN	O	of	_	0	SENT_68	[p5l1400t1885r1475b1947],
15	lymphopenia	NN	O	lymphopenia	prep_of	13	SENT_68	[p5l1505t1885r1970b1966],
16	may	MD	O	may	aux	18	SENT_68	[p5l2005t1904r2153b1966],
17	be	VB	O	be	auxpass	18	SENT_68	[p5l11t1987r95b2049],
18	explained	VBN	O	explain	_	0	SENT_68	[p5l122t1986r465b2068],
19	by	IN	O	by	_	0	SENT_68	[p5l487t1987r570b2067],
20	a	DT	O	a	dep	22	SENT_68	[p5l594t2006r631b2048],
21	possible	JJ	O	possible	amod	22	SENT_68	[p5l653t1986r940b2068],
22	direct	JJ	O	direct	agent	18	SENT_68	[p5l967t1986r1170b2049],
23	or	CC	O	or	_	0	SENT_68	[p5l1195t2006r1270b2049],
24	indirect	JJ	O	indirect	amod	25	SENT_68	[p5l1293t1986r1568b2049],
25	inﬂuence	NN	O	inﬂuence	conj_or	22	SENT_68	[p5l1592t1986r1919b2049],
26	of	IN	O	of	_	0	SENT_68	[p5l1944t1987r2019b2049],
27	the	DT	O	the	det	30	SENT_68	[p5l2038t1987r2150b2049],
28	C	NN	O	c	nn	30	SENT_68	[p5l15t2091r70b2153],
29	allelic	JJ	O	allelic	amod	30	SENT_68	[p5l120t2090r328b2152],
30	variant	NN	O	variant	prep_of	22	SENT_68	[p5l372t2090r623b2152],
31	on	IN	O	on	_	0	SENT_68	[p5l672t2110r761b2152],
32	IMPDH2	NN	O	impdh2	nn	34	SENT_68	[p5l803t2091r1132b2151],
33	gene	NN	O	gene	nn	34	SENT_68	[p5l1181t2110r1348b2171],
34	expression	NN	O	expression	prep_on	30	SENT_68	[p5l1398t2090r1791b2171],
35	.	.	O	.	_	0	SENT_68	[p5l1398t2090r1791b2171],

1	Previous	JJ	O	previous	amod	2	SENT_69	[p5l1843t2090r2150b2152],
2	studies	NNS	O	study	nsubj	4	SENT_69	[p5l14t2193r258b2255],
3	have	VBP	O	have	aux	4	SENT_69	[p5l285t2193r449b2255],
4	demonstrated	VBN	O	demonstrate	_	0	SENT_69	[p5l477t2193r971b2255],
5	that	IN	O	that	complm	15	SENT_69	[p5l997t2193r1137b2255],
6	MMF-treated	JJ	MISC	mmf-treated	amod	9	SENT_69	[p5l1164t2193r1659b2255],
7	kidney	NN	O	kidney	nn	9	SENT_69	[p5l1684t2193r1922b2274],
8	transplant	NN	O	transplant	nn	9	SENT_69	[p5l1946t2202r2149b2255, p5l11t2295r195b2376],
9	recipients	NNS	O	recipient	nsubj	15	SENT_69	[p5l243t2295r591b2376],
10	carrying	VBG	O	carry	partmod	9	SENT_69	[p5l641t2295r930b2376],
11	21	CD	NUMBER	21	num	14	SENT_69	[p5l984t2296r1083b2357],
12	IMPDH2	NN	O	impdh2	nn	14	SENT_69	[p5l1131t2297r1460b2357],
13	3757C	NN	O	3757c	nn	14	SENT_69	[p5l1511t2296r1736b2358],
14	allele	NN	O	allele	dobj	10	SENT_69	[p5l1787t2295r1974b2357],
15	displayed	VBD	O	display	ccomp	4	SENT_69	[p5l2026t2295r2149b2357, p5l12t2399r246b2480],
16	much	RB	O	much	advmod	17	SENT_69	[p5l316t2399r513b2461],
17	higher	JJR	O	higher	amod	19	SENT_69	[p5l583t2399r811b2480],
18	IMPDH	NN	O	impdh	nn	19	SENT_69	[p5l882t2401r1179b2460],
19	activity	NN	O	activity	dobj	15	SENT_69	[p5l1251t2399r1503b2480],
20	compared	VBN	O	compare	_	0	SENT_69	[p5l1573t2399r1929b2480],
21	with	IN	O	with	prepc_compared_with	15	SENT_69	[p5l1995t2399r2151b2461],
22	IMPDH2	NN	O	impdh2	pobj	15	SENT_69	[p5l8t2502r336b2562],
23	3757TT	CD	NUMBER	3757tt	num	25	SENT_69	[p5l392t2501r670b2563],
24	wild-type	JJ	O	wild-type	amod	25	SENT_69	[p5l719t2501r1049b2582],
25	patients	NNS	O	patient	dep	22	SENT_69	[p5l1104t2490r1442b2582],
26	.9	CD	NUMBER	.9	dep	25	SENT_69	[p5l1104t2490r1442b2582],
27	Furthermore	RB	O	furthermore	advmod	25	SENT_69	[p5l1497t2501r1981b2576],
28	,	,	O	,	_	0	SENT_69	[p5l1497t2501r1981b2576],
29	the	DT	O	the	appos	22	SENT_69	[p5l2038t2501r2150b2563],

1	LYMPHOCYTE	NN	O	lymphocyte	nn	2	SENT_70	[p5l7t2627r502b2684],
2	COUNTS	NNS	O	count	_	0	SENT_70	[p5l532t2627r836b2684],

1	Lymphocyte	NN	O	lymphocyte	nn	2	SENT_71	[p6l30t1005r118b1490],
2	counts	NNS	O	count	_	0	SENT_71	[p6l37t711r104b982],
3	:	:	O	:	_	0	SENT_71	[p6l37t711r104b982],
4	[	CD	NUMBER	[	dep	2	SENT_71	[p6l27t346r118b684],
5	x	CC	O	x	_	0	SENT_71	[p6l27t346r118b684],
6	:1	CD	NUMBER	:1	num	8	SENT_71	[p6l27t346r118b684],
7	m3luL	NN	O	m3lul	nn	8	SENT_71	[p6l27t346r118b684],
8	}	NN	O	}	dep	2	SENT_71	[p6l27t346r118b684],

1	3	CD	NUMBER	3	num	5	SENT_72	[p6l938t1766r975b1852],
2	122	CD	NUMBER	122	num	5	SENT_72	[p6l1213t1801r1277b1852],
3	Time	NNP	O	Time	nn	5	SENT_72	[p6l928t1946r1129b2013],
4	[	CD	NUMBER	[	num	5	SENT_72	[p6l1156t1946r1458b2030],
5	weeks	NNS	NUMBER	week	_	0	SENT_72	[p6l1156t1946r1458b2030],
6	]	IN	O	]	amod	5	SENT_72	[p6l1156t1946r1458b2030],

1	Lymphocyte	NN	O	lymphocyte	nsubj	2	SENT_73	[p7l10t1021r94b1509],
2	counts	VBZ	O	count	_	0	SENT_73	[p7l14t728r78b998],
3	§	CD	NUMBER	§	dobj	2	SENT_73	[p7l14t596r95b701],
4	[	CD	NUMBER	[	dep	3	SENT_73	[p7l14t596r95b701],
5	:	:	O	:	_	0	SENT_73	[p7l14t596r95b701],
6	x	CC	O	x	_	0	SENT_73	[p7l14t596r95b701],
7	‘	CD	NUMBER	‘	num	8	SENT_73	[p7l14t596r95b701],
8	l	NN	O	l	dobj	2	SENT_73	[p7l14t596r95b701],
9	D3lpl	NN	O	d3lpl	dep	8	SENT_73	[p7l7t360r95b583],
10	.	.	O	.	_	0	SENT_73	[p7l7t360r95b583],

1	.	.	O	.	_	0	SENT_74	[p7l7t360r95b583],

1	[	NN	O	[	_	0	SENT_75	[p7l7t360r95b583],
2	]	SYM	O	]	dep	1	SENT_75	[p7l7t360r95b583],

1	3	CD	NUMBER	3	_	0	SENT_76	[p7l1015t1660r1237b1714],
2	?	.	O	?	_	0	SENT_76	[p7l1015t1660r1237b1714],
3	'	''	O	'	_	0	SENT_76	[p7l1015t1660r1237b1714],

1	57	CD	NUMBER	57	_	0	SENT_77	[p7l1015t1660r1237b1714],
2	'	''	O	'	_	0	SENT_77	[p7l1015t1660r1237b1714],
3	TT	NN	O	tt	dep	1	SENT_77	[p7l1015t1660r1237b1714],
4	--	:	O	--	_	0	SENT_77	[p7l1274t1667r1541b1711],
5	I	PRP	O	I	dep	1	SENT_77	[p7l1274t1667r1541b1711],
6	--	:	O	--	_	0	SENT_77	[p7l1274t1667r1541b1711],
7	~	NN	O	~	dep	5	SENT_77	[p7l1274t1667r1541b1711],
8	375	CD	NUMBER	375	num	7	SENT_77	[p7l1611t1660r1834b1714],
9	?	.	O	?	_	0	SENT_77	[p7l1611t1660r1834b1714],

1	TG	NN	O	tg	_	0	SENT_78	[p7l1611t1660r1834b1714],

1	‘	NN	O	‘	nn	2	SENT_79	[p7l321t1812r344b1860],
2	ll	NN	O	ll	_	0	SENT_79	[p7l321t1812r344b1860],
3	2	CD	NUMBER	2	number	4	SENT_79	[p7l462t1812r499b1866],
4	4	CD	NUMBER	4	dep	2	SENT_79	[p7l607t1766r641b1860],
5	a	DT	O	a	det	7	SENT_79	[p7l897t1776r937b1866],
6	12	CD	NUMBER	12	num	7	SENT_79	[p7l1170t1812r1241b1866],
7	2	CD	NUMBER	2	dep	4	SENT_79	[p7l2033t1775r2104b1866],

1	Fig	NN	O	fig	_	0	SENT_80	[p7l94t2076r139b2107],
2	1	CD	NUMBER	1	dep	1	SENT_80	[p7l158t2076r182b2100],
3	.	.	O	.	_	0	SENT_80	[p7l158t2076r182b2100],

1	Relationship	NN	O	relationship	nsubj	6	SENT_81	[p7l219t2076r400b2107],
2	between	IN	O	between	_	0	SENT_81	[p7l418t2076r542b2101],
3	IMPDH2	NN	O	impdh2	nn	4	SENT_81	[p7l559t2076r684b2100],
4	3757T	NN	O	3757t	prep_between	1	SENT_81	[p7l701t2075r844b2101],
5	>	JJR	O	>	amod	6	SENT_81	[p7l701t2075r844b2101],
6	C	NN	O	c	_	0	SENT_81	[p7l701t2075r844b2101],
7	polymorphism	NN	O	polymorphism	nn	10	SENT_81	[p7l862t2076r1071b2107],
8	and	CC	O	and	_	0	SENT_81	[p7l1089t2076r1142b2101],
9	lymphocyte	NN	O	lymphocyte	nn	10	SENT_81	[p7l1161t2076r1332b2107],
10	counts	NNS	O	count	dobj	6	SENT_81	[p7l1349t2077r1448b2101],
11	in	IN	O	in	_	0	SENT_81	[p7l1466t2076r1488b2100],
12	the	DT	O	the	det	15	SENT_81	[p7l1505t2076r1552b2101],
13	early	JJ	O	early	amod	15	SENT_81	[p7l1569t2076r1638b2107],
14	posttransplant	JJ	O	posttransplant	amod	15	SENT_81	[p7l1656t2076r1868b2107],
15	period	NN	O	period	prep_in	10	SENT_81	[p7l1886t2076r1977b2107],
16	in	IN	O	in	_	0	SENT_81	[p7l1996t2076r2018b2100],
17	all	DT	O	all	det	29	SENT_81	[p7l2036t2076r2066b2101],
18	patients	NNS	O	patient	dep	29	SENT_81	[p7l16t2131r277b2200],
19	(	IN	O	(	_	0	SENT_81	[p7l308t2130r396b2199],
20	A	DT	O	a	det	21	SENT_81	[p7l308t2130r396b2199],
21	)	NN	O	)	prep_(	18	SENT_81	[p7l308t2130r396b2199],
22	and	CC	O	and	_	0	SENT_81	[p7l427t2131r547b2186],
23	patients	NNS	O	patient	conj_and	21	SENT_81	[p7l581t2131r843b2200],
24	without	IN	O	without	_	0	SENT_81	[p7l871t2131r1115b2186],
25	ATG	NN	ORGANIZATION	atg	nn	26	SENT_81	[p7l1141t2130r1286b2187],
26	therapy	NN	O	therapy	prep_without	18	SENT_81	[p7l1316t2131r1568b2201],
27	(	NN	O	(	nn	29	SENT_81	[p7l1596t2130r1705b2199],
28	B	NN	O	b	nn	29	SENT_81	[p7l1596t2130r1705b2199],
29	)	NN	O	)	prep_in	6	SENT_81	[p7l1596t2130r1705b2199],
30	.	.	O	.	_	0	SENT_81	[p7l1596t2130r1705b2199],

1	IMPDH2	NN	O	impdh2	nn	3	SENT_82	[p7l7t2350r336b2410],
2	3757C	NN	O	3757c	nn	3	SENT_82	[p7l378t2349r604b2411],
3	allele	NN	O	allele	nsubjpass	5	SENT_82	[p7l647t2348r834b2411],
4	was	VBD	O	be	auxpass	5	SENT_82	[p7l873t2368r1004b2411],
5	associated	VBN	O	associate	_	0	SENT_82	[p7l1047t2348r1412b2411],
6	with	IN	O	with	_	0	SENT_82	[p7l1449t2348r1604b2411],
7	a	DT	O	a	det	10	SENT_82	[p7l1647t2368r1684b2410],
8	signiﬁcantly	RB	O	signiﬁcantly	advmod	9	SENT_82	[p7l1726t2348r2150b2429],
9	impaired	JJ	O	impaired	amod	10	SENT_82	[p7l13t2452r333b2533],
10	ability	NN	O	ability	prep_with	5	SENT_82	[p7l376t2452r593b2533],
11	of	IN	O	of	_	0	SENT_82	[p7l633t2452r708b2514],
12	MPA	NN	ORGANIZATION	mpa	prep_of	10	SENT_82	[p7l745t2453r939b2513],
13	to	TO	O	to	aux	14	SENT_82	[p7l977t2461r1046b2514],
14	inhibit	VB	O	inhibit	xcomp	5	SENT_82	[p7l1088t2452r1319b2514],
15	lymphocyte	NN	O	lymphocyte	nn	16	SENT_82	[p7l1359t2452r1767b2533],
16	proliferation	NN	O	proliferation	dobj	14	SENT_82	[p7l1808t2452r2146b2533, p7l13t2543r239b2616],
17	.	.	O	.	_	0	SENT_82	[p7l1808t2452r2146b2533, p7l13t2543r239b2616],

1	”	NN	O	”	ccomp	25	SENT_83	[p7l1808t2452r2146b2533, p7l13t2543r239b2616],
2	Accordingly	RB	O	accordingly	advmod	1	SENT_83	[p7l272t2554r724b2635],
3	,	,	O	,	_	0	SENT_83	[p7l272t2554r724b2635],
4	our	PRP$	O	we	poss	5	SENT_83	[p7l763t2574r884b2616],
5	observation	NN	O	observation	nsubjpass	25	SENT_83	[p7l919t2554r1335b2616],
6	of	IN	O	of	_	0	SENT_83	[p7l1371t2554r1446b2616],
7	higher	JJR	O	higher	amod	9	SENT_83	[p7l1476t2554r1704b2635],
8	lymphocyte	NN	O	lymphocyte	nn	9	SENT_83	[p7l1738t2554r2146b2635],
9	counts	NNS	O	count	prep_of	5	SENT_83	[p7l14t2664r244b2718],
10	and	CC	O	and	_	0	SENT_83	[p7l307t2655r436b2717],
11	a	DT	O	a	det	13	SENT_83	[p7l498t2675r536b2717],
12	lower	JJR	O	lower	amod	13	SENT_83	[p7l595t2655r793b2718],
13	incidence	NN	O	incidence	prep_of	5	SENT_83	[p7l853t2655r1190b2718],
14	of	IN	O	of	_	0	SENT_83	[p7l1252t2656r1328b2718],
15	lymphopenia	NN	O	lymphopenia	prep_of	13	SENT_83	[p7l1382t2655r1846b2737],
16	among	IN	O	among	_	0	SENT_83	[p7l1908t2675r2148b2736],
17	IMPDH2	NN	O	impdh2	nn	18	SENT_83	[p7l8t2760r336b2820],
18	3757C	NN	O	3757c	prep_among	25	SENT_83	[p7l389t2759r615b2822],
19	allele	NN	O	allele	nn	20	SENT_83	[p7l668t2759r856b2821],
20	carriers	NNS	O	carrier	nsubjpass	25	SENT_83	[p7l910t2759r1178b2821],
21	receiving	VBG	O	receive	partmod	20	SENT_83	[p7l1231t2759r1553b2840],
22	MMF	NN	O	mmf	dobj	21	SENT_83	[p7l1606t2761r1815b2820],
23	may	MD	O	may	aux	25	SENT_83	[p7l1866t2779r2014b2840],
24	be	VB	O	be	auxpass	25	SENT_83	[p7l2062t2759r2146b2821],
25	explained	VBN	O	explain	_	0	SENT_83	[p7l14t2862r357b2943],
26	by	IN	O	by	_	0	SENT_83	[p7l390t2862r473b2943],
27	the	DT	O	the	det	28	SENT_83	[p7l506t2862r617b2924],
28	resistance	NN	O	resistance	agent	25	SENT_83	[p7l653t2862r1005b2924],
29	to	TO	O	to	_	0	SENT_83	[p7l1041t2871r1110b2924],
30	MPA	NN	ORGANIZATION	mpa	nn	31	SENT_83	[p7l1147t2863r1341b2923],
31	treatment	NN	O	treatment	prep_to	25	SENT_83	[p7l1374t2871r1726b2924],
32	of	IN	O	of	_	0	SENT_83	[p7l1762t2862r1836b2924],
33	subjects	NNS	O	subject	prep_of	31	SENT_83	[p7l1867t2862r2147b2943],
34	with	IN	O	with	_	0	SENT_83	[p7l9t2964r164b3027],
35	the	DT	O	the	det	38	SENT_83	[p7l195t2964r306b3027],
36	IMPDH2	NN	O	impdh2	nn	38	SENT_83	[p7l333t2966r661b3026],
37	3757C	NN	O	3757c	nn	38	SENT_83	[p7l694t2965r919b3027],
38	allele	NN	O	allele	prep_with	33	SENT_83	[p7l952t2964r1158b3027],
39	.	.	O	.	_	0	SENT_83	[p7l952t2964r1158b3027],

1	It	PRP	O	it	nsubj	4	SENT_84	[p7l98t3070r154b3130],
2	must	MD	O	must	aux	4	SENT_84	[p7l181t3077r354b3130],
3	be	VB	O	be	cop	4	SENT_84	[p7l379t3068r463b3130],
4	stressed	JJ	O	stressed	_	0	SENT_84	[p7l493t3068r793b3144],
5	,	,	O	,	_	0	SENT_84	[p7l493t3068r793b3144],
6	however	RB	O	however	advmod	4	SENT_84	[p7l823t3068r1142b3143],
7	,	,	O	,	_	0	SENT_84	[p7l823t3068r1142b3143],
8	that	IN	O	that	complm	17	SENT_84	[p7l1172t3068r1312b3130],
9	the	DT	O	the	det	11	SENT_84	[p7l1339t3068r1450b3130],
10	lymphocyte	NN	O	lymphocyte	nn	11	SENT_84	[p7l1479t3068r1887b3149],
11	counts	NNS	O	count	nsubjpass	17	SENT_84	[p7l1916t3077r2147b3130],
12	may	MD	O	may	aux	17	SENT_84	[p7l12t3190r160b3252],
13	be	VB	O	be	auxpass	17	SENT_84	[p7l185t3171r269b3233],
14	at	IN	O	at	advmod	17	SENT_84	[p7l301t3180r366b3233],
15	least	JJS	O	least	pobj	14	SENT_84	[p7l394t3171r557b3233],
16	partially	RB	O	partially	advmod	17	SENT_84	[p7l585t3171r880b3252],
17	affected	VBN	O	affect	ccomp	4	SENT_84	[p7l909t3171r1187b3233],
18	by	IN	O	by	_	0	SENT_84	[p7l1215t3171r1297b3252],
19	ATG	NN	ORGANIZATION	atg	nn	20	SENT_84	[p7l1322t3172r1511b3233],
20	treatment	NN	O	treatment	agent	17	SENT_84	[p7l1539t3180r1909b3246],
21	,	,	O	,	_	0	SENT_84	[p7l1539t3180r1909b3246],
22	which	WDT	O	which	nsubjpass	24	SENT_84	[p7l1937t3171r2148b3233],
23	was	VBD	O	be	auxpass	24	SENT_84	[p7l9t3293r140b3336],
24	implemented	VBN	O	implement	rcmod	20	SENT_84	[p7l179t3273r652b3354],
25	in	IN	O	in	_	0	SENT_84	[p7l690t3273r756b3335],
26	some	DT	O	some	det	27	SENT_84	[p7l796t3293r979b3336],
27	patients	NNS	O	patient	prep_in	24	SENT_84	[p7l1018t3273r1301b3354],
28	enrolled	VBN	O	enrol	partmod	27	SENT_84	[p7l1341t3273r1637b3336],
29	in	IN	O	in	_	0	SENT_84	[p7l1675t3273r1742b3335],
30	our	PRP$	O	we	poss	31	SENT_84	[p7l1781t3293r1902b3336],
31	study	NN	O	study	prep_in	28	SENT_84	[p7l1941t3273r2144b3354],
32	.	.	O	.	_	0	SENT_84	[p7l1941t3273r2144b3354],

1	Nevertheless	RB	O	nevertheless	advmod	13	SENT_85	[p7l12t3377r491b3453],
2	,	,	O	,	_	0	SENT_85	[p7l12t3377r491b3453],
3	the	DT	O	the	det	4	SENT_85	[p7l547t3377r658b3439],
4	diiferences	NNS	O	diiference	nsubjpass	13	SENT_85	[p7l713t3377r1098b3439],
5	in	IN	O	in	_	0	SENT_85	[p7l1151t3377r1218b3438],
6	lymphocyte	NN	O	lymphocyte	nn	7	SENT_85	[p7l1270t3377r1678b3458],
7	counts	NNS	O	count	prep_in	4	SENT_85	[p7l1732t3386r1963b3439],
8	and	CC	O	and	_	0	SENT_85	[p7l2019t3377r2148b3439],
9	incidence	NN	O	incidence	conj_and	7	SENT_85	[p7l13t3480r351b3542],
10	of	IN	O	of	_	0	SENT_85	[p7l378t3480r454b3542],
11	lymphopenia	NN	O	lymphopenia	prep_of	7	SENT_85	[p7l474t3480r939b3561],
12	were	VBD	O	be	auxpass	13	SENT_85	[p7l960t3499r1132b3542],
13	preserved	VBN	O	preserve	_	0	SENT_85	[p7l1158t3480r1508b3561],
14	among	IN	O	among	_	0	SENT_85	[p7l1536t3499r1775b3561],
15	the	DT	O	the	det	16	SENT_85	[p7l1801t3480r1912b3542],
16	group	NN	O	group	prep_among	13	SENT_85	[p7l1938t3499r2147b3561],
17	after	IN	O	after	_	0	SENT_85	[p7l15t3583r181b3644],
18	exclusion	NN	O	exclusion	prep_after	13	SENT_85	[p7l212t3582r540b3645],
19	of	IN	O	of	_	0	SENT_85	[p7l570t3583r645b3644],
20	AT	IN	O	at	dep	21	SENT_85	[p7l667t3583r789b3644],
21	G-treated	JJ	MISC	g-treated	amod	22	SENT_85	[p7l793t3582r1142b3645],
22	individuals	NNS	O	individual	prep_of	18	SENT_85	[p7l1172t3582r1576b3658],
23	,	,	O	,	_	0	SENT_85	[p7l1172t3582r1576b3658],
24	suggesting	VBG	O	suggest	xcomp	13	SENT_85	[p7l1610t3582r1978b3663],
25	that	IN	O	that	complm	30	SENT_85	[p7l2008t3582r2148b3644],
26	the	DT	O	the	det	28	SENT_85	[p7l13t3686r124b3748],
27	observed	VBN	O	observe	amod	28	SENT_85	[p7l155t3686r475b3748],
28	elfect	NN	O	elfect	nsubj	30	SENT_85	[p7l505t3686r697b3748],
29	was	VBD	O	be	cop	30	SENT_85	[p7l722t3705r853b3748],
30	due	JJ	O	due	ccomp	24	SENT_85	[p7l884t3686r1013b3748],
31	to	TO	O	to	_	0	SENT_85	[p7l1043t3695r1112b3748],
32	the	DT	O	the	det	33	SENT_85	[p7l1143t3686r1254b3748],
33	presence	NN	O	presence	prep_to	30	SENT_85	[p7l1283t3705r1599b3767],
34	of	IN	O	of	_	0	SENT_85	[p7l1630t3686r1705b3748],
35	the	DT	O	the	det	37	SENT_85	[p7l1729t3686r1841b3748],
36	C	NN	O	c	nn	37	SENT_85	[p7l1873t3687r1929b3748],
37	allele	NN	O	allele	prep_of	33	SENT_85	[p7l1959t3686r2147b3748],
38	and	CC	O	and	_	0	SENT_85	[p8l15t18r144b80],
39	not	RB	O	not	conj_and	30	SENT_85	[p8l175t27r292b80],
40	related	JJ	O	related	dep	30	SENT_85	[p8l323t18r574b80],
41	to	TO	O	to	_	0	SENT_85	[p8l605t27r674b80],
42	ATG	NN	ORGANIZATION	atg	nn	43	SENT_85	[p8l704t19r892b80],
43	therapy	NN	O	therapy	prep_to	40	SENT_85	[p8l923t18r1211b99],
44	.	.	O	.	_	0	SENT_85	[p8l923t18r1211b99],

1	In	IN	O	in	_	0	SENT_86	[p8l98t122r171b182],
2	conclusion	NN	O	conclusion	prep_in	7	SENT_86	[p8l201t120r583b196],
3	,	,	O	,	_	0	SENT_86	[p8l201t120r583b196],
4	our	PRP$	O	we	poss	6	SENT_86	[p8l617t140r735b183],
5	present	JJ	DATE	present	amod	6	SENT_86	[p8l764t129r1020b201],
6	results	NNS	O	result	nsubj	7	SENT_86	[p8l1050t120r1271b183],
7	suggested	VBD	O	suggest	_	0	SENT_86	[p8l1304t120r1636b201],
8	that	IN	O	that	complm	13	SENT_86	[p8l1667t120r1801b182],
9	IMPDH2	NN	O	impdh2	nn	11	SENT_86	[p8l1827t122r2146b182],
10	gene	NN	O	gene	nn	11	SENT_86	[p8l13t244r175b305],
11	polymorphism	NN	O	polymorphism	nsubj	13	SENT_86	[p8l207t224r704b305],
12	may	MD	O	may	aux	13	SENT_86	[p8l736t244r880b305],
13	be	VB	O	be	ccomp	7	SENT_86	[p8l908t224r991b286],
14	of	IN	O	of	_	0	SENT_86	[p8l1025t224r1098b286],
15	clinical	JJ	O	clinical	amod	18	SENT_86	[p8l1126t224r1365b286],
16	and	CC	O	and	_	0	SENT_86	[p8l1399t224r1524b286],
17	biological	JJ	O	biological	amod	18	SENT_86	[p8l1555t224r1888b305],
18	signiﬁcance	NN	O	signiﬁcance	prep_of	13	SENT_86	[p8l1921t224r2146b305, p8l13t346r205b389],
19	and	CC	O	and	_	0	SENT_86	[p8l239t326r364b388],
20	that	IN	O	that	complm	32	SENT_86	[p8l395t326r529b389],
21	assessment	NN	O	assessment	nsubj	32	SENT_86	[p8l561t335r939b389],
22	of	IN	O	of	_	0	SENT_86	[p8l969t327r1042b389],
23	individual	JJ	O	individual	amod	25	SENT_86	[p8l1068t326r1406b389],
24	genetic	JJ	O	genetic	amod	25	SENT_86	[p8l1436t327r1683b407],
25	variability	NN	O	variability	prep_of	21	SENT_86	[p8l1708t326r2050b407],
26	of	IN	O	of	_	0	SENT_86	[p8l2079t327r2152b389],
27	the	DT	O	the	det	29	SENT_86	[p8l13t429r121b491],
28	IMPDH	NN	O	impdh	nn	29	SENT_86	[p8l141t431r427b491],
29	genes	NNS	O	gene	prep_of	25	SENT_86	[p8l446t449r638b510],
30	may	MD	O	may	aux	32	SENT_86	[p8l664t449r808b510],
31	be	VB	O	be	cop	32	SENT_86	[p8l829t429r911b491],
32	useful	JJ	O	useful	ccomp	7	SENT_86	[p8l937t429r1143b491],
33	to	TO	O	to	aux	34	SENT_86	[p8l1168t438r1235b491],
34	design	VB	O	design	xcomp	32	SENT_86	[p8l1263t429r1481b510],
35	proper	JJ	O	proper	amod	36	SENT_86	[p8l1504t449r1739b510],
36	therapy	NN	O	therapy	dobj	34	SENT_86	[p8l1763t429r2025b510],
37	for	IN	O	for	_	0	SENT_86	[p8l2048t430r2148b491],
38	kidney	NN	O	kidney	prep_for	34	SENT_86	[p8l12t533r242b614],
39	and	CC	O	and	_	0	SENT_86	[p8l270t533r395b595],
40	possibly	RB	O	possibly	advmod	38	SENT_86	[p8l423t533r696b614],
41	other	JJ	O	other	amod	43	SENT_86	[p8l722t533r906b595],
42	transplant	NN	O	transplant	nn	43	SENT_86	[p8l934t533r1280b614],
43	recipients	NNS	O	recipient	prep_for	34	SENT_86	[p8l1308t533r1656b614],
44	.	.	O	.	_	0	SENT_86	[p8l1308t533r1656b614],

1	REFERENCES	NNS	O	reference	_	0	SENT_87	[p8l17t725r525b785],

1	1	LS	NUMBER	1	_	0	SENT_88	[p8l92t871r138b925],
2	.	.	O	.	_	0	SENT_88	[p8l92t871r138b925],

1	Dalal	JJ	PERSON	dalal	amod	2	SENT_89	[p8l181t870r354b925],
2	P	NN	PERSON	p	_	0	SENT_89	[p8l375t872r433b937],
3	,	,	O	,	_	0	SENT_89	[p8l375t872r433b937],
4	Grafals	NN	O	grafal	nn	5	SENT_89	[p8l458t870r690b925],
5	M	NN	O	m	appos	2	SENT_89	[p8l711t872r796b937],
6	,	,	O	,	_	0	SENT_89	[p8l711t872r796b937],
7	Chhabra	NNP	PERSON	Chhabra	nn	8	SENT_89	[p8l820t870r1094b925],
8	D	NNP	PERSON	D	appos	2	SENT_89	[p8l1114t872r1187b937],
9	,	,	O	,	_	0	SENT_89	[p8l1114t872r1187b937],
10	et	FW	O	et	nn	11	SENT_89	[p8l1211t878r1269b925],
11	al	FW	O	al	appos	2	SENT_89	[p8l1291t870r1360b925],
12	:	:	O	:	_	0	SENT_89	[p8l1291t870r1360b925],
13	Mycophenolate	JJ	O	mycophenolate	amod	14	SENT_89	[p8l1386t870r1879b942],
14	mofetil	NN	O	mofetil	dep	2	SENT_89	[p8l1900t870r2144b925],
15	:	:	O	:	_	0	SENT_89	[p8l1900t870r2144b925],
16	safety	NN	O	safety	dep	2	SENT_89	[p8l14t953r197b1025],
17	and	CC	O	and	_	0	SENT_89	[p8l225t953r340b1008],
18	eﬂicacy	NN	O	eﬂicacy	conj_and	16	SENT_89	[p8l370t953r601b1025],
19	in	IN	O	in	_	0	SENT_89	[p8l629t953r688b1007],
20	the	DT	O	the	det	21	SENT_89	[p8l716t953r815b1008],
21	prophylaxis	NN	O	prophylaxis	prep_in	16	SENT_89	[p8l844t953r1207b1025],
22	of	IN	O	of	_	0	SENT_89	[p8l1237t953r1304b1008],
23	acute	JJ	O	acute	amod	26	SENT_89	[p8l1330t961r1497b1008],
24	kidney	NN	O	kidney	nn	26	SENT_89	[p8l1526t953r1738b1025],
25	transplantation	NN	O	transplantation	nn	26	SENT_89	[p8l1765t953r2146b1025, p8l12t1036r137b1091],
26	rejection	NN	O	rejection	prep_of	21	SENT_89	[p8l164t1036r460b1108],
27	.	.	O	.	_	0	SENT_89	[p8l164t1036r460b1108],

1	Ther	NNP	O	Ther	nn	3	SENT_90	[p8l491t1036r645b1091],
2	Clin	NNP	O	Clin	nn	3	SENT_90	[p8l674t1036r805b1091],
3	Risk	NNP	O	Risk	_	0	SENT_90	[p8l833t1036r978b1091],
4	Manag	NNP	O	Manag	dep	3	SENT_90	[p8l1004t1038r1223b1108],
5	5:139	CD	NUMBER	5:139	num	4	SENT_90	[p8l1251t1036r1435b1103],
6	,	,	O	,	_	0	SENT_90	[p8l1251t1036r1435b1103],
7	2009	CD	DATE	2009	num	4	SENT_90	[p8l1466t1037r1611b1091],

1	2	LS	NUMBER	2	_	0	SENT_91	[p8l88t1120r138b1174],
2	.	.	O	.	_	0	SENT_91	[p8l88t1120r138b1174],

1	Zimmermann	NNP	ORGANIZATION	Zimmermann	nn	2	SENT_92	[p8l182t1119r622b1174],
2	AG	NNP	ORGANIZATION	AG	_	0	SENT_92	[p8l667t1120r801b1185],
3	,	,	O	,	_	0	SENT_92	[p8l667t1120r801b1185],
4	Gu	NNP	PERSON	Gu	nn	5	SENT_92	[p8l853t1120r950b1174],
5	JJ	NN	PERSON	jj	appos	2	SENT_92	[p8l997t1121r1077b1185],
6	,	,	O	,	_	0	SENT_92	[p8l997t1121r1077b1185],
7	Laliberte	NNP	PERSON	Laliberte	nn	8	SENT_92	[p8l1126t1119r1415b1174],
8	J	NNP	PERSON	J	appos	2	SENT_92	[p8l1463t1121r1510b1185],
9	,	,	O	,	_	0	SENT_92	[p8l1463t1121r1510b1185],
10	et	FW	O	et	nn	11	SENT_92	[p8l1561t1127r1619b1174],
11	al	FW	O	al	appos	2	SENT_92	[p8l1667t1119r1737b1174],
12	:	:	O	:	_	0	SENT_92	[p8l1667t1119r1737b1174],
13	Inosine50monophosphate	NN	O	inosine50monophosphate	nn	14	SENT_92	[p8l1789t1119r2146b1174, p8l12t1202r526b1274],
14	dehydrogenase	NN	O	dehydrogenase	dep	2	SENT_92	[p8l555t1202r1048b1274],
15	:	:	O	:	_	0	SENT_92	[p8l555t1202r1048b1274],
16	regulation	NN	O	regulation	dep	2	SENT_92	[p8l1079t1202r1404b1274],
17	of	IN	O	of	_	0	SENT_92	[p8l1431t1202r1497b1257],
18	expression	NN	O	expression	prep_of	16	SENT_92	[p8l1521t1202r1854b1274],
19	and	CC	O	and	_	0	SENT_92	[p8l1882t1202r1997b1257],
20	role	NN	O	role	conj_and	18	SENT_92	[p8l2023t1202r2147b1257],
21	in	IN	O	in	_	0	SENT_92	[p8l10t1286r69b1341],
22	cellular	JJ	O	cellular	amod	23	SENT_92	[p8l93t1286r329b1341],
23	proliferation	NN	O	proliferation	prep_in	16	SENT_92	[p8l352t1286r756b1358],
24	and	CC	O	and	_	0	SENT_92	[p8l782t1286r897b1341],
25	T	NN	O	t	nn	27	SENT_92	[p8l921t1288r969b1341],
26	lymphocyte	NN	O	lymphocyte	nn	27	SENT_92	[p8l992t1286r1356b1358],
27	activation	NN	O	activation	prep_in	16	SENT_92	[p8l1382t1286r1707b1341],
28	.	.	O	.	_	0	SENT_92	[p8l1382t1286r1707b1341],

1	Prog	NN	O	prog	nn	3	SENT_93	[p8l1734t1288r1884b1358],
2	Nucleic	JJ	O	nucleic	amod	3	SENT_93	[p8l1907t1286r2149b1341],
3	Acid	NN	O	acid	_	0	SENT_93	[p8l7t1372r159b1428],
4	Res	NNP	O	Res	nn	5	SENT_93	[p8l188t1374r307b1428],
5	Mol	NNP	O	Mol	dep	3	SENT_93	[p8l336t1372r465b1428],
6	Biol	NNP	O	Biol	dep	3	SENT_93	[p8l493t1372r623b1428],
7	61:181	CD	NUMBER	61:181	num	6	SENT_93	[p8l652t1373r873b1440],
8	,	,	O	,	_	0	SENT_93	[p8l652t1373r873b1440],
9	1998	CD	DATE	1998	num	6	SENT_93	[p8l908t1373r1049b1428],

1	3	LS	NUMBER	3	_	0	SENT_94	[p8l85t1472r135b1526],
2	.	.	O	.	_	0	SENT_94	[p8l85t1472r135b1526],

1	Nguyen	NNP	ORGANIZATION	Nguyen	nn	2	SENT_95	[p8l178t1473r423b1543],
2	T	NN	ORGANIZATION	t	_	0	SENT_95	[p8l457t1473r520b1538],
3	,	,	O	,	_	0	SENT_95	[p8l457t1473r520b1538],
4	Park	NNP	O	Park	nn	5	SENT_95	[p8l557t1471r706b1526],
5	JY	NN	O	jy	appos	2	SENT_95	[p8l738t1473r842b1538],
6	,	,	O	,	_	0	SENT_95	[p8l738t1473r842b1538],
7	Scudiere	NNP	O	Scudiere	nn	8	SENT_95	[p8l880t1471r1155b1527],
8	JR	NNP	O	JR	appos	2	SENT_95	[p8l1190t1473r1295b1538],
9	,	,	O	,	_	0	SENT_95	[p8l1190t1473r1295b1538],
10	et	FW	O	et	nn	11	SENT_95	[p8l1332t1479r1390b1526],
11	al	FW	O	al	appos	2	SENT_95	[p8l1426t1471r1495b1526],
12	:	:	O	:	_	0	SENT_95	[p8l1426t1471r1495b1526],
13	Mycophenolic	JJ	O	mycophenolic	amod	16	SENT_95	[p8l1534t1471r1986b1543],
14	acid	NN	O	acid	nn	16	SENT_95	[p8l2020t1471r2148b1526],
15	(	NN	O	(	nn	16	SENT_95	[p8l12t1555r282b1629],
16	cellcept	NN	O	cellcept	nsubj	20	SENT_95	[p8l12t1555r282b1629],
17	and	CC	O	and	_	0	SENT_95	[p8l305t1556r419b1611],
18	myofortic	JJ	O	myofortic	amod	19	SENT_95	[p8l440t1555r772b1629],
19	)	NN	O	)	conj_and	16	SENT_95	[p8l440t1555r772b1629],
20	induced	VBD	O	induce	dep	2	SENT_95	[p8l796t1556r1049b1611],
21	injury	NN	O	injury	dobj	20	SENT_95	[p8l1070t1556r1254b1628],
22	of	IN	O	of	_	0	SENT_95	[p8l1274t1557r1341b1611],
23	the	DT	O	the	det	26	SENT_95	[p8l1358t1556r1457b1611],
24	upper	JJ	O	upper	amod	26	SENT_95	[p8l1478t1574r1666b1628],
25	GI	NN	O	gi	nn	26	SENT_95	[p8l1689t1557r1773b1611],
26	tract	NN	O	tract	prep_of	21	SENT_95	[p8l1794t1564r1955b1611],
27	.	.	O	.	_	0	SENT_95	[p8l1794t1564r1955b1611],

1	Am	NNP	O	Am	nn	3	SENT_96	[p8l1977t1557r2096b1610],
2	J	NNP	O	J	nn	3	SENT_96	[p8l2116t1558r2147b1611],
3	Surg	NNP	O	Surg	_	0	SENT_96	[p8l11t1642r155b1713],
4	Pathol	NNP	O	Pathol	dep	3	SENT_96	[p8l182t1641r389b1696],
5	33:1355	CD	NUMBER	33:1355	num	4	SENT_96	[p8l417t1641r676b1709],
6	,	,	O	,	_	0	SENT_96	[p8l417t1641r676b1709],
7	2009	CD	DATE	2009	num	4	SENT_96	[p8l707t1642r852b1697],

1	4	LS	NUMBER	4	_	0	SENT_97	[p8l85t1741r135b1795],
2	.	.	O	.	_	0	SENT_97	[p8l85t1741r135b1795],

1	Gensburger	NN	PERSON	gensburger	nn	2	SENT_98	[p8l180t1740r556b1812],
2	o	NN	O	o	_	0	SENT_98	[p8l595t1741r667b1807],
3	,	,	O	,	_	0	SENT_98	[p8l595t1741r667b1807],
4	Van	NNP	PERSON	Van	nn	6	SENT_98	[p8l706t1742r840b1795],
5	Schaik	NNP	PERSON	Schaik	nn	6	SENT_98	[p8l878t1740r1088b1795],
6	RH	NNP	O	RH	appos	2	SENT_98	[p8l1123t1742r1255b1807],
7	,	,	O	,	_	0	SENT_98	[p8l1123t1742r1255b1807],
8	Picard	NNP	PERSON	Picard	nn	9	SENT_98	[p8l1295t1740r1498b1795],
9	N	NNP	O	N	appos	2	SENT_98	[p8l1535t1742r1607b1807],
10	,	,	O	,	_	0	SENT_98	[p8l1535t1742r1607b1807],
11	et	FW	O	et	nn	12	SENT_98	[p8l1647t1748r1705b1795],
12	al	FW	O	al	appos	2	SENT_98	[p8l1743t1740r1813b1795],
13	:	:	O	:	_	0	SENT_98	[p8l1743t1740r1813b1795],
14	Polymorphisms	NNS	O	polymorphism	dep	2	SENT_98	[p8l1854t1740r2146b1812, p8l8t1826r228b1898],
15	in	IN	O	in	_	0	SENT_98	[p8l267t1826r326b1880],
16	type	NN	O	type	prep_in	14	SENT_98	[p8l365t1834r497b1898],
17	I	CD	NUMBER	i	num	16	SENT_98	[p8l537t1828r562b1880],
18	and	CC	O	and	_	0	SENT_98	[p8l603t1826r718b1881],
19	II	CD	NUMBER	ii	num	23	SENT_98	[p8l757t1828r810b1880],
20	inosine	NN	O	inosine	nn	23	SENT_98	[p8l850t1826r1076b1881],
21	monophosphate	NN	O	monophosphate	nn	23	SENT_98	[p8l1115t1826r1629b1898],
22	dehydrogenase	NN	O	dehydrogenase	nn	23	SENT_98	[p8l1670t1826r2147b1898],
23	genes	NNS	O	gene	prep_in	14	SENT_98	[p8l9t1930r186b1984],
24	and	CC	O	and	_	0	SENT_98	[p8l220t1912r335b1967],
25	association	NN	O	association	conj_and	14	SENT_98	[p8l367t1912r716b1967],
26	with	IN	O	with	_	0	SENT_98	[p8l743t1912r881b1967],
27	clinical	JJ	O	clinical	amod	28	SENT_98	[p8l913t1912r1136b1967],
28	outcome	NN	O	outcome	prep_with	25	SENT_98	[p8l1167t1920r1442b1967],
29	in	IN	O	in	_	0	SENT_98	[p8l1474t1912r1533b1966],
30	patients	NNS	O	patient	prep_in	28	SENT_98	[p8l1563t1912r1815b1984],
31	on	IN	O	on	_	0	SENT_98	[p8l1847t1930r1926b1967],
32	mycophenolate	JJ	O	mycophenolate	amod	33	SENT_98	[p8l1956t1930r2146b1984, p8l8t1998r326b2070],
33	mofetil	NN	O	mofetil	prep_on	30	SENT_98	[p8l355t1998r598b2053],
34	.	.	O	.	_	0	SENT_98	[p8l355t1998r598b2053],

1	Pharmacogenet	NNP	MISC	Pharmacogenet	_	0	SENT_99	[p8l629t1998r1127b2070],
2	Genomics	NNP	MISC	Genomics	dep	1	SENT_99	[p8l1157t1998r1475b2054],
3	20:537	CD	NUMBER	20:537	num	2	SENT_99	[p8l1504t1998r1725b2065],
4	,	,	O	,	_	0	SENT_99	[p8l1504t1998r1725b2065],
5	2010	CD	DATE	2010	num	2	SENT_99	[p8l1756t1999r1903b2053],

1	5	CD	NUMBER	5	_	0	SENT_100	[p8l85t2096r135b2151],
2	.	.	O	.	_	0	SENT_100	[p8l85t2096r135b2151],

1	Grinyo	NNP	PERSON	Grinyo	nn	2	SENT_101	[p8l180t2096r400b2168],
2	J	NNP	PERSON	J	_	0	SENT_101	[p8l427t2098r475b2163],
3	,	,	O	,	_	0	SENT_101	[p8l427t2098r475b2163],
4	Vanrenterghem	NNP	O	Vanrenterghem	nn	5	SENT_101	[p8l504t2096r1011b2168],
5	Y	NN	O	y	appos	2	SENT_101	[p8l1037t2098r1109b2163],
6	,	,	O	,	_	0	SENT_101	[p8l1037t2098r1109b2163],
7	Nashan	NN	MISC	nashan	nn	8	SENT_101	[p8l1138t2096r1378b2151],
8	B	NN	O	b	appos	2	SENT_101	[p8l1405t2098r1470b2163],
9	,	,	O	,	_	0	SENT_101	[p8l1405t2098r1470b2163],
10	et	FW	O	et	nn	11	SENT_101	[p8l1501t2104r1558b2151],
11	al	FW	O	al	appos	2	SENT_101	[p8l1587t2096r1656b2151],
12	:	:	O	:	_	0	SENT_101	[p8l1587t2096r1656b2151],
13	Association	NNP	O	Association	dep	2	SENT_101	[p8l1685t2096r2059b2151],
14	of	IN	O	of	_	0	SENT_101	[p8l2086t2096r2152b2151],
15	four	CD	NUMBER	four	num	17	SENT_101	[p8l9t2182r142b2237],
16	DNA	NN	MISC	dna	nn	17	SENT_101	[p8l170t2183r345b2236],
17	polymorphisms	NNS	O	polymorphism	prep_of	13	SENT_101	[p8l370t2182r856b2254],
18	with	IN	O	with	_	0	SENT_101	[p8l881t2182r1019b2237],
19	acute	JJ	O	acute	amod	20	SENT_101	[p8l1048t2190r1215b2237],
20	rejection	NN	O	rejection	prep_with	17	SENT_101	[p8l1244t2182r1524b2254],
21	after	IN	O	after	_	0	SENT_101	[p8l1553t2182r1701b2237],
22	kidney	NN	O	kidney	nn	23	SENT_101	[p8l1727t2182r1939b2254],
23	transplantation	NN	O	transplantation	prep_after	20	SENT_101	[p8l1965t2190r2146b2237, p8l8t2268r351b2340],
24	.	.	O	.	_	0	SENT_101	[p8l1965t2190r2146b2237, p8l8t2268r351b2340],

1	Transpl	NNP	O	Transpl	_	0	SENT_102	[p8l381t2268r626b2340],
2	Int	NNP	O	Int	dep	1	SENT_102	[p8l654t2270r745b2323],
3	21:879	CD	NUMBER	21:879	num	2	SENT_102	[p8l773t2269r994b2335],
4	,	,	O	,	_	0	SENT_102	[p8l773t2269r994b2335],
5	2008	CD	DATE	2008	num	2	SENT_102	[p8l1025t2269r1171b2323],

1	6	CD	NUMBER	6	_	0	SENT_103	[p8l86t2367r135b2421],
2	.	.	O	.	_	0	SENT_103	[p8l86t2367r135b2421],

1	Skorka	FW	MISC	skorka	_	0	SENT_104	[p8l180t2366r402b2421],
2	A	NN	MISC	a	dep	1	SENT_104	[p8l436t2367r509b2433],
3	,	,	O	,	_	0	SENT_104	[p8l436t2367r509b2433],
4	Bednarczuk	NN	O	bednarczuk	nn	5	SENT_104	[p8l548t2366r930b2421],
5	T	NN	O	t	appos	2	SENT_104	[p8l963t2367r1027b2433],
6	,	,	O	,	_	0	SENT_104	[p8l963t2367r1027b2433],
7	Bar-Andziak	JJ	O	bar-andziak	amod	8	SENT_104	[p8l1066t2366r1476b2421],
8	E	NN	O	e	appos	2	SENT_104	[p8l1511t2367r1576b2433],
9	,	,	O	,	_	0	SENT_104	[p8l1511t2367r1576b2433],
10	et	FW	O	et	nn	11	SENT_104	[p8l1617t2374r1674b2421],
11	al	FW	O	al	appos	2	SENT_104	[p8l1712t2366r1782b2421],
12	:	:	O	:	_	0	SENT_104	[p8l1712t2366r1782b2421],
13	Lymphoid	JJ	O	lymphoid	amod	19	SENT_104	[p8l1822t2366r2147b2438],
14	tyrosine	NN	O	tyrosine	nn	19	SENT_104	[p8l9t2451r261b2523],
15	phosphatase	NN	O	phosphatase	nn	19	SENT_104	[p8l292t2451r687b2523],
16	(	CD	NUMBER	(	num	19	SENT_104	[p8l722t2450r1215b2524],
17	PTPN22/LYP	NN	O	ptpn22/lyp	nn	19	SENT_104	[p8l722t2450r1215b2524],
18	)	NN	O	)	nn	19	SENT_104	[p8l722t2450r1215b2524],
19	variant	NN	O	variant	dep	2	SENT_104	[p8l1246t2451r1469b2506],
20	and	CC	O	and	_	0	SENT_104	[p8l1502t2451r1616b2506],
21	Graves	NN	O	grave	nn	23	SENT_104	[p8l1649t2452r1887b2506],
22	’	NN	O	’	nn	23	SENT_104	[p8l1649t2452r1887b2506],
23	disease	NN	O	disease	conj_and	19	SENT_104	[p8l1921t2451r2147b2506],
24	in	IN	O	in	_	0	SENT_104	[p8l9t2537r69b2591],
25	a	DT	O	a	det	27	SENT_104	[p8l121t2555r154b2592],
26	Polish	JJ	MISC	polish	amod	27	SENT_104	[p8l205t2537r399b2592],
27	population	NN	O	population	prep_in	23	SENT_104	[p8l449t2537r813b2609],
28	:	:	O	:	_	0	SENT_104	[p8l449t2537r813b2609],
29	association	NN	O	association	nn	33	SENT_104	[p8l869t2537r1218b2592],
30	and	CC	O	and	_	0	SENT_104	[p8l1271t2537r1385b2592],
31	gene	NN	O	gene	nn	33	SENT_104	[p8l1436t2555r1584b2609],
32	dose-dependent	JJ	O	dose-dependent	amod	33	SENT_104	[p8l1638t2537r2148b2609],
33	correlation	NN	O	correlation	dep	2	SENT_104	[p8l10t2622r360b2677],
34	with	IN	O	with	_	0	SENT_104	[p8l383t2622r521b2677],
35	age	NN	O	age	prep_with	33	SENT_104	[p8l549t2640r654b2694],
36	of	IN	O	of	_	0	SENT_104	[p8l683t2622r750b2677],
37	onset	NN	O	onset	prep_of	35	SENT_104	[p8l773t2630r957b2677],
38	.	.	O	.	_	0	SENT_104	[p8l773t2630r957b2677],

1	Clin	NNP	PERSON	Clin	nn	2	SENT_105	[p8l988t2622r1119b2677],
2	Endocrinol	NNP	PERSON	Endocrinol	_	0	SENT_105	[p8l1146t2622r1504b2677],
3	(	NN	O	(	nn	5	SENT_105	[p8l1533t2621r1720b2695],
4	Oxf	NN	O	oxf	nn	5	SENT_105	[p8l1533t2621r1720b2695],
5	)	NN	O	)	dep	2	SENT_105	[p8l1533t2621r1720b2695],
6	.	.	O	.	_	0	SENT_105	[p8l1533t2621r1720b2695],

1	622679	CD	NUMBER	622679	_	0	SENT_106	[p8l1751t2623r1971b2689],
2	,	,	O	,	_	0	SENT_106	[p8l1751t2623r1971b2689],
3	2005	CD	DATE	2005	num	4	SENT_106	[p8l2001t2622r2145b2677],
4	7	CD	NUMBER	7	dep	1	SENT_106	[p8l85t2721r135b2775],
5	.	.	O	.	_	0	SENT_106	[p8l85t2721r135b2775],

1	Miller	NNP	ORGANIZATION	Miller	nn	2	SENT_107	[p8l179t2720r374b2775],
2	SA	NNP	ORGANIZATION	SA	_	0	SENT_107	[p8l418t2720r529b2787],
3	,	,	O	,	_	0	SENT_107	[p8l418t2720r529b2787],
4	Dykes	NNP	PERSON	Dykes	nn	5	SENT_107	[p8l575t2720r770b2792],
5	DD	NNP	O	DD	appos	2	SENT_107	[p8l813t2721r948b2787],
6	,	,	O	,	_	0	SENT_107	[p8l813t2721r948b2787],
7	Polesky	NNP	O	Polesky	nn	8	SENT_107	[p8l994t2720r1237b2792],
8	HF	NNS	O	hf	appos	2	SENT_107	[p8l1279t2721r1400b2775],
9	:	:	O	:	_	0	SENT_107	[p8l1279t2721r1400b2775],
10	A	DT	O	a	det	11	SENT_107	[p8l1445t2721r1505b2774],
11	simple	JJ	O	simple	dep	2	SENT_107	[p8l1546t2720r1751b2792],
12	salting	VBG	O	salt	partmod	11	SENT_107	[p8l1796t2720r2001b2792],
13	out	RP	O	out	prt	12	SENT_107	[p8l2045t2728r2148b2775],
14	procedure	NN	O	procedure	dobj	12	SENT_107	[p8l9t2806r335b2878],
15	for	IN	O	for	_	0	SENT_107	[p8l355t2806r447b2861],
16	extracting	VBG	O	extract	prepc_for	12	SENT_107	[p8l467t2806r780b2878],
17	DNA	NN	O	dna	dobj	16	SENT_107	[p8l799t2807r975b2860],
18	from	IN	O	from	_	0	SENT_107	[p8l991t2806r1145b2861],
19	human	JJ	O	human	amod	21	SENT_107	[p8l1164t2806r1384b2861],
20	nucleated	JJ	O	nucleated	amod	21	SENT_107	[p8l1403t2806r1713b2861],
21	cells	NNS	O	cell	prep_from	16	SENT_107	[p8l1733t2806r1885b2861],
22	.	.	O	.	_	0	SENT_107	[p8l1733t2806r1885b2861],

1	Nucleic	JJ	O	nucleic	amod	2	SENT_108	[p8l1907t2806r2149b2861],
2	Acids	NNS	O	acid	_	0	SENT_108	[p8l8t2891r187b2946],
3	Res	NNP	O	Res	dep	2	SENT_108	[p8l216t2892r336b2946],
4	16:1215	CD	NUMBER	16:1215	num	3	SENT_108	[p8l368t2891r623b2957],
5	,	,	O	,	_	0	SENT_108	[p8l368t2891r623b2957],
6	1988	CD	DATE	1988	num	3	SENT_108	[p8l658t2892r800b2946],

1	8	CD	NUMBER	8	_	0	SENT_109	[p8l86t2989r135b3044],
2	.	.	O	.	_	0	SENT_109	[p8l86t2989r135b3044],

1	Wang	NNP	PERSON	Wang	nn	2	SENT_110	[p8l178t2990r365b3060],
2	J	NNP	PERSON	J	_	0	SENT_110	[p8l395t2990r442b3055],
3	,	,	O	,	_	0	SENT_110	[p8l395t2990r442b3055],
4	Yang	NNP	PERSON	Yang	nn	5	SENT_110	[p8l476t2990r646b3060],
5	JW	NNP	PERSON	JW	appos	2	SENT_110	[p8l676t2990r798b3055],
6	,	,	O	,	_	0	SENT_110	[p8l676t2990r798b3055],
7	Zeevi	NNP	PERSON	Zeevi	nn	8	SENT_110	[p8l832t2988r1011b3043],
8	A	NNP	O	A	appos	2	SENT_110	[p8l1040t2989r1114b3055],
9	,	,	O	,	_	0	SENT_110	[p8l1040t2989r1114b3055],
10	et	FW	O	et	nn	11	SENT_110	[p8l1149t2996r1206b3043],
11	al	FW	O	al	appos	2	SENT_110	[p8l1239t2988r1309b3043],
12	:	:	O	:	_	0	SENT_110	[p8l1239t2988r1309b3043],
13	IMPDH1	NN	O	impdh1	nn	15	SENT_110	[p8l1345t2989r1643b3043],
14	gene	NN	O	gene	nn	15	SENT_110	[p8l1678t3006r1826b3060],
15	polymorphisms	NNS	O	polymorphism	dep	2	SENT_110	[p8l1857t2988r2146b3060, p8l8t3073r228b3145],
16	and	CC	O	and	_	0	SENT_110	[p8l271t3073r386b3128],
17	association	NN	O	association	dep	2	SENT_110	[p8l428t3073r777b3128],
18	with	IN	O	with	_	0	SENT_110	[p8l813t3073r952b3128],
19	acute	JJ	O	acute	amod	20	SENT_110	[p8l994t3081r1161b3128],
20	rejection	NN	O	rejection	prep_with	15	SENT_110	[p8l1203t3073r1484b3145],
21	in	IN	O	in	_	0	SENT_110	[p8l1524t3073r1583b3128],
22	renal	JJ	O	renal	amod	24	SENT_110	[p8l1623t3073r1786b3128],
23	transplant	NN	O	transplant	nn	24	SENT_110	[p8l1826t3073r2148b3145],
24	patients	NNS	O	patient	prep_in	20	SENT_110	[p8l8t3158r277b3230],
25	.	.	O	.	_	0	SENT_110	[p8l8t3158r277b3230],

1	Clin	NNP	O	Clin	nn	2	SENT_111	[p8l310t3158r441b3214],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_111	[p8l468t3158r810b3213],
3	Ther	NNP	O	Ther	dep	2	SENT_111	[p8l838t3158r993b3213],
4	83:711	CD	NUMBER	83:711	num	3	SENT_111	[p8l1021t3159r1242b3225],
5	,	,	O	,	_	0	SENT_111	[p8l1021t3159r1242b3225],
6	2008	CD	DATE	2008	num	3	SENT_111	[p8l1272t3159r1418b3214],

1	9	CD	NUMBER	9	_	0	SENT_112	[p8l86t3258r135b3312],
2	.	.	O	.	_	0	SENT_112	[p8l86t3258r135b3312],

1	Sombogaard	JJ	O	sombogaard	amod	2	SENT_113	[p8l180t3257r581b3329],
2	F	NN	O	f	_	0	SENT_113	[p8l613t3259r673b3324],
3	,	,	O	,	_	0	SENT_113	[p8l613t3259r673b3324],
4	van	NN	PERSON	van	nn	6	SENT_113	[p8l704t3275r817b3312],
5	Schaik	NNP	PERSON	Schaik	nn	6	SENT_113	[p8l850t3257r1060b3312],
6	RH	NNP	O	RH	appos	2	SENT_113	[p8l1091t3259r1223b3324],
7	,	,	O	,	_	0	SENT_113	[p8l1091t3259r1223b3324],
8	Mathot	NNP	PERSON	Mathot	nn	9	SENT_113	[p8l1258t3257r1494b3312],
9	RA	NN	O	ra	appos	2	SENT_113	[p8l1527t3258r1655b3324],
10	,	,	O	,	_	0	SENT_113	[p8l1527t3258r1655b3324],
11	et	FW	O	et	nn	12	SENT_113	[p8l1690t3265r1748b3312],
12	al	FW	O	al	appos	2	SENT_113	[p8l1782t3257r1851b3312],
13	:	:	O	:	_	0	SENT_113	[p8l1782t3257r1851b3312],
14	Interpatient	JJ	O	interpatient	amod	15	SENT_113	[p8l1888t3259r2146b3329, p8l9t3343r155b3398],
15	variability	NN	O	variability	nsubjpass	25	SENT_113	[p8l187t3343r506b3415],
16	in	IN	O	in	_	0	SENT_113	[p8l541t3343r600b3397],
17	IMPDH	NN	O	impdh	nn	18	SENT_113	[p8l636t3345r900b3397],
18	activity	NN	O	activity	prep_in	15	SENT_113	[p8l937t3343r1162b3415],
19	in	IN	O	in	_	0	SENT_113	[p8l1196t3343r1255b3397],
20	MMF-treated	JJ	O	mmf-treated	amod	23	SENT_113	[p8l1292t3343r1732b3398],
21	renal	JJ	O	renal	amod	23	SENT_113	[p8l1768t3343r1929b3398],
22	transplant	NN	O	transplant	nn	23	SENT_113	[p8l1965t3351r2146b3398, p8l8t3429r171b3501],
23	patients	NNS	O	patient	prep_in	18	SENT_113	[p8l216t3429r468b3501],
24	is	VBZ	O	be	auxpass	25	SENT_113	[p8l515t3429r560b3484],
25	correlated	VBN	O	correlate	dep	2	SENT_113	[p8l607t3429r932b3484],
26	with	IN	O	with	_	0	SENT_113	[p8l975t3429r1113b3484],
27	IMPDH	NN	O	impdh	nn	28	SENT_113	[p8l1159t3431r1423b3483],
28	type	NN	O	type	nn	33	SENT_113	[p8l1469t3437r1601b3501],
29	II	CD	NUMBER	ii	num	30	SENT_113	[p8l1649t3431r1702b3483],
30	3757T	NN	O	3757t	npadvmod	31	SENT_113	[p8l1749t3429r1946b3484],
31	>	JJR	O	>	amod	33	SENT_113	[p8l1996t3437r2046b3480],
32	C	NN	O	c	nn	33	SENT_113	[p8l2099t3430r2149b3484],
33	polymorphism	NN	O	polymorphism	prep_with	25	SENT_113	[p8l8t3515r483b3587],
34	.	.	O	.	_	0	SENT_113	[p8l8t3515r483b3587],

1	Pharmacogenet	NNP	MISC	Pharmacogenet	_	0	SENT_114	[p8l514t3515r1012b3587],
2	Genomics	NNP	MISC	Genomics	dep	1	SENT_114	[p8l1042t3515r1360b3570],
3	19:626	CD	NUMBER	19:626	num	2	SENT_114	[p8l1393t3516r1611b3582],
4	,	,	O	,	_	0	SENT_114	[p8l1393t3516r1611b3582],
5	2009	CD	DATE	2009	num	2	SENT_114	[p8l1641t3516r1787b3570],

1	10	CD	NUMBER	10	_	0	SENT_115	[p9l89t20r173b75],
2	.	.	O	.	_	0	SENT_115	[p9l89t20r173b75],

1	Winnicki	NNP	MISC	Winnicki	nn	2	SENT_116	[p9l215t20r503b75],
2	W	NNP	O	W	_	0	SENT_116	[p9l546t21r635b87],
3	,	,	O	,	_	0	SENT_116	[p9l546t21r635b87],
4	Weigel	NNP	PERSON	Weigel	nn	5	SENT_116	[p9l681t20r905b92],
5	G	NNP	PERSON	G	appos	2	SENT_116	[p9l951t20r1023b87],
6	,	,	O	,	_	0	SENT_116	[p9l951t20r1023b87],
7	Sunder-Plassmann	NNP	O	Sunder-Plassmann	nn	8	SENT_116	[p9l1071t20r1664b75],
8	G	NNP	O	G	appos	5	SENT_116	[p9l1710t20r1783b87],
9	,	,	O	,	_	0	SENT_116	[p9l1710t20r1783b87],
10	et	FW	O	et	dep	5	SENT_116	[p9l1830t28r1888b75],
11	211	CD	NUMBER	211	dep	5	SENT_116	[p9l1933t20r2003b75],
12	:	:	O	:	_	0	SENT_116	[p9l1933t20r2003b75],
13	An	DT	O	a	det	14	SENT_116	[p9l2049t21r2148b74],
14	inosine	NN	O	inosine	dep	5	SENT_116	[p9l9t106r236b161],
15	5	CD	NUMBER	5	num	14	SENT_116	[p9l300t106r901b178],
16	’	SYM	O	’	dep	19	SENT_116	[p9l300t106r901b178],
17	-	:	O	-	_	0	SENT_116	[p9l300t106r901b178],
18	monophosphate	NN	O	monophosphate	nn	19	SENT_116	[p9l300t106r901b178],
19	dehydrogenase	NN	O	dehydrogenase	dep	14	SENT_116	[p9l966t106r1442b178],
20	2	CD	NUMBER	2	num	22	SENT_116	[p9l1507t107r1542b160],
21	single-nucleotide	JJ	O	single-nucleotide	amod	22	SENT_116	[p9l1605t106r2147b178],
22	polymorphism	NN	O	polymorphism	nsubj	23	SENT_116	[p9l8t192r467b264],
23	impairs	VBZ	O	impair	rcmod	19	SENT_116	[p9l503t192r737b264],
24	the	DT	O	the	det	25	SENT_116	[p9l774t192r872b247],
25	effect	NN	O	effect	dobj	23	SENT_116	[p9l910t192r1081b247],
26	of	IN	O	of	_	0	SENT_116	[p9l1117t192r1183b247],
27	mycophenolic	JJ	O	mycophenolic	amod	28	SENT_116	[p9l1214t192r1657b264],
28	acid	NN	O	acid	prep_of	25	SENT_116	[p9l1693t192r1836b247],
29	.	.	O	.	_	0	SENT_116	[p9l1693t192r1836b247],

1	Pharmacogenomics	NNS	MISC	pharmacogenomic	_	0	SENT_117	[p9l1875t192r2146b247, p9l10t278r380b350],
2	J	NNP	O	J	dep	1	SENT_117	[p9l407t279r438b333],
3	10:70	CD	NUMBER	10:70	num	2	SENT_117	[p9l470t279r650b345],
4	,	,	O	,	_	0	SENT_117	[p9l470t279r650b345],
5	2010	CD	DATE	2010	num	2	SENT_117	[p9l681t279r827b333],

